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Abstract  
All organisms contain RNA ligases for the modification or repair of RNA molecules.  The 
RtcB family have a novel 3ʹ-5ʹ RNA ligase activity and are conserved in all three domains of 
life.  Metazoan homologues of RtcB have essential roles in tRNA maturation and the 
unfolded protein response.  In E. coli, expression of RtcB from the σ54-dependent rtcBA 
operon is regulated by transcriptional activator RtcR.  Neither the signals that induce rtcB 
expression nor the natural substrates of RtcB in E. coli are known.  The objective of this 
project is to understand the regulation of rtcB expression by RtcR and the biological function 
of RtcB in E. coli. 
In this study, we confirm the roles of RtcR and σ54 in rtcB transcription in E. coli.  Using a 
series of truncated rtcBA promoter fusions with the reporter gene lacZ, we have identified an 
inverted repeat that we hypothesise is the RtcR binding site in the promoter of rtcB.  Mutation 
of the inverted repeat supports its involvement in RtcR binding.  Using a similar approach, we 
have identified a possible σ70 promoter responsible for transcription of rtcR and provide 
evidence of negative autoregulation of rtcR.  Moreover, we also demonstrate for the first time 
the requirement of IHF for RtcR-dependent transcription of rtcB and confirm the putative 
binding site of IHF in the rtcBA promoter in vivo and in vitro.   
Using a combination of genetic screening with a chromosomal rtcBA-lacZ fusion and 
quantitative PCR analysis, we have uncovered several conditions where transcription of rtcB 
is activated in E. coli.  Expression of Rof, an inhibitor of Rho transcription termination, 
induced rtcB transcription in an RtcR-dependent manner, indicating a possible link between 
RtcB function and disruption of transcription termination.  Furthermore, treatment of cells 
with chloramphenicol and induction of endoribonuclease MazF increased rtcB transcription, 
suggesting that RtcB may respond to the translational status of the cell.  We have used these 
conditions to perform CRAC (crosslinking and analysis of cDNA) of RtcB, in order to 
identify substrate RNAs that interact with RtcB in vivo.  Many interactions between RtcB and 
RNAs were identified including rRNAs, tRNAs, sRNAs and mRNAs and several candidates 
were further analysed by qPCR.   
Taken together, the data suggests that rtcB has features typical of a σ54-dependent promoter 
and that RtcB expression can be activated in a variety of stress conditions, thereby allowing 
interaction with a range of cellular RNAs in E. coli.  Nevertheless, the specific signal(s) 
detected by RtcR and the biological function of RtcB in E. coli remain elusive.  
ii 
 
Acknowledgements  
I would like to thank my supervisor Kenn Gerdes for the opportunity to work on this project 
and for help and guidance throughout.  I also thank Kristoffer Winther for useful scientific 
discussions and help with experimental procedures.  I am grateful to Kathryn Turnbull for 
many useful discussions, scientific and otherwise.  I also acknowledge and thank past and 
present members of the Gerdes group for their support, technical expertise and suggestions.   
I am grateful to members of the Centre for Bacterial Cell Biology, Newcastle University and 
the Centre for Bacterial Stress Response and Persistence, University of Copenhagen for 
providing a welcoming and stimulating work environment.  I thank Michael Sørensen and his 
group (University of Copenhagen) for an interesting collaboration. 
Finally, I thank Mick Hollier, Susan Hann and David Hann for their constant love, 
encouragement and moral support.   
  
iii 
 
Contents 
Abstract .................................................................................................................................... i 
Acknowledgements ................................................................................................................. ii 
Contents ................................................................................................................................. iii 
List of figures ........................................................................................................................ vii 
List of tables ........................................................................................................................... ix 
Abbreviations .......................................................................................................................... x 
Chapter 1 Introduction ....................................................................................................... 1 
 Overview ...................................................................................................................... 1 1.1
 Promoter recognition in bacterial transcription ........................................................... 2 1.2
1.2.1 Bacterial transcription and the RNA polymerase holoenzyme ............................ 2 
1.2.2 The σ factor of RNA polymerase holoenzyme ..................................................... 3 
 Sigma 54-dependent transcription ............................................................................... 5 1.3
1.3.1 Mode of transcription initiation by σ54-associated RNAP .................................... 5 
1.3.2 Bacterial enhancer binding proteins ..................................................................... 8 
1.3.2.1 ATPase domain of bEBPs ............................................................................. 8 
1.3.2.2 Regulatory domain of bEBPs ...................................................................... 10 
1.3.2.3 DNA binding domain of bEBPs .................................................................. 11 
1.3.3 The role of integration host factor in σ54-dependent transcription ..................... 13 
1.3.4 The σ54 regulon ................................................................................................... 14 
 Sigma 54-dependent transcription of the rtcBA operon in E. coli ............................. 14 1.4
1.4.1 Features of the rtcBA promoter .......................................................................... 14 
1.4.2 RtcR, the bEBP of the rtcBA operon .................................................................. 15 
 The RNA ligase RtcB ................................................................................................ 17 1.5
1.5.1 Types and functions of RNA ligases .................................................................. 17 
1.5.1.1 5ʹ-3ʹ RNA ligases ........................................................................................ 17 
1.5.1.2 2ʹ-5ʹ RNA ligases ........................................................................................ 19 
1.5.1.3 3ʹ-5ʹ RNA ligases ........................................................................................ 20 
iv 
 
1.5.2 Mechanism of action of RtcB ............................................................................. 20 
1.5.3 Additional activities of RtcB in DNA modification ........................................... 24 
 Function and conservation of RtcB ........................................................................... 24 1.6
1.6.1 Members of the RtcB family are present in all domains of life ......................... 24 
1.6.2 Function in eukaryotes and archaea.................................................................... 25 
1.6.2.1 tRNA maturation ......................................................................................... 25 
1.6.2.2 The unfolded protein response .................................................................... 27 
1.6.2.3 Other indications of function ...................................................................... 29 
1.6.3 Function in bacteria ............................................................................................ 32 
1.6.4 Genes commonly associated with rtcB in bacteria ............................................. 34 
1.6.4.1 The RNA cyclase RtcA ............................................................................... 34 
1.6.4.2 Ro, an RNA scavenger ................................................................................ 36 
1.6.4.3 The RtcB cofactor archease......................................................................... 37 
 Aims of this work ...................................................................................................... 38 1.7
Chapter 2 Materials and methods .................................................................................... 39 
 Bacterial strains, media and growth conditions ......................................................... 39 2.1
 Standard DNA procedures ......................................................................................... 39 2.2
 Strain construction ..................................................................................................... 46 2.3
 Plasmid construction .................................................................................................. 50 2.4
2.4.1 Transcriptional fusions ....................................................................................... 50 
2.4.2 Overexpression of rtc genes ............................................................................... 55 
2.4.3 Expression of tagged rtc genes ........................................................................... 56 
2.4.4 Others ................................................................................................................. 57 
 Preparation and transformation of TSB chemically competent cells......................... 59 2.5
 Preparation and electroporation of competent cells ................................................... 59 2.6
 Genomic DNA purification ....................................................................................... 59 2.7
 Genomic DNA library construction ........................................................................... 60 2.8
 Mapping transposon insertion sites ............................................................................ 60 2.9
 Beta-galactosidase assay ............................................................................................ 61 2.10
v 
 
 Total RNA purification .............................................................................................. 61 2.11
 Quantitative PCR ....................................................................................................... 62 2.12
 Protein purification of His6-tagged RtcR and IHF ..................................................... 63 2.13
 Electrophoretic mobility shift assay........................................................................... 64 2.14
 CRAC analysis ........................................................................................................... 65 2.15
 Western blot analysis ................................................................................................. 67 2.16
Chapter 3 Regulation of the rtcBA operon ...................................................................... 68 
 Introduction ................................................................................................................ 68 3.1
 Results ........................................................................................................................ 69 3.2
3.2.1 The rtcBA operon behaves as a typical σ54-dependent promoter ....................... 69 
3.2.1.1 Confirmation of RtcR-dependency of rtcBA transcription ......................... 69 
3.2.1.2 Confirmation of σ54-dependency of rtcBA transcription ............................. 69 
3.2.2 Identification of an RtcR binding region in the rtcBA promoter ........................ 70 
3.2.2.1 Identification of minimal promoter requirements for rtcBA transcription .. 70 
3.2.2.2 Mutagenesis reveals an inverted repeat important for RtcR-dependent rtcBA 
transcription ................................................................................................................... 74 
3.2.2.3 Purification of RtcR and in vitro analysis of rtcBA promoter binding ........ 75 
3.2.3 IHF-dependency of rtcBA transcription ............................................................. 79 
3.2.3.1 IHF is required for RtcR-dependent rtcBA transcription ............................ 79 
3.2.3.2 IHF binding sites are functional in mediating rtcBA transcription ............. 81 
3.2.3.3 IHF binds to rtcBA promoter DNA in vitro ................................................ 84 
3.2.4 Regulation of rtcR transcription ......................................................................... 87 
3.2.4.1 Mapping the rtcR promoter ......................................................................... 87 
3.2.4.2 Evidence of negative auto-regulation of rtcR transcription ........................ 88 
 Discussion .................................................................................................................. 90 3.3
Chapter 4 Activation of rtcBA transcription in E. coli .................................................... 96 
 Introduction ................................................................................................................ 96 4.1
 Results ........................................................................................................................ 96 4.2
4.2.1 The rtc genes are non-essential for growth in laboratory conditions ................. 96 
4.2.2 Genetic screening for regulators of rtcBA expression ........................................ 97 
vi 
 
4.2.2.1 Screening for inhibitors of rtcBA transcription ........................................... 97 
4.2.2.2 Screening for activators of rtcBA transcription ........................................... 98 
4.2.3 Rof overexpression activates rtcBA transcription ............................................ 100 
4.2.4 Agents that target translation induce rtcB transcription ................................... 105 
4.2.4.1 Chloramphenicol treatment activates rtcB transcription ........................... 105 
4.2.4.2 MazF activates rtcB transcription ............................................................. 108 
 Discussion ................................................................................................................ 110 4.3
Chapter 5 Function of RtcB in E. coli ........................................................................... 116 
 Introduction .............................................................................................................. 116 5.1
 Results ...................................................................................................................... 117 5.2
5.2.1 CRAC of RtcB .................................................................................................. 117 
5.2.1.1 Experimental procedure and high throughput sequencing ........................ 117 
5.2.1.2 Identification of candidate RNA targets of RtcB ...................................... 118 
5.2.1.3 RNAs identified by CRAC are unaffected by deletion of rtcB ................. 123 
5.2.2 No evidence for regulation of ribosomal RNA by RtcB .................................. 128 
5.2.2.1 RtcB does not influence rRNA levels in standard conditions ................... 128 
5.2.2.2 RtcB does not repair rRNA following amino acid starvation ................... 128 
 Discussion ................................................................................................................ 130 5.3
Chapter 6 Summary and perspectives ........................................................................... 134 
Appendix A ......................................................................................................................... 138 
Appendix B ......................................................................................................................... 139 
References ........................................................................................................................... 140 
 
  
vii 
 
List of figures 
Figure 1  The σ cycle. ................................................................................................................. 4 
Figure 2  Regions and functions of σ54. ...................................................................................... 4 
Figure 3  Structures of the σ54. ................................................................................................... 7 
Figure 4  Initiation of transcription at σ54-dependent promoters. ............................................... 9 
Figure 5  Negative regulation of the ATPase activity of bEBPs. ............................................. 12 
Figure 6  Organisation and features of the σ54-dependent rtcBA operon of E. coli. ................. 16 
Figure 7  Mechanism of RNA ligation by RtcB. ...................................................................... 23 
Figure 8  The role of RtcB in metazoan tRNA splicing. .......................................................... 30 
Figure 9  The role of RtcB in the IRE1 pathway of the UPR. .................................................. 30 
Figure 10  Expression of a mutant form of RtcR, RtcRΔN, activates rtcBA transcription. ..... 71 
Figure 11  Deletion of rpoN reduces the growth rate of E. coli MG1655. ............................... 72 
Figure 12  Construction of transcriptional lacZ fusions. .......................................................... 73 
Figure 13  Promoter requirements for rtcBA transcription. ...................................................... 76 
Figure 14  Mutations in rtcO of the rtcBA promoter reduce transcription. .............................. 78 
Figure 15  Protein purification of RtcR. ................................................................................... 80 
Figure 16  Purified RtcR is unable to bind promoter rtcBA DNA in vitro. .............................. 80 
Figure 17  Transcription of rtcBA is dependent on the presence of functional IHF................. 82 
Figure 18  Mutations in IHF binding sites reduce rtcBA transcription. ................................... 85 
Figure 19  Protein purification of IHF. ..................................................................................... 86 
Figure 20  Purified IHF binds to rtcBA promoter DNA in vitro. ............................................. 86 
Figure 21  Promoter requirements for rtcR transcription. ........................................................ 90 
Figure 22  Negative autoregulation of rtcR transcription. ........................................................ 91 
Figure 23  Deletion of the rtc genes has no effect on growth of E. coli MG1655. .................. 99 
Figure 24  Activation of the transcriptional rtcBA-lacZ fusion by the yaeP-rof-tilS locus is 
RtcR dependent. ..................................................................................................................... 103 
Figure 25  Expression of Rof induces transcription of the rtcBA-lacZ fusion in an RtcR-
dependent manner. .................................................................................................................. 104 
Figure 26  Transcription of the rtcBA-lacZ fusion increases concurrently with a reduction in 
growth of E. coli strains during Rof expression. .................................................................... 106 
Figure 27  Levels of rtcB mRNA increase during treatment with chloramphenicol. ............. 107 
Figure 28  Levels of rtcB mRNA increase during MazF expression. .................................... 111 
Figure 29  RtcB mediates recovery of growth following MazF expression. .......................... 112 
viii 
 
Figure 30  Deletion of rtcB has no effect on cell viability during MazF expression. ............ 113 
Figure 31  CRAC of RtcB in E. coli. ...................................................................................... 119 
Figure 32  Overview of interactions between RtcB and RNAs identified by CRAC. ........... 122 
Figure 33  Interactions between RtcB and RNAs encoding 50S ribosome proteins in E. coli.
 ................................................................................................................................................ 124 
Figure 34  Interactions between RtcB and RNA encoding 30S ribosome proteins in E. coli.
 ................................................................................................................................................ 125 
Figure 35  Other interactions between RtcB and RNA in E. coli.. ......................................... 126 
Figure 36  Stability of RNAs crosslinked to RtcB are unchanged upon deletion of rtcB. ..... 127 
Figure 37  Stability of rRNA is unchanged upon deletion of rtcB. ........................................ 129 
Figure 38  Overview of the regulation and function of the rtcBA operon of E. coli. ............. 137 
 
  
ix 
 
List of tables 
Table 1  Strains used in this study ............................................................................................ 40 
Table 2  Plasmids used in this study ......................................................................................... 41 
Table 3  Oligonucleotides used in this study ............................................................................ 43 
Table 4  Oligonucleotides used in this study for qPCR ............................................................ 62 
Table 5  Candidate genes for inhibiting rtcBA transcription. ................................................... 99 
Table 6  Candidate genes for inducing rtcBA transcription.................................................... 102 
Table 7  Summary of RNAs identified by CRAC of RtcB during chloramphenicol treatment 
or MazF expression or both. ................................................................................................... 121 
 
  
x 
 
Abbreviations  
A Adenosine 
AAA+ ATPase associated with various cellular activities 
Amp Ampicillin 
AMP Adenosine monophosphate 
aSD Anti-Shine-Dalgarno 
ATP Adenosine triphosphate 
bEBP Bacterial enhancer binding protein 
bp Base pairs(s) 
C Cytidine 
CARF CRISPR-associated Rossmann fold 
CFU Colony forming units 
Cml Chloramphenicol 
CRAC Crosslinking and analysis of cDNA 
DNA Deoxyribonucleic acid 
ds Double-stranded 
EBP Enhancer binding protein 
ECM Extracellular matrix 
EMSA Electrophoretic mobility shift assay 
ER Endoplasmic reticulum 
G Guanosine 
GMP Guanosine monophosphate 
GTP Guanosine triphosphate 
HTH Helix-turn-helix 
IHF Integration host factor 
IPTG Isopropyl-β-D-1-thiogalactopyranoside 
IR Inverted repeat 
Kan Kanamycin 
Kb Kilobases 
LB Lysogeny broth 
MCS Multiple cloning site 
mRNA Messenger RNA 
NA Nutrient agar 
xi 
 
Nt Nucleotide 
NTP Nucleoside triphosphate 
OD Optical density 
ON Over night 
ORF Open reading frame 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PNPase Polynucleotide phosphorase 
qPCR Quantitative PCR 
RNA Ribonucleic acid 
RNAi RNA interference 
RNAL RNA ligase 
RNAP RNA polymerase 
rRNA Ribosomal RNA 
RT Room temperature 
RT-PCR Reverse-transcription PCR 
Rtc RNA terminal cyclase 
SD Shine-Dalgarno 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
sRNA Small RNA 
siRNA Small interfering RNA 
σ Sigma factor 
T Thymidine 
TA Toxin-antitoxin 
tRNA Transfer RNA 
ts Temperature sensitive 
U Uridine 
UAS Upstream activating sequence 
UPR Unfolded protein response 
wHTH Winged helix-turn-helix 
WT Wild-type 
X-gal 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
 
1 
 
Chapter 1 Introduction 
 Overview 1.1
The rtcB gene is highly conserved with homologues in eukaryotes, archaea and bacteria 
(Englert et al., 2011; Popow et al., 2012).  In Escherichia coli K-12, rtcB is part of the rtcBA 
operon and is expressed from a promoter regulated by the alternative sigma factor σ54 
(Genschik et al., 1998).  Initiation of transcription from a σ54-dependent promoter requires a 
transcriptional activator, which is itself activated by the detection of metabolic or 
environmental signals (Bush and Dixon, 2012).  Accordingly, transcription from the rtcBA 
promoter requires the product of neighbouring gene rtcR (Genschik et al., 1998).  RtcR and 
other transcriptional activators of σ54-dependent transcription are known as bacterial enhancer 
binding proteins (bEBPs), owing to functional similarity with eukaryotic enhancer binding 
proteins (EBPs) of RNA polymerase (RNAP) II (Ghosh et al., 2010).  bEBPs are a subgroup 
of the AAA+ (ATPase associated with various cellular activities) family of proteins and 
initiate transcription from σ54–dependent promoters by binding to upstream activating 
sequences (UASs) and interacting with the RNAP holoenzyme to facilitate open promoter 
complex formation (Bush and Dixon, 2012).  A signal sensory component of bEBPs restricts 
this activity to appropriate cellular conditions.  Despite extensive knowledge about the 
process of σ54–dependent transcription in general, little is known regarding the regulation of 
σ54–dependent rtcBA transcription by RtcR. 
The protein product of the rtcB gene was demonstrated to have activity as an RNA ligase 
(RNAL) by Tanaka and Shuman (2011).  RNALs are ubiquitous enzymes involved in 
modification or repair of RNA molecules by joining breaks in the backbone of RNA to create 
phosphodiester bonds (Burroughs and Aravind, 2016; Pascal, 2008; Popow et al., 2012).  The 
RtcB family of RNALs catalyse RNA ligation by a novel mechanism (Chakravarty and 
Shuman, 2012; Chakravarty et al., 2012; Tanaka et al., 2011a), which, when combined with 
their high degree of conservation, suggests they have an important role in RNA modification.  
Indeed, recent studies have identified essential roles for metazoan RtcB in transfer (t)RNA 
maturation, ligating tRNA halves following endonuclease-mediated intron excision (Popow et 
al., 2011), and in the splicing of XBP-1 messenger (m)RNA after intron removal by IRE1 
endonuclease, generating an active transcription factor in the unfolded protein response 
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(UPR) (Jurkin et al., 2014; Kosmaczewski et al., 2014; Lu et al., 2014).  However, the extent 
of its biological function is unclear, particularly in bacteria. 
This chapter provides an overview of the current state of knowledge regarding the regulation, 
mechanism of action and function of RtcB.  Section 1.2 gives a general introduction to 
bacterial transcription and the role of σ factors in promoter specification.  In Section 1.3, the 
characteristics of σ54–dependent transcription and the σ54 regulon are discussed, while Section 
1.4 describes the genetic organisation and regulatory components of the rtcBA operon in E. 
coli.  The classification and mechanism of action of RNALs are outlined in Section 1.5, with 
particular focus on the RtcB family.  Section 1.6 concerns the conservation and known 
physiological functions of RtcB and the function of genes associated with bacterial rtcB.  
Finally, the aims of the study are outlined in Section 1.7. 
 Promoter recognition in bacterial transcription 1.2
1.2.1 Bacterial transcription and the RNA polymerase holoenzyme 
Gene transcription is a fundamental and highly regulated process that defines the ability of 
cells to grow in and adapt to their surroundings.  In all free living organisms, it is executed by 
the DNA-dependent multi-subunit enzyme RNAP, which shares structural and functional 
similarity in all domains of life despite differences in complexity (Sekine et al., 2012).  There 
are three main phases of transcription: initiation, which involves promoter recognition and 
binding, polymerisation of the first few ribonucleotides and promoter clearance by RNAP; 
elongation, whereby ribonucleotides are sequentially added to the growing RNA transcript 
according to the sequence of the DNA template; and termination, where RNAP reaches the 
end of the gene and dissociates from the DNA template, releasing the RNA (Weaver, 2012). 
Whereas the majority of eukaryotes have three RNAP enzymes, specialising in transcription 
of ribosomal (r)RNA, mRNA or tRNA respectively, bacterial organisms utilise a single 
RNAP to achieve transcription of all classes of RNA (Weaver, 2012).  The core bacterial 
RNAP consists of five subunits, β, βʹ, two α and ω, which together are competent for RNA 
synthesis from a DNA template alone.  However, in order to mediate initiation of 
transcription, an additional subunit is required, known as the σ or ‘specificity’ factor, which 
associates with core RNAP to form the RNAP holoenzyme (Burgess and Travers, 1969; 
Ghosh et al., 2010).  
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1.2.2 The σ factor of RNA polymerase holoenzyme 
An essential regulatory component of bacterial transcription, the σ factor directs and initiates 
promoter-specific transcription by associating with core RNAP and recognising conserved 
motifs upstream of the transcription start site to enable engagement with the promoter.  In 
addition, the σ factor mediates transition from a closed promoter complex with RNAP to an 
open promoter complex, initiating strand separation of duplex DNA.  The roles of σ factors in 
transcription initiation are reviewed by Feklistov et al. (2014) and Saecker et al. (2011).  The 
σ factor dissociates from core RNAP in a stochastic manner, facilitated by competition for 
interaction with RNAP from the elongating RNA transcript, usually during the early 
elongation phase of transcription (Shimamoto et al., 1986; Yang and Lewis, 2010).  
Following its release from RNAP, it re-joins the cellular pool of σ factors and is free to 
compete for binding to other core RNAPs (Mooney et al., 2005; Travers and Burgess, 1969).  
This recycling process is known as the σ cycle, as depicted in Figure 1. 
There are usually multiple σ factors within an organism, each recognising distinct promoter 
sequences to mediate promoter selectivity and differential gene transcription by RNAP.  A 
primary σ factor is responsible for the majority of transcription initiation, including general 
‘housekeeping’ genes necessary for growth, while a variable number of alternative σ factors 
direct transcription of specific subsets of stress-response genes (Ghosh et al., 2010; Mooney 
et al., 2005).  The differing promoter specificities of σ factors, in combination with the 
processes regulating their availability in the σ factor pool and thereby driving competition for 
RNAP binding in the σ cycle, allow bacteria to adjust the transcription profile of the cell in 
response to changes in environmental conditions.  The regulatory mechanisms that govern σ 
factor interaction with RNAP are reviewed by Osterberg et al. (2011). 
There are two classes of σ factor, grouped according to primary sequence similarity, 
consensus sequence of the DNA elements they recognise and their mode of activation.  The 
majority belong to the σ70 class, named for the primary σ factor of E. coli and are further sub-
divided according to their possession of the four domains conserved in housekeeping σ factors 
(Wosten, 1998).  In contrast to the diversity of the σ70 class, σ54 is the sole member of the σ54 
class but is widely dispersed among bacteria, with approximately 60% of bacteria encoding at 
least one σ54 gene (Wigneshweraraj et al., 2008).  As discussed in Section 1.3, σ54 has a 
distinct mechanism of transcription initiation to σ factors of the σ70 class, recognising 
promoter sequences that differ in position, sequence and spacing to σ70 and require additional 
regulatory components.  
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Figure 1  The σ cycle. 
Sigma (σ) factors compete for binding to core RNA polymerase.  Once the RNAP holoenzyme is 
formed, the σ factor mediates promoter engagement and formation of an open promoter complex 
(OC).  The σ factor is released stochastically from the elongating complex (EC) and returns to the σ 
factor pool.  RNAP interacts with other regulatory factors during the elongation and termination 
phases of transcription, such as NusA, which is involved in transcription termination and 
antitermination.  Taken from Mooney et al. (2005). 
 
 
 
Figure 2  Regions and functions of σ54. 
σ54 is divided into three regions.  Region I, at the N-terminal, mediates interactions with transcriptional 
activators of σ54-dependent transcription, known as bEBPs.  It also contacts the -12 promoter DNA 
element and has interactions with core RNA polymerase (not shown).  Region II links regions I and 
III.  C-terminal region III contains the main core RNA polymerase-binding domains and is also 
responsible for interaction with promoter elements at -24 and -12, as indicated in the green boxes 
where the highly conserved GG and GC motifs are underlined.  Taken from Osterberg et al. (2011). 
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E. coli has seven σ factors: primary factor σ70 and six alternatives.  Five of these, σ38, σ32, σ28, 
σ24 and σ19, belong to the σ70 class and transcribe genes involved in the stationary phase of 
growth, response to heat shock, motility, response to stress on membrane proteins and ferric 
citrate transport respectively (Ishihama, 2000).  Alternative factor σ54 transcribes genes in 
response to nitrogen limitation and other stresses, as discussed in the next section.  As the 
housekeeping σ factor, σ70 is the most abundant with the strongest binding affinity for core 
RNAP, occupying an estimated 78% of holoenzymes during exponential growth, while σ54-
associated RNAP constitutes 8% (Ishihama, 2000; Maeda et al., 2000). 
 Sigma 54-dependent transcription 1.3
1.3.1 Mode of transcription initiation by σ54-associated RNAP 
Transcription by the σ54-associated RNAP holoenzyme has been described as a second 
paradigm of bacterial transcription, differing substantially from that directed by σ70-RNAP.  
As illustrated in Figure 2, σ54 can be divided into three regions, which do not share sequence 
or structural homology to the σ70 class and make distinct contacts with both core RNAP and 
promoter DNA (Buck and Cannon, 1992; Buck et al., 2000; Wong et al., 1994; Zhang et al., 
2016). 
The major interactions between σ54 and core RNAP are mediated by the core binding domain 
of region III, which is the most conserved domain of σ54 orthologues.  Mutations (Tintut and 
Gralla, 1995) and deletions (Wong et al., 1994) of residues in the core binding domain were 
found to disrupt the formation of the holoenzyme, while this domain alone was sufficient for 
high affinity RNAP binding (Gallegos and Buck, 1999).  Moreover, the structure of the σ54-
RNAP holoenzyme (Figure 3) revealed extensive contacts between the core binding domain 
and moieties of the α, β and βʹ subunits (Yang et al., 2015).  Despite the lack of sequence and 
structural similarity between σ54 and σ70, comparison of the holoenzyme structures indicates 
they contact similar regions of core RNAP, albeit with different functional domains (Yang et 
al., 2015; Zhang et al., 2016).   
σ54-regulated promoters have several features that distinguish them from those regulated by 
the σ70 family and define the process of σ54-dependent transcription.  In contrast to σ70 
recognition sites, which are positioned at -10 and -35 relative to the +1 transcription start site 
with the exact sequence and spacing varying for each member, σ54 recognises -24 and -12 
promoter elements (Kustu et al., 1989; Zhao et al., 2010).  An extended σ54 consensus 
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sequence was established by calculating the relative nucleotide frequency at each position of 
186 σ54–regulated promoters from over 40 species (Barrios et al., 1999).  The resulting 
consensus sequence of mrNrYTGGCACG-N4-TTGCWNNw (where uppercase and lowercase 
indicate highly and weakly conserved nucleotides respectively; R represents purines (A/G), Y 
represents pyrimidines (C/T); W is A/T; M is C/G and N is any nucleotide) spans from -31 to 
-8, centred around highly conserved GG and GC motifs at -24 and -12 respectively.   
Binding of σ-associated RNAP to promoter elements to form a closed promoter complex is 
the first stage of transcription initiation.  As indicated in Figure 2 and Figure 3C, region III of 
σ54 contains the major determinants for promoter DNA binding (Guo and Gralla, 1997; Wong 
et al., 1994).  A cluster of ten residues at the C-terminal end of region III termed the RpoN 
box, the most conserved feature of σ54, are responsible for binding to the -24 sequence, as 
demonstrated by mutagenesis (Taylor et al., 1996) and cleavage of RpoN box-adjacent DNA 
by a proximity-based cleavage reagent conjugated to σ54 (Burrows et al., 2003).  Structural 
information revealed the presence of a helix-turn-helix (HTH) motif, a signature of DNA 
binding proteins, of which residues of the RpoN box form the DNA recognition helix 
(Doucleff et al., 2005; Doucleff et al., 2007; Yang et al., 2015).  In contrast, contact with the -
12 element is more complex, involving region I as well as a second HTH of region III 
(Burrows et al., 2003; Wong et al., 1994).   
Unlike σ70 family-associated RNAP, which spontaneously isomerise DNA to form an open 
promoter complex, σ54-RNAP-bound -24/-12 elements remain closed and transcriptionally 
silent as a result of the inhibitory function of region I of σ54.  Recently, Yang et al. (2015) 
showed that, according to the structure of σ54-RNAP in complex with promoter DNA, region I 
interacts with the HTH of region III to form a structural unit that is positioned close to the -12 
promoter element and impedes DNA entry into the active site of RNAP.  This is consistent 
with biochemical studies that identified residues of regions I and III responsible for -12 
binding (Cannon et al., 1994; Chaney and Buck, 1999; Wang and Gralla, 1996) and 
demonstrated that σ54 inhibited association of RNAP with pre-melted DNA but deletion of 
region I removed this obstacle (Cannon et al., 1999).  The interaction of region I and III of σ54 
with the -12 element has been shown to distort DNA at the base pair immediately 
downstream, contributing to the formation of a fork junction-like structure called the 
regulatory centre (Bose et al., 2008; Burrows et al., 2003; Morris et al., 1994; Yang et al., 
2015).  The regulatory centre is located at the point of nucleation of DNA melting according 
to the structure of the σ70-RNAP holoenzyme, therefore preventing DNA isomerisation,  
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Figure 3  Structures of the σ54. 
(A) Structure of σ54.  (B) Structure of σ54-associated RNAP holoenzyme.  (C) Electron density map 
and structural model of the σ54- RNAP-promoter DNA complex.  In all cases, the structures show 
region I (RI; purple), region II (divided into RII.1, RII.2 and RII.3; red and yellow) and region III, 
which is divided into the core binding domain (CBD; green), the extra-long α helix and helix-turn-
helix (ELH-HTH; orange), and the RpoN box (RpoN; lime).  The subunits of core RNAP are shown as 
follows: β (blue), βʹ (pink), α1 (light grey), α2 (dark grey) and ω (lilac).  The -24 and -12 promoter 
DNA elements are also indicated.  Taken from Yang et al. (2015). 
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formation of the transcription bubble and entry of promoter DNA into the active site of σ54-
RNAP (Zhang et al., 2016; Zuo and Steitz, 2015). 
In order to overcome this barrier to transcription initiation, σ54-dependent promoters require a 
transcriptional activator, known as a bEBP, which binds to a UAS and interacts with the σ54-
RNAP holoenzyme-promoter DNA complex (Buck et al., 1986; Sasse-Dwight and Gralla, 
1988).  As the inhibitory determinant of σ54, region I is the main bEBP interaction domain.  
Structural data suggests region I is positioned favourably for contact with bEBPs and is 
stabilised upon interaction (Siegel and Wemmer, 2016; Yang et al., 2015).  Furthermore, 
binding to region I has been demonstrated for several members of the bEBP family, including 
PspF, NifA and NtrC1 (Bordes et al., 2003; Chaney et al., 2001; Siegel and Wemmer, 2016).  
bEBPs have a highly conserved ATPase domain, which in the adenosine triphosphate (ATP)-
bound state, interacts with region I and converts the chemical energy from ATP hydrolysis to 
mechanical energy to induce conformational change of σ54 at the regulatory centre (Bordes et 
al., 2004; Bose et al., 2008; Burrows et al., 2008; Chaney et al., 2001).  This enables promoter 
melting at the regulatory centre and eliminates the obstruction of promoter DNA from the 
RNAP catalytic site, resulting in open complex formation. 
Figure 4 illustrates the sequence of events during initiation of σ54-dependent transcription. 
1.3.2 Bacterial enhancer binding proteins 
bEBPs are essential for initiation of transcription from σ54-dependent promoters.  The 
majority of bEBPs have three domains: the regulatory domain at the N-terminal of the protein, 
the central and highly conserved ATPase domain and the C-terminal DNA binding domain 
(reviewed by Bush and Dixon (2012) and Shingler (2010)). 
1.3.2.1 ATPase domain of bEBPs 
The central ATPase domain consists of seven highly conserved motifs, many of which are 
hallmarks of the AAA+ superfamily of proteins.  AAA+ proteins function in a diverse range 
of cellular processes but all involve the binding and hydrolysis of ATP, converting the energy 
produced into mechanical force to remodel their substrates (Snider et al., 2008).  In the case of 
bEBPs, the ATPase domain mediates interaction with σ54 and drives conformational changes 
to promote open promoter complex formation by the σ54-RNAP holoenzyme. 
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Figure 4  Initiation of transcription at σ54-dependent promoters. 
(A) σ54–associated RNAP is directed to promoters with GG and GC motifs at -24 and -12 respectively, 
relative to the +1 transcription start site.  The σ54–RNAP holoenzyme is unable to spontaneously form 
an open complex with promoter DNA and requires a transcriptional activator (enhancer binding 
protein; EBP).  The activator binds as a dimer to an upstream activating sequence (UAS) and 
oligomerises (commonly as a hexamer as shown) upon activation by a specific signal.  (B) Interaction 
between the EBP and σ54–RNAP is facilitated by DNA bending, usually mediated by integration host 
factor (IHF).  This loops out the intervening sequence between UASs and -12/-24 elements and 
mediates correct interfacing between σ54–RNAP and the EBP.  (C) The activator hydrolyses ATP and 
uses the energy to mediate contact with σ54-RNAP at the regulatory centre, removing the repressive 
interactions between the -12 promoter element and σ54.  This enables open promoter complex 
formation and initiation of transcription.  Taken from Bush and Dixon (2012). 
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Central to this activity are the Walker A and B motifs, which bind and hydrolyse ATP 
respectively (Snider et al., 2008; Walker et al., 1982).  In order to bind ATP, bEBPs 
oligomerise, predominantly into hexamers, forming a ring shape that creates the ATP binding 
pocket at the interface between individual proteins (Rappas et al., 2007).  Using various ATP 
and ADP analogues that mimic the ATP-bound ‘ground’ state, the ATP hydrolysis ‘transition’ 
state and the ADP-bound post-hydrolysis state, structural data has revealed that there are 
substantial rearrangements within the ATPase domain during the ATP hydrolysis cycle, 
which are coupled to σ54 by two surface-exposed loops that are unique to bEBPs (Chen et al., 
2007a; Rappas et al., 2007; Sysoeva et al., 2013).  In particular, the GAFTGA motif within 
loop 1, which is the most conserved of the bEBP-unique features, is known to be an essential 
contact surface with σ54 (Dago et al., 2007; Zhang et al., 2009).  In the ATP ground state, 
loops 1 and 2 are extended away from the bEBP oligomer, enabling the GAFTGA motif to 
contact region I of σ54 (Chen et al., 2007a).  The transition state stabilises this interaction and 
region I undergoes a significant conformational rearrangement, increasing its distance from 
region III and relinquishing the obstruction of promoter DNA from core RNAP (Bose et al., 
2008; Chen et al., 2007a; Sharma et al., 2014).  In addition, contacts between σ54 and the -12 
to -8 region of promoter DNA increased during this state, indicating the initial nucleation of 
DNA melting (Burrows et al., 2008).  In the ADP-bound state, the loops flatten and return to 
their positions on the surface of the bEBP, while the open complex forms, with core RNAP 
contacting promoter DNA.   
Therefore, the central ATPase domain is the essential catalytic component of bEBPs, 
necessary for σ54–dependent transcription, but relies on the regulatory and DNA binding 
domains to maintain promoter specificity in appropriate cellular conditions. 
1.3.2.2 Regulatory domain of bEBPs 
The N-terminal domain is the regulatory component of bEBPs, confining ATPase activity to 
relevant conditions by responding directly or indirectly to a variety of environmental or 
metabolic signals.  It is the most variable part of the bEBP, with the motifs contained 
determining the type of signal detected.   
The bEBPs characterised to date perceive signals in three ways.  Many bEBPs belong to two-
component systems and are activated by a sensory histidine kinase that phosphorylates an 
aspartate residue of the response regulator motif within the regulatory domain (Yamamoto et 
al., 2005).  For example, NtrC is phosphorylated by NtrB in nitrogen limiting conditions 
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(Austin and Dixon, 1992; Reitzer, 2003), while ZraR is phosphorylated by ZraS, which is 
thought to sense high concentrations of zinc and lead ions (Leonhartsberger et al., 2001).  
Others bEBPs directly bind small ligands that are generally substrates for the enzymatic 
activity of the gene products they regulate.  Examples include DmpR and XylR, which are 
activated by the binding of specific aromatic compounds to vinyl 4 reductase (V4R) motifs in 
their regulatory domains (O'Neill et al., 1998; Shingler and Moore, 1994) and NorR and NifA, 
which use GAF motifs to bind nitric oxide and 2-oxoglutarate respectively (D'Autreaux et al., 
2005; Little and Dixon, 2003).  NifA is also subject to additional regulation by interaction 
with anti-activator protein NifL, which sequesters NifA in conditions inappropriate for 
nitrogen fixation.  The ATPase activity of PspF, a bEBP that naturally lacks a regulatory 
domain, is also restricted by binding to an anti-activator, PspA, which dissociates in 
conditions where membrane integrity is compromised (Elderkin et al., 2005). 
Upon deletion of the regulatory domains of several bEBPs, including DmpR, XylR and NorR, 
the resulting truncated proteins were found to be constitutively active and competent to 
activate σ54-dependent transcription in the absence of a signal (Fernández et al., 1995; 
Gardner et al., 2003; O'Neill et al., 1998), as illustrated in Figure 5.  In contrast, deletion of 
the regulatory domain of NtrC produced a constitutively inactive bEBP, unable to initiate 
transcription (Drummond et al., 1990).  Therefore, signal detection by the regulatory domain 
can positively regulate the ATPase domain and stimulate its activity or, more frequently, 
relieve repression of the ATPase domain in a mechanism of negative regulation.  These 
regulatory mechanisms can target the activity of the central domain at the level of 
oligomerisation, ATP hydrolysis and σ54 interaction. 
1.3.2.3 DNA binding domain of bEBPs 
The DNA binding domain provides promoter specificity for the action of the regulatory and 
ATPase domains of bEBPs.  The HTH motif of the domain binds to specific UASs usually 
between 150 and 200 base pairs (bp) upstream of the transcription start site (Leonhartsberger 
et al., 2001; Porter et al., 1993; Tucker et al., 2005), tethering the bEBP to the correct 
promoter and enabling direct interaction with promoter-bound σ54 at the regulatory centre. 
bEBPs bind in a dimeric conformation to UASs, which take the form of inverted repeats (IRs) 
(De Carlo et al., 2006; Sallai and Tucker, 2005; Vidangos et al., 2013).  The length and 
spacing of repeats and the number of binding sites varies for each promoter and bEBP.  For 
example, NtrC binds to two UASs upstream of the glnA promoter consisting of 5-6 bp half-   
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Figure 5  Negative regulation of the ATPase activity of bEBPs. 
Schematic illustration of the negative mechanism of control of the central ATPase domain by the N-
terminal regulatory domain of bEBPs.  The regulatory domain inhibits the activity of the central 
domain, which is intrinsically competent for ATP binding and hydrolysis.  Signal detection (e.g. 
ligand binding or phosphorylation) by the regulatory domain leads to derepression of the central 
domain.  Deletion of the regulatory domain results in a constitutively activated bEBP. 
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sites separated by a 7 bp AT-rich region (Porter et al., 1993; Reitzer et al., 1989).  In contrast, 
ZraR binds to a single IR consisting of 16 bp half-sites separated by 14 bp in the zraP 
promoter (Leonhartsberger et al., 2001), while NorR binds to three IRs consisting of 3-5 bp 
half-sites with a consensus of GT-N7-AT (Tucker et al., 2005). 
Interestingly, NorR must bind all three UASs in the norVW promoter in order to form a stable 
oligomer with the ability to initiate σ54-dependent transcription upon activation by nitric oxide 
(Bush et al., 2015; Justino et al., 2005).  Other bEBPs do not show the same strict DNA-
dependency for oligomerisation as NorR, as indicated by the ability of truncated variants 
lacking the DNA binding domain to activate transcription (Berger et al., 1994; Jovanovic et 
al., 1999; North and Kustu, 1997).  However, concentration of bEBPs at promoter DNA by 
UAS-binding is commonly found to facilitate and stabilise the process of oligomerisation (De 
Carlo et al., 2006; Porter et al., 1993).   
1.3.3 The role of integration host factor in σ54-dependent transcription 
For a productive interaction between the σ54-RNAP holoenzyme bound at the -24/-12 
promoter elements and the bEBP tethered to the UAS, topological changes in DNA must 
occur.  In some cases, the flexibility of the intervening sequence enables the interaction, as 
demonstrated by the glnA promoter (Carmona et al., 1997).  Those lacking propensity for 
DNA flexibility rely on interaction with proteins to facilitate DNA looping.  Accordingly, 
binding sites for the global regulator integration host factor (IHF), which alters DNA 
architecture to enable bending, are frequently found in the region between the UAS and the -
24/-12 elements (Arfin et al., 2000; Huo et al., 2009).  The position of IHF binding relative to 
the promoter ensures correct interfacing between σ54-RNAP and bEBP, which is crucial for 
efficient transcription (Huo et al., 2006). 
IHF-mediated topological changes in DNA can have other regulatory effects on σ54-dependent 
transcription (Shingler 2011).  These include preventing non-specific cross-activation by 
reducing promoter accessibility to other bEBPs (Perez-Martin and De Lorenzo, 1995; 
Wassem et al., 2000), stimulating formation of an open complex at the DmpR-regulated Po 
promoter (Sze et al., 2001), mediating cooperative DNA binding with PspF at the psp 
promoter (Jovanovic and Model, 1997) and recruiting σ54-RNAP to the XylR-dependent Pu 
promoter and aiding its interaction with additional stimulatory elements further upstream 
(Bertoni et al., 1998). 
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1.3.4 The σ54 regulon 
A major function of σ54-associated RNAP is to transcribe genes involved in the assimilation 
of ammonia in order to generate the intracellular nitrogen donors glutamate and glutamine in 
response to nitrogen limitation (Reitzer, 2003; Reitzer and Schneider, 2001).  The bEBP NtrC 
is the principle regulator during the nitrogen stress response and activates σ54-dependent 
transcription from over 20 promoters (Brown et al., 2014).  Among the proteins expressed are 
glutamine synthetase, the key enzyme involved in glutamine biosynthesis in low nitrogen 
conditions, and many transporter proteins involved in uptake of ammonia, glutamine, 
glutamate and other amino acids, in an effort to scavenge nitrogen-containing compounds for 
glutamine synthesis. 
In addition, the σ54 regulon incorporates operons of diverse function including flagellar 
biosynthesis, maintenance of membrane integrity, toxic metal tolerance and several involved 
in the utilisation of alternative carbon sources, (Reitzer and Schneider, 2001; Zhao et al., 
2010).  Therefore, there is no obvious single theme linking the functions of all σ54-regulated 
genes.  According to the Pro54 database, there are 96 annotated σ54-dependent promoters in E. 
coli K-12, (Liang et al., 2017), one of which directs transcription of the rtcBA operon. 
 Sigma 54-dependent transcription of the rtcBA operon in E. coli 1.4
1.4.1 Features of the rtcBA promoter  
The rtcB gene of E. coli K-12 was discovered by Genschik et al. (1998) during an 
investigation to characterise the product of the downstream rtcA gene, so named for its 
activity as a RNA terminal cyclase, (further discussed in Section 1.6.4.1).  Owing to the 
shared directionality and close proximity of the rtcB and rtcA genes, with the start codon of 
rtcA immediately following the stop codon of rtcB, they were considered to form a hitherto 
uncharacterised operon. 
Examination of the DNA sequence upstream of the rtcBA operon led to the identification of a 
region with high similarity to the σ54 consensus sequence, including correctly spaced GG and 
GC doublets corresponding to the -24 and -12 promoter elements, suggesting that 
transcription of rtcBA was σ54-dependent (Genschik et al., 1998).  Supporting this, two 
putative binding sites for IHF were present further upstream of the -24/-12 elements, one on 
the other strand to the rtcB coding sequence and orientated away from rtcB (ihf1) and the 
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other on the same strand and orientated towards rtcB (ihf2).  As discussed in Section 1.3.2, a 
key requirement for transcription via σ54-associated RNAP is the ATPase activity of a 
dedicated bEBP to enable open promoter complex formation.  Genschik et al. (1998) found 
that the product of adjacent gene rtcR fulfilled this function for rtcBA transcription. 
Figure 6 shows the organisation of the rtcBA-rtcR locus of E. coli and the sequence between 
rtcB and rtcR, annotated with the features identified by Genschik et al. (1998).  The sequence 
of the σ54 and IHF binding sites are also compared to published consensus sequences. 
1.4.2 RtcR, the bEBP of the rtcBA operon 
The rtcR gene was considered as a candidate transcriptional activator of rtcBA owing to its 
resemblance to other bEBPs (Genschik et al., 1998).  The central domain of RtcR showed 
approximately 60% similarity to equivalent domains of other bEBPs, including the seven 
highly conserved regions necessary for ATPase activity and interaction with σ54.  The C-
terminus of RtcR was found to contain an HTH motif, consistent with the DNA binding 
domain of bEBPs for mediating interaction with UAS(s).  However, the N-terminal domain of 
RtcR was found to have no similarity with the regulatory domain of other bEBPs, implying 
that it may have a novel mechanism of signal detection or recognise a different type of signal. 
Recently, the regulatory domain of RtcR was found to contain a divergent CRISPR-associated 
Rossmann fold (CARF) domain, which are widespread among proteins genetically linked 
with CRISPR-cas systems but not directly associated with CRISPR-cas function (Makarova et 
al., 2014).  The CARF domain is predicted to bind nucleotides or nucleotide-derived 
molecules via a Rossman-like fold, which contributes to a well conserved pocket containing a 
positively charged residue (Lintner et al., 2011; Makarova et al., 2014).  The majority of 
CARF domain-containing proteins also have a winged HTH (wHTH) motif, a HTH variant 
(Aravind et al., 2005) and an effector domain, most commonly with enzymatic activity 
against nucleic acids, such as a nuclease (Makarova et al., 2014; Makarova et al., 2013).  
Together, this has led to the hypothesis that the CARF domain functions to detect ligand 
binding and transmit the signal to an effector domain, which responds to the stimulus with 
catalytic activity.  This is also consistent with the function of RtcR as a bEBP.  As a distantly 
related member of the CARF domain superfamily, RtcR has a similar domain organisation, 
with a HTH and an effector ATPase domain.  However, RtcR proteins generally lack the 
highly conserved basic residue of the CARF domain pocket, suggesting they may bind 
alternative ligands (Makarova et al., 2014).  
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          TTACCGGGGCATTTTCAGTGGTCAGTAATTCGTAATTCATTTTGTTTTTCTCTTTTCGTT  
          ----:----|----:----|----:----|----:----|----:----|----:----| 
          AATGGCCCCGTAAAAGTCACCAGTCATTAAGCATTAAGTAAAACAAAAAGAGAAAAGCAA  
          K  V  P  A  N  E  T  T  L  L  E  Y  N  M        SD 
                                            rtcB           
 
          GTTTGCTGTCCTGATAATTGCAACCGTCGTGCCAGAAAATTAAATAAGCAGCTTAATTTT  
          ----:----|----:----|----:----|----:----|----:----|----:----| 
          CAAACGACAGGACTATTAACGTTGGCAGCACGGTCTTTTAATTTATTCGTCGAATTAAAA  
                +1          -12         -24                      ihf2 
                 
                 ihf1 
          TTAATTCATTGTTTTAAAAAAGATTATATCTTTACGTCCGTAACCGGAGATTTCCCGCAA  
          ----:----|----:----|----:----|----:----|----:----|----:----| 
          AATTAAGTAACAAAATTTTTTCTAATATAGAAATGCAGGCATTGGCCTCTAAAGGGCGTT  
                                                      
                                                          rtcR 
                                                          M  R  K  T 
          AGCCAATTTACCGATAATGAAATATCGTCTTTTATAAGGATATCTAAGATGCGTAAAACA  
          ----:----|----:----|----:----|----:----|----:----|----:----| 
          TCGGTTAAATGGCTATTACTTTATAGCAGAAAATATTCCTATAGATTCTACGCATTTTGT  
 
B σ54 consensus sequence:   mrNrYTGGCACGNNNNTTGCWNNw 
σ54 binding site, rtcBA promoter:  TTTTCTGGCACGACGGTTGCAATT 
 
C IHF consensus sequence:    WATCAANNNNTTR 
ihf1:      ATTCATTGTTTTA 
ihf2:      AATTAAAAAATTA 
 
Figure 6  Organisation and features of the σ54-dependent rtcBA operon of E. coli. 
(A) Genetic organisation of the rtcBA-rtcR gene cluster (filled boxes) and surrounding genes (empty 
boxes), with the sequence of the rtcR-rtcB intergenic region.  Notable features identified by Genschik 
et al. (1998) are annotated including: the -24/-12 promoter elements; two putative IHF binding sites 
(ihf1 and ihf2); the transcription start site of rtcBA (+1); putative Shine-Dalgarno (SD) sequence of 
rtcB and start codons of rtcB and rtcR.  (B) Alignment of the σ54 consensus sequence (Barrios et al., 
1999) with the σ54 binding site in the rtcBA promoter.  (C) Alignment of the IHF consensus sequence 
(Friedman, 1988; Goodrich et al., 1990) with the proposed binding sites ihf1 and ihf2.  For (B) and (C) 
uppercase letters indicate highly conserved nucleotides; lowercase letters indicate weak conservation; 
R represents purines (A/G), Y represents pyrimidines (C/T); W is A/T; M is C/G and N is any 
nucleotide.  The highly conserved GG and GC elements at -24 and -12 respectively are bold and 
nucleotides in the rtcBA promoter that match the consensus (including N) are red. 
  
glpR rtcB rtcA 
rtcR malT 
1 kb 
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Using reverse-transcription polymerase chain reaction (RT-PCR) to measure transcription 
from the rtcBA promoter, Genschik et al. (1998) demonstrated that rtcB and rtcA were 
transcribed in E. coli cells expressing a truncated version of RtcR lacking the N-terminal 
regulatory domain but not full-length RtcR.  As truncated RtcR became constitutively active 
in the absence of its regulatory domain, this suggests that the activity of RtcR is negatively 
regulated in the absence of its (currently unknown) activating signal, as well as establishing 
that RtcR acts as a transcriptional activator of rtcBA.  Consistent with the presence of -24/-12 
elements upstream of the rtcBA operon, inactivation of the rpoN gene that encodes σ54 
prevented transcription of rtcBA during truncated RtcR expression.  Transcription of both 
genes was restored by complementation of the rpoN-inactivated strain, demonstrating 
activation of rtcBA transcription by RtcR is σ54-dependent.  Further, primer extension analysis 
using RNA extracted from cells expressing truncated RtcR mapped the transcription start site 
of rtcBA to a C located 12 nucleotides downstream of the -12 element. 
 The RNA ligase RtcB 1.5
1.5.1 Types and functions of RNA ligases 
RNALs are widespread in organisms from all domains of life and catalyse the formation of 
phosphodiester bonds to join breaks in the backbone structure of RNA during splicing, repair 
and modification processes.  Known RNALs can be categorised into three groups, based on 
the type of phosphodiester bond created and the origin of the phosphate incorporated into the 
bond, which is referred to as the junction phosphate (Popow et al., 2012). 
1.5.1.1 5ʹ-3ʹ RNA ligases 
The first RNAL activity was discovered in bacteriophages, plants and fungi and involved 
ATP-dependent ligation of RNA substrates with a 3ʹ-hydroxyl group and a 5ʹ-phosphate 
group to form a 2ʹ-hydroxyl, 3ʹ,5ʹ-phosphodiester bond (Konarska et al., 1981; Peebles et al., 
1979; Silber et al., 1972).  This group of enzymes are referred to as 5ʹ-3ʹ RNALs to indicate 
that a 5ʹ-phosphate is joined to a 3ʹ-hydroxyl (the phosphate-linked end is named first).  ATP 
is central to ligation, which proceeds through three adenylate transfer steps (Cherepanov and 
de Vries, 2002; El Omari et al., 2006; Greer et al., 1983b).  First, the ligase reacts with ATP to 
form a ligase-adenosine monophosphate (AMP) intermediate, displacing pyrophosphate.  
Next, AMP is transferred from the ligase to the 5ʹ-phosphate of RNA, forming an 
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intermediate with a high energy phosphoanhydride bond, App-RNA.  Finally, the 3ʹ-hydroxyl 
of RNA attacks the double phosphate bond of the App-RNA intermediate, sealing the RNA 
substrates in a 3ʹ,5ʹ-phosphodiester bond and releasing AMP. 
5ʹ-3ʹ RNALs are frequently associated with domains that catalyse RNA end healing prior to 
ligation to increase their repertoire to RNAs with 2ʹ,3ʹ-cyclic phosphate and a 5ʹ-hydroxyl 
terminals, which are commonly occurring products of ribonuclease activity (Burroughs and 
Aravind, 2016).  This involves dephosphorylation of the 3ʹ-end RNA substrate and 
phosphorylation of the 5ʹ-end RNA substrate to produce suitable terminals for 5ʹ-3ʹ RNAL 
activity.  Therefore, the junction phosphate of the subsequent 3ʹ,5ʹ-phosphodiester bond 
originates from the γ-phosphate of NTP used to phosphorylate the 5ʹ-end and not from the 
substrate-derived phosphate, which is another distinguishing feature of this type of RNAL 
(Greer et al., 1983b).  Different enzymatic activities are responsible for end healing, as 
demonstrated in the following examples.  
Rnl1, a 5ʹ-3ʹ RNAL identified in bacteriophages and some bacterial and archaeal species, 
utilises a separate enzyme, Pnpk, to perform end healing prior to RNA ligation (Burroughs 
and Aravind, 2016; Popow et al., 2012; Zillmann et al., 1991).  Pnpk has dual activity as a 
phosphatase, dephosphorylating the 2ʹ,3ʹ-cyclic phosphate to generate a 2ʹ,3ʹ-diol, and as a 
kinase, phosphorylating the 5ʹ-hydroxyl group (Das and Shuman, 2013b).  The best 
characterised Rnl1 enzyme is from T4 bacteriophage, which, in combination with T4 Pnpk, 
has been demonstrated to repair the anticodon loop of host tRNA
Lys
, thereby evading attempts 
to prohibit phage propagation and allowing continued phage protein synthesis in E. coli 
(Amitsur et al., 1987). 
Rnl1-type 5ʹ-3ʹ RNALs are also widespread in plants and fungi, but unlike the Rnl1 ligases of 
bacteriophages, bacteria and archaea, all components required to process and ligate RNA 
terminals are contained within the same enzyme (Burroughs and Aravind, 2016; Popow et al., 
2012).  Prototypical ligases from Arabidopsis thaliana (AtRNL) and Saccharomyces 
cerevisiae (Trl1) have separate domains for cyclic phosphodiesterase, kinase and ligase 
activity (Remus and Shuman, 2014; Wang and Shuman, 2005).  The cyclic phosphodiesterase 
activity hydrolyses the 2ʹ,3ʹ-cyclic phosphate group, yielding a 2ʹ-phosphate-3ʹ-hydroxyl 
terminal, while the kinase activity phosphorylates the 5ʹ-hydroxyl group.  Therefore, upon 
ligation the 3ʹ,5ʹ-phosphodiester linkage also bears a 2ʹ-phosphate, which can be hydrolysed 
to the typical 2ʹ-hydroxyl by the activity of a separate phosphotransferase (Culver et al., 1997; 
Keppetipola et al., 2007).  The function of 5ʹ-3ʹ RNALs of plants and fungi is well studied, 
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with essential roles in tRNA splicing, sealing tRNA halves following endoribonuclease-
mediated intron removal, and in XBP-1 mRNA splicing, an essential transcription factor in the 
UPR (Sidrauski et al., 1996; Yoshihisa, 2014). 
Another family of 5ʹ-3ʹ RNAL, Rnl2, exists in some species as a stand-alone ligase and in 
others is associated with Pnpk or other accessory phosphatases and kinases (Burroughs and 
Aravind, 2016).  Rnl2 homologues are widespread in protists and viral genomes and to a 
lesser degree in archaea and bacteria (Popow et al., 2012).  The most studied example is the 
T4 bacteriophage Rnl2, which exhibits a preference for ligating nicks in duplex RNA or 
RNA-DNA hybrids (Ho et al., 2004; Nandakumar and Shuman, 2004).  Little is known about 
the functions of the Rnl2 family, with the exception of its established role in the mitochondria 
of kinetoplastids, where it is involved in insertion or deletion of uridine in mRNA, an editing 
process that creates translatable transcripts (McManus et al., 2001). 
5ʹ-3ʹ RNALs appear to be largely absent from metazoa, and are less prevalent in archaea and 
bacteria that other types of RNALs (Popow et al., 2012).  5ʹ-3ʹ RNAL activity has been 
detected in human HeLa cell extracts but no homology to Rnl1, Rnl2 or any other ligase 
domain has been identified (Burroughs and Aravind, 2016; Zillmann et al., 1991).   
1.5.1.2 2ʹ-5ʹ RNA ligases 
An unusual type of RNAL activity capable of forming a 3ʹ-hydroxyl, 2ʹ,5ʹ-phosphodiester 
bond between RNA substrates with a 2ʹ,3ʹ-cyclic phosphate at the 3ʹ-terminal and a 5ʹ-
hydroxyl at the 5ʹ-terminal was first detected in several bacterial extracts (Greer et al., 1983a).  
Characterisation of the purified E. coli enzyme, named LigT (‘ligase tRNA’), revealed that it 
had both RNA ligase and nuclease activities, establishing an equilibrium that slightly 
favoured the nuclease reaction in vitro (Arn and Abelson, 1996).  In contrast to other RNALs, 
the 2ʹ-5ʹ RNAL activity was found to occur independently of nucleoside triphosphate (NTP) 
and unlike 5ʹ-3ʹ RNALs, LigT catalysed direct ligation without prior end healing steps, with 
the junction phosphate donated by the 2ʹ,3ʹ-cyclic phosphate group. 
Homologues of LigT are widely found in bacteria and archaea and 2ʹ-5ʹ RNAL activity has 
been identified in some eukaryotes, including Spinacea oleracea chloroplasts (Arn and 
Abelson, 1996; Molina-Serrano et al., 2012; Rehse and Tahirov, 2005).  However, the 
function of 2ʹ-5ʹ RNALs is unknown.  Structures of LigT homologues from the archaeon 
Pyrococcus horikoshii and the bacterium Thermus thermophilus revealed structural similarity 
with the cyclic phosphodiesterase domain of plant and fungal 5ʹ-3ʹ RNALs (Kato et al., 2003; 
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Rehse and Tahirov, 2005).  Accordingly, Remus et al. (2014) determined that LigT from E. 
coli can also hydrolyse the 2ʹ,3ʹ-cyclic phosphate group of an RNA substrate to form a 2ʹ-
phosphate-3ʹ-hydroxyl terminal, implicating that LigT has roles in RNA end healing.  
Although the 2ʹ-5ʹ-phosphodiester bond formed by LigT is considered unusual, examples of 
its occurrence exist in nature (Trujillo et al., 1987).  Therefore, both the cyclic 
phosphodiesterase and ligase/nuclease functions of LigT may be relevant for its function in 
vivo. 
1.5.1.3 3ʹ-5ʹ RNA ligases 
A 3ʹ-5ʹ RNAL activity, which catalysed ligation of RNA substrates with either 2ʹ,3ʹ -cyclic 
phosphate or 3ʹ-phosphate terminals together with 5ʹ-hydroxyl terminals to generate a 2ʹ-
hydroxyl, 3ʹ,5ʹ-phosphodiester bond, was initially detected in HeLa cells and archaea 
(Filipowicz et al., 1983; Kjems and Garrett, 1988).  Upon purification of the 3ʹ-5ʹ RNAL 
activity, the proteins responsible were found to be homologues of E. coli RtcB (Englert et al., 
2011; Popow et al., 2011), which was previously annotated as part of an operon with RNA 
cyclase RtcA, but to which no function had been assigned (Genschik et al., 1998).  The 
mechanism of action of this novel family of RNALs was subsequently investigated using the 
E. coli and archaeal homologues, as discussed in Section 1.5.2.  The known functions of RtcB 
are described in Section 1.6. 
1.5.2 Mechanism of action of RtcB 
RtcB and its homologues have a distinct mechanism of ligation to the 5ʹ-3ʹ and 2ʹ-5ʹ RNALs.  
Like 2ʹ-5ʹ RNALs, RtcB was found to recognise RNA with 2ʹ,3ʹ-cyclic phosphate and 5ʹ-
hydroxyl ends (Arn and Abelson, 1996; Tanaka and Shuman, 2011).  However, it was also 
able to ligate 3ʹ-phosphate RNA terminals to the 5ʹ-hydroxyl and joined these groups in a 
different way to 2ʹ-5ʹ RNALs, forming a phosphodiester bond between the 3ʹ-phosphate and 
5ʹ-hydroxyl in a 3ʹ-5ʹ ligase activity (Filipowicz et al., 1983).  In contrast to 5ʹ-3ʹ RNALs, end 
healing was unnecessary for ligation and the junction phosphate originated from the RNA 
substrate rather than the γ-phopsphate of an NTP (Filipowicz and Shatkin, 1983; Zofallova et 
al., 2000). 
Owing to the similarity with 2ʹ-5ʹ RNALs, RtcB was initially thought to catalyse a single-step 
nucleophilic attack by the 5ʹ-hydroxyl group on the 2ʹ,3ʹ-cyclic phosphate (Arn and Abelson, 
1998).  However, this was inconsistent with an early report that inclusion of GTP enhanced 
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ligation (Kjems and Garrett, 1988).  Investigation into the requirements of purified RtcB 
confirmed that its activity was strictly dependent on the presence of GTP and that RNA 
ligation was abolished when GTP was omitted from the reaction or exchanged with another 
NTP (Tanaka et al., 2011a; Tanaka and Shuman, 2011).  This indicated that the ligation 
pathway was more complex, likely involving guanylylation, similar to the 
nucleotidyltransferase activity involved in 5ʹ-3ʹ RNA ligation. 
Accordingly, RtcB has been demonstrated to react with GTP to form an RtcB-guanosine 
monophosphate (GMP) intermediate.  Following incubation of RtcB with [α-32P]GTP, Tanaka 
et al. (2011a) observed transferral of the radiolabel to RtcB, which was not the case upon 
incubation with γ-phosphate-radiolabelled GTP ([γ-32P]GTP), indicating the formation of 
RtcB-GMP.  Crystal structures of an archaeal RtcB homologue from P. horikoshii further 
elucidated the guanylylation pathway of RtcB (Desai et al., 2013; Englert et al., 2012; Okada 
et al., 2006).  The site of guanylylation in P. horikoshii was identified as a highly conserved 
histidine residue within the active site, which formed a covalent bond with the α-phosphate of 
GMP (Englert et al., 2012).  Biochemical analysis of E. coli RtcB revealed substitution of the 
equivalent histidine rendered RtcB inactive (Chakravarty et al., 2012).  A highly conserved 
cysteine residue was also determined to be essential for RtcB activity, owing to its role in the 
coordination of two Mn
2+
 ions in the RtcB active site (Englert et al., 2012).  Comparison of 
RtcB structures with and without GTP revealed the Mn
2+
 ions were central to the process of 
guanylylation (Desai et al., 2013).  The first Mn
2+
 was associated with RtcB in the absence of 
GTP and interacted with GTP upon entry to the RtcB active site, while the second Mn
2+ 
 
 
entered the active site in complex with GTP and orientated it with respect to the histidine 
residue to promote hydrolysis to GMP and expulsion of pyrophosphate.  This is comparable 
to the nucleotidylation of 5ʹ-3ʹ RNALs, except that they use Mg2+ and ATP as cofactors rather 
than Mn
2+
 and GTP (Cherepanov and de Vries, 2002; El Omari et al., 2006).   
Following guanylylation of RtcB, GMP was transferred from the RtcB-GMP intermediate to 
the 3ʹ-phosphate terminal of RNA, as demonstrated by incubation of RtcB-GMP with a non-
ligatable RNA substrate bearing 5ʹ-phosphate and 3ʹ-32phosphate ends (Chakravarty and 
Shuman, 2012).  This resulted in the accumulation of an RNA intermediate with a 3ʹ-end 
phosphoanhydride bond (RNA-ppG), distinguishable from the initial substrate by 
polyacrylamide gel electrophoresis (PAGE).  Some residues important for this stage of 
ligation have also been characterised.  For example, mutation of an arginine residue at a 
predicted 3ʹ-terminal RNA contact site of RtcB (according to structural studies) allowed RtcB 
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guanylylation but would not permit guanylylation of the 3ʹ-phosphate RNA terminal (Englert 
et al., 2012). 
On the basis of the two guanylate intermediates identified, two mechanisms of RtcB ligation 
were presented in conflicting reports.  Desai and Raines (2012) proposed that RtcB-GMP 
transfers GMP to 3ʹ-phosphate RNA to form RNA-ppG, which is subject to attack by the 
adjacent 2ʹ-hydroxyl, leading to cyclisation of the phosphate to generate a 2ʹ,3ʹ-cyclic 
phosphate suitable for ligation with 5ʹ-hydroxyl RNA.  This would imply that guanylylation is 
dispensible for ligation of RNA substrates with a preformed 2ʹ,3ʹ-cyclic phosphate.  An 
alternative mechanism was presented by Chakravarty and Shuman (2012), whereby RtcB 
reacts with GTP to form RtcB-GMP and catalyses the hydrolysis of 2ʹ,3ʹ-cyclic phosphate to 
3ʹ-phosphate, which is then guanylylated by RtcB-GMP to form RNA-ppG.  The 
phosphoanhydride bond of RNA-ppG is then attacked by the 5ʹ-hydroxyl RNA, forming a 
3ʹ,5ʹ-phosphodiester.  In this scheme, guanylylation is necessary for ligation of all RtcB 
substrates. 
In support of their model, Chakravarty and Shuman (2012) demonstrated that ligation of RNA 
with 2ʹ,3ʹ-cyclic phosphate and 5ʹ-hydroxyl ends only occurred at significant levels in the 
presence of GTP.  Furthermore, in the absence of a suitable 5ʹ-hydroxyl substrate to complete 
ligation, RtcB-GMP has been shown to hydrolyse 2ʹ,3ʹ-cyclic phosphates, yielding 3ʹ-
phosphate terminals (Chakravarty and Shuman, 2012; Tanaka et al., 2011a).  This cyclic 
phosphodiesterase activity of RtcB suggests that ligation proceeds via nucleophilic attack on 
the 3ʹ-phosphate group rather than 2ʹ,3ʹ-cyclic phosphate.  The finding that the presence of a 
2ʹ-hydroxyl significantly stimulates phosphodiester synthesis between the adjacent 3ʹ-
phosphate and an RNA substrate bearing a 5ʹ-hydroxyl also favours hydrolysis of the 2ʹ,3ʹ-
cyclic phosphate prior to the final step in ligation (Chakravarty et al., 2012).  An arginine 
residue predicted by structural analysis of RtcB to coordinate interaction between the RNA-
ppG and 5ʹ-hydroxyl RNA substrates has also been confirmed to significantly reduce the 
formation of the phosphodiester bond, but not other ligation steps, when substituted for 
alanine (Maughan and Shuman, 2016).  Therefore, it appears that RtcB plays a direct role in 
each stage of the ligation pathway: 2ʹ,3ʹ-cyclic phosphodiesterase activity, activation of the 3ʹ-
phosphate by guanylylation and sealing of RNA-ppG and 5ʹ-hydroxyl RNA, all of which are 
dependent on the reaction of RtcB with GTP.  Together, the biochemical and structural 
analyses of RtcB have contributed to the widely accepted mechanism of action proposed by 
Chakravarty and Shuman (2012), as depicted in Figure 7.  
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Figure 7  Mechanism of RNA ligation by RtcB. 
(A) The cyclic phosphodiesterase activity of RtcB.  RtcB is activated by guanylylation of a conserved 
histidine in the catalytic site, to form an RtcB-GMP intermediate.  RtcB-GMP coordinates hydrolysis 
of RNA substrates with 2ʹ,3ʹ-cyclic phosphate terminals to form open 3ʹ-phosphate ends.  (B) The 
ligase activity of RtcB.  Following hydrolysis of the 2ʹ,3ʹ-cyclic phosphate, GMP is transferred from 
RtcB to the 3ʹ-phosphate RNA terminal, forming an RNA-ppG intermediate.  The high energy, 
activated phosphoanhydride bond of RNA-ppG is attacked by an RNA substrate bearing a 5ʹ-hydroxyl 
terminal, forming a 2ʹ-hydroxyl, 3ʹ,5ʹ-phosphodiester bond and eliminating GMP.  Taken from 
Chakravarty and Shuman (2012). 
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1.5.3 Additional activities of RtcB in DNA modification 
RtcB has also been implicated in DNA repair or modification.  Purified RtcB from E. coli was 
capable of performing intramolecular and intermolecular ligation of a 5ʹ-hydroxyl DNA 
substrate with a single ribonucleotide at the 3ʹ-end bearing a 3ʹ-phosphate (Das et al., 2013).  
However, this activity was significantly less efficient than ligation of an equivalent RNA 
substrate (8% ligation compared to 68% respectively).  RtcB also catalysed ligation of an all-
DNA broken stem-loop structure, but not non-complementary DNA substrates or nicks in 
double-stranded DNA, suggesting that DNA ligation by RtcB requires intermolecular 
complementarity but unpaired 3ʹ-phosphate or 5ʹ-hydroxyl terminals (Das et al., 2013). 
Although the final step of ligation between the 3ʹ-DNA-ppG intermediate and 5ʹ-hydroxyl 
appeared to be slower than ligation of RNA substrates, guanylylation of the 3ʹ-phosphate to 
generate the DNA-ppG intermediate occurred at a similar rate to RNA-ppG formation and 
was catalysed on single-stranded, stem-loop and double-stranded DNA substrates (Das et al., 
2013).  Das et al. (2014) demonstrated that 3ʹ-phosphate guanylylation of a single-stranded 
DNA substrate rendered it resistant to the activity of E. coli exonucleases I and III and the 
phosphatase domain of T4 Pnpk in vitro.  Further, formation of DNA-ppG primed synthesis 
of templated DNA by a variety of DNA polymerases from different families (Chauleau et al., 
2015; Das et al., 2014).  However, the resulting repaired DNA contains an unconventional 
pyrophosphate bond, which Chauleau et al. (2015) determined was resistant to the proof-
reading activity of DNA polymerases and other repair mechanisms.   
Therefore, based on in vitro data, 3ʹ-end guanylylation by RtcB could act as a protective cap 
or an unconventional primer for DNA synthesis, but the cost of incorporating a pyrophosphate 
into the DNA backbone in the latter scenario is unclear.  Although inefficient compared to its 
RNAL activity, DNA ligation by RtcB suggests that it could also represent a novel family of 
DNA ligases.  However, to date no in vivo function of RtcB has been attributed to its activity 
in DNA modification, either as a ligase or a capping enzyme.   
 Function and conservation of RtcB 1.6
1.6.1 Members of the RtcB family are present in all domains of life 
As described in Section 1.5.1.3, 3ʹ-5ʹ RNAL activity was first discovered in extracts from 
human HeLa cell lines (Filipowicz et al., 1983; Filipowicz and Shatkin, 1983) and shortly 
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thereafter in cell extracts from the archaea Desulfurococcus mobilis and Haloferax volcanii. 
(Gomes and Gupta, 1997; Kjems and Garrett, 1988; Zofallova et al., 2000).  Purification of 
this activity from the archaeon Methanopyrus kandleri revealed that the protein responsible 
was a homologue of E. coli RtcB (Englert et al., 2011; Genschik et al., 1998).  Accordingly, 
the purified RNAL from HeLa cells, named HSPC117, was also identified as a member of the 
RtcB family (Popow et al., 2011).   
Bioinformatical analysis has revealed that RtcB is prevalent in all domains of life (Englert et 
al., 2011; Popow et al., 2012).  RtcB is present in the majority of eukaryotic organisms, 
including metazoa and protists, with the notable exception of some lineages of fungi and 
plants.  In addition, almost all known archaea have an RtcB homologue.  A member of the 
RtcB family was identified in 55% of 965 bacteria (Popow et al., 2012), covering a diverse 
range of species from E. coli (Genschik et al., 1998) and Salmonella enterica serovar 
Typhimurium (Chen et al., 2013) to Mycobacterium tuberculosis (Selvaraj et al., 2012), 
Rhodopirellula baltica (Studholme and Dixon, 2004) and Deinococcus deserti (de Groot et 
al., 2014).  An rtcB gene is also encoded by some viruses (Pope et al., 2014; Popow et al., 
2012; Senčilo et al., 2013).  Phylogenetic analysis of the RtcB family revealed three types that 
can be grouped at the domain level, with the eukaryotic and archaeal types showing greater 
similarity than the bacterial (Englert et al., 2011).  This suggests that RtcB was present in the 
last common ancestor, with gene loss in some clades of bacteria and eukaryotes   
1.6.2 Function in eukaryotes and archaea 
1.6.2.1 tRNA maturation 
The presence of introns within tRNA transcripts has been observed in organisms from all 
three domains of life and must be processed to generate mature and functional tRNA (Chan 
and Lowe, 2009; Popow et al., 2012).  While bacterial tRNA introns are self-splicing, in 
eukaryotes and archaea tRNA splicing is a two-step enzymatic process, with endonuclease-
mediated excision of the intron followed by ligation of the tRNA halves catalysed by an 
RNAL.  The endonuclease reaction is conserved among eukaryotes and archaea, cleaving pre-
tRNA at the intron-exon junctions to generate a 2ʹ,3ʹ-cyclic phosphate group at the 3ʹ- end of 
the 5ʹ-exon and a 5ʹ-hydroxyl group at the 5ʹ-end of the 3ʹ-exon (reviewed in (Yoshihisa, 
2014)).  As described in Section 1.5.1.1, fungi and plants use 5ʹ-3ʹ RNALs (exemplified by 
AtRNL and Trl1) to complete tRNA splicing, first healing the 2ʹ,3ʹ-cyclic phosphate to a 2ʹ-
phosphate-3ʹ-hydroxyl group at the 5ʹ-exon and the 5ʹ-hydroxyl to a 5ʹ-phosphate at the 3ʹ-
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exon before ligating the two terminals, incorporating γ-phosphate from ATP into the junction 
in the process (Greer et al., 1983b; Remus and Shuman, 2014).  However, as both 3ʹ-5ʹ and 5ʹ-
3ʹ RNAL activities were detected in HeLa cell extracts and implicated in ligating tRNA 
halves after intron excision in humans (Filipowicz et al., 1983; Filipowicz and Shatkin, 1983; 
Zillmann et al., 1991), it was unclear whether both the endonuclease and ligase reactions were 
conserved in eukaryote tRNA splicing or whether the ligation steps were catalysed by 
different mechanisms. 
This was resolved by Popow et al. (2011), who identified the enzyme responsible for the 3ʹ-5ʹ 
RNAL activity as an RtcB homologue known as HSPC117.  Characterisation of human RtcB 
revealed it as the missing component of mammalian tRNA splicing (Popow et al., 2011).  
Small interfering (si)RNA-mediated depletion of human RtcB significantly reduced 
processing of pre-tRNA into mature tRNA in HeLa cell extracts, as did mutation of a 
conserved residue in the predicted catalytic core of RtcB, according to the structure in 
archaeon P. horikoshii (Okada et al., 2006).  This was also the case for murine RtcB.  
Substrate specificity of human RtcB was confirmed by the inability to ligate tRNA exon 
halves modified by dephosphorylation of the 2ʹ,3ʹ-cyclic phosphate or phosphorylation of the 
5ʹ-hydroxyl and by the incorporation of the 2ʹ,3ʹ-cyclic phosphate into the phosphodiester 
bond, as indicated by Filipowicz and Shatkin (1983).  Using inducible pre-tRNA
Ile
 carrying 
mutations and pre-tRNA
Phe
 from S. cerevisiae in order to distinguish from endogenous pre-
tRNAs, the role of human RtcB was also investigated in vivo (Popow et al., 2011).  Depletion 
of RtcB in HeLa cells resulted in a significant reduction in the formation of mature tRNA
Ile
 
and tRNA
Phe 
reporters, confirming the role of RtcB in mammalian tRNA splicing.  The use of 
5ʹ-3ʹ RNALs in fungi and plants in tRNA splicing may account for the low conservation of 
RtcB homologues in these organisms, as reliance on another type for tRNA ligation may have 
made RtcB dispensible (Englert et al., 2011). 
Ligation of endonuclease-cleaved tRNA exons by the 3ʹ-5ʹ RNAL activity of H. volcanii cell 
extracts (Gomes and Gupta, 1997; Zofallova et al., 2000), suggests that RtcB is also 
responsible for tRNA ligation in archaea.  In support of this, purified RtcB from archaeon 
Pyrobaculum aerophilum was able to ligate pre-tRNA halves cleaved by the archaeal tRNA 
splicing endonuclease and the authors were able to demonstrate that the 2ʹ,3ʹ-cyclic phosphate 
from the 5ʹ-exon was the source of the junction phosphate in the resulting phosphodiester 
bond (Englert et al., 2011).  Furthermore, 5ʹ-3ʹ RNALs are less prevalent in archaea than 3ʹ-5ʹ 
RNALs (Popow et al., 2011), favouring a mechanism of tRNA ligation in archaea similar to 
metazoa rather than fungi and plants. 
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In mammals, RtcB forms part of a larger protein complex that mediates tRNA ligation (Figure 
8).  Additional components include the DEAD-box helicase DDX1, CGI-99, FAM98B and 
ASW.  Popow et al. (2011) found that individual silencing of the other proteins in the tRNA 
ligase complex by RNA interference (RNAi) did not significantly affect tRNA maturation, 
indicating that RtcB was the only essential component.  However, purified human RtcB 
cannot function indefinitely in vitro, which supports a regulatory function for one or more 
accessory proteins (Popow et al., 2014; Popow et al., 2012).  Accordingly, Popow et al. 
(2014) identified archease as an additional component of the mammalian tRNA ligase 
complex, which enabled RtcB to consume all available RNA substrates in vitro and 
significantly impaired tRNA maturation upon depletion by siRNA.  Archease was determined 
to stimulate the activity of human RtcB by mediating guanylation to form the active RtcB-
GMP intermediate (see Figure 7).  This activity was further enhanced by DDX1-mediated 
ATP hydrolysis, demonstrating a functional role for another member of the tRNA ligase 
complex.  CGI-99 is implicated in mediating association of the components of the tRNA 
ligase complex as silencing of this protein destabilised the complex (Perez-Gonzalez et al., 
2014).  The function of FAM98B and ASW in tRNA ligation remain unclear but could 
include cellular localisation and stabilisation of RtcB or the RNA substrates.  Homologues of 
DDX1, CGI-99, FAM98B and ASW are absent in bacteria and archaea (Popow et al., 2012) 
but archease is present in all domains of life and has also been found to augment the function 
of RtcB in archaea (Desai et al., 2014b) and bacteria (Desai et al., 2015), as discussed further 
in Section 1.6.4.3. 
1.6.2.2 The unfolded protein response 
The UPR is an intracellular stress response system of eukaryotes that arises from the 
accumulation of unfolded proteins in the lumen of the endoplasmic reticulum (ER).  ER stress 
is sensed by transmembrane proteins that span the ER membrane, initiating signalling 
pathways and culminating in significant alteration of gene transcription and translation, the 
desired outcome of which is to decrease the protein load entering the ER and enhance the 
protein folding capabilities of the ER.  There are three major UPR signalling pathways, which 
are conserved to varying degrees in eukaryotes (reviewed by Hollien (2013)).  One of the 
three signalling pathways, the IRE1 branch of the UPR, detects the build-up of unfolded 
proteins via the intra-lumenal domain of transmembrane protein IRE1, triggering its 
oligomerisation to form an active endonuclease on the cytosolic face of the ER membrane.  
The IRE1 endonuclease excises the intron from XBP-1 mRNA, producing spliced XBP-1 
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mRNA for translation.  The resulting XBP-1 protein is a transcription factor that upregulates 
expression of genes to mediate recovery of ER stress, such as protein chaperones (reviewed 
by Walter and Ron (2011)).  The IRE1 pathway is highly conserved in metazoan, fungi and 
plants, but not protists (Hollien, 2013).  In S. cerevisiae, the 5ʹ-3ʹ RNAL Trl1 is required to 
complete XBP-1 splicing following IRE1 cleavage (Sidrauski et al., 1996).  Following the 
characterisation of RtcB as the missing RNAL component of the tRNA splicing machinery in 
humans and other animals, a process catalysed by Trl1 and its homologues in fungi and 
plants, it was implicated as the ligase responsible for sealing XBP-1 exons in metazoa.  This 
hypothesis was addressed by three separate approaches.   
Lu et al. (2014) conducted a genome-wide RNAi screen in mouse fibroblast cells to search for 
candidate XBP-1-ligating RNALs by utilising a synthetic IRE1 signalling circuit that, upon 
induction of ER stress and XBP-1 splicing, initiated apoptosis rather than the UPR.  siRNA-
mediated depletion of RtcB rescued cells from apoptosis and further investigation revealed 
that accumulation of XBP-1 protein was significantly reduced, suggesting that RtcB 
functioned in the pathway at the level of XBP-1 splicing.  A catalytic mutant of RtcB lacking 
ligase activity was unable to rescue cells from apoptosis, demonstrating that the RNA ligase 
activity of RtcB was necessary for XBP-1 splicing.  Purified IRE1 and RtcB were sufficient to 
produce spliced XBP-1 mRNA in vitro, confirming RtcB as the ligase component.   
Kosmaczewski et al. (2014) used the nematode Caenorhabditis elegans to investigate the 
function of RtcB in a living metazoan model.  Deletion of rtcB reduced the life span of 
nematodes and caused growth defects, which were recovered by expressing intron-less 
versions of relevant tRNAs, confirming the role of RtcB in tRNA ligation.  However, under 
constant induction of ER stress, nematodes lacking RtcB had drastically reduced life spans 
irrespective of the presence of intron-less tRNAs, indicating a tRNA maturation-independent 
function for RtcB.  RT-PCR revealed that while the longer, pre-spliced version of XBP-1 was 
present in wild-type and rtcB null animals, the shorter post-splicing transcript was only 
detectable in wild-type, demonstrating the role of RtcB in ligation of IRE1-cleaved XBP-1 
mRNA.  The phenotypes associated with rtcB deletion during the UPR were complemented 
by expression of wild-type RtcB, but as observed with Lu et al. (2014), a mutated version of 
RtcB lacking RNA ligase activity was not. 
In addition to its stimulatory role in tRNA ligation, Jurkin et al. (2014) found that archease 
was also an RtcB co-factor for XBP-1 ligation.  While wild-type levels of spliced XBP-1 
mRNA were detectable in HeLa cells upon RNAi depletion of RtcB alone during ER stress, 
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depletion of both RtcB and archease abolished XBP-1 splicing.  This suggests that low levels 
of RtcB are sufficient for XBP-1 exon ligation, with the proviso that archease is also present at 
wild-type levels.  Jurkin et al. (2014) also demonstrated that targeted deletion of rtcB in 
plasma cells in a mouse model, where activation of the UPR is known to be important for 
production of high levels of antibody, significantly reduced antibody secretion in response to 
lipopolysaccharide challenge. 
Together, Lu et al. (2014), Kosmaczewski et al. (2014) and Jurkin et al. (2014) robustly 
demonstrated that metazoan RtcB has an essential function in the IRE1 arm of the UPR, 
catalysing XBP-1 mRNA ligation (Figure 9).  This is of particular interest because of the 
emerging role of the UPR in diseases, such as cancer and neurodegenerative disorders (Hazari 
et al., 2016; Xiang et al., 2017), which could make RtcB a relevant therapeutic target.  In 
support of this, an RNAi screen of C. elegans expressing α-synuclein as a model for 
Parkinson’s disease identified RtcB as a candidate neuroprotective protein (Hamamichi et al., 
2008).  In accordance with the accumulation of misfolded proteins such as α-synuclein as a 
key feature of Parkinson’s disease, the regenerative role of RtcB was confirmed to be 
mediated via the IRE1 arm of the UPR (Ray et al., 2014). 
1.6.2.3 Other indications of function 
An RNAi screen of C. elegans with a mutation in cytoskeletal protein β-spectrin as a model of 
axonal injury identified RtcB as a candidate regulator of axon regeneration (Nix et al., 2014).  
Further investigation by Kosmaczewski et al. (2015) revealed that RtcB localised at the tips of 
neurons damaged by laser axotomy and that deletion of the rtcB gene significantly increased 
axon regeneration in C. elegans as little as six hours following neuron damage.  The 
phenotype could be complemented by expression of wild-type RtcB from a neuron-specific 
promoter but not with a ligase-defective mutant, indicating that the observed effect was 
caused by the loss of RtcB ligase activity in neurons.  Therefore, as an inhibitor of axon 
regeneration, RtcB could represent a therapeutic target for axonal injury.  Interestingly, when 
the rtcB mutant nematodes were provided with pre-spliced tRNA to rescue growth defects 
associated with impaired tRNA processing, axon regeneration remained high and did not 
return to the wild-type phenotype.  Furthermore, expression of pre-spliced XBP-1 in neuron 
had no effect on axon regeneration.  This suggests that inhibition of axon regeneration by 
RtcB is independent of its function in tRNA maturation and the UPR and that RtcB ligase 
activity has a role in at least one other biological pathway in metazoa.  
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Figure 8  The role of RtcB in metazoan tRNA splicing. 
Intron-containing pre-tRNAs undergo splicing to mature.  The intron is removed by the tRNA 
endonuclease (consisting for four splicing endonuclease (SEN) subunits as indicated; speculative 
organisation) and the 5ʹ- and 3ʹ-exons are sealed by the tRNA ligase complex, which consists of ligase 
component RtcB and accessory proteins archease (arch), DDX1, CGI-99, FAM98 and ASW 
(speculative organization).  Adapted from Popow et al. (2014). 
 
 
 
Figure 9  The role of RtcB in the IRE1 pathway of the UPR. 
IRE1 senses the accumulation of unfolded proteins in the ER lumen and oligomerises to cleave XBP-1 
mRNA.  RtcB and its cofactor archease ligate the exons, producing a spliced XBP-1 transcript, which 
encodes a transcription factor that alters the transcription profile of the cell to alleviate ER stress. 
Taken from Filipowicz (2014). 
  
31 
 
RtcB was identified as a component of a large multi-protein RNA transporting granule 
isolated from mouse brain (Kanai et al., 2004).  Transport of RNA is thought to be an 
important mechanism for regulating protein expression in specific cellular compartments, 
particularly in neurons (Kiebler and Bassell, 2006).  Other components of the mammalian 
tRNA ligase complex, DDX1 and CGI-99, were also associated with the granule.  More 
recently, RtcB, DDX1, FAM98B and CGI-99 were found to be complexed in another granule 
isolated from both nuclear and cytoplasmic fractions of human embryonic kidney cell line 
HEK293T (Perez-Gonzalez et al., 2014).  RNA was also a significant constituent of the 
granule and was necessary for its assembly in the nucleus.  CGI-99 was found to have roles in 
stabilisation of the granule.  Monitoring of the shuttling activity of the granule revealed 
nuclear import was dependent on active transcription, while the complex was readily exported 
to the cytoplasm.  The association of RtcB with granules that shuttle RNA around the cell via 
cytoskeletal interactions (Kanai et al., 2004) may explain the localisation of RtcB at the tips of 
damaged neurons (Kosmaczewski et al., 2015) and is also consistent with its nuclear function 
as a tRNA ligase and its cytoplasmic function in the UPR.  These findings extend the role of 
the tRNA ligase complex to cell-wide RNA metabolism, and sequencing of the RNAs 
associated with these granules may provide further indication as to the function of RtcB in 
eukaryotes. 
RtcB has been implicated in embryo development in mice, as depletion of RtcB was 
associated with increased foetal death at the post-implantation stage (Wang et al., 2010).  The 
positive correlation between placental expression of RtcB and successful foetal development 
in the study might be explained by the essential roles of RtcB in tRNA maturation or the 
UPR.  In addition, murein RtcB was found to be a regulator of cell adhesion with the 
extracellular matrix (ECM) by modulating the interaction of various adhesins (Ding et al., 
2010; Hu et al., 2008).  RtcB is also involved in cell migration by regulating the expression of 
various ECM components (Ma et al., 2014).  Regulation of cell adhesion and migration by 
RtcB could also account for its role in foetal development.  However, it is currently unclear 
how RtcB regulates these processes. 
Together, this indicates that RtcB and its associated proteins may be involved in RNA ligation 
activities that affect a range of cellular processes in eukaryotes, many of which have 
implications in clinical settings.  
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1.6.3 Function in bacteria 
Both biochemical and in vivo analyses have revealed a wide range of repair activity for RtcB 
purified from E. coli.  In vitro, RtcB was able to seal a broken stem-loop RNA molecule 
cleaved by the site-specific endoribonuclease activity of yeast γ-toxin (Tanaka and Shuman, 
2011) and perform intramolecular and intermolecular ligation of a single-stranded RNA 
substrate to generate a circular RNA product (Tanaka et al., 2011a), with the caveat that the 
RNAs had either a 2ʹ,3ʹ-cyclic phosphate or a 3ʹ-phosphate group at the 3ʹ-end and a 5ʹ-
hydroxyl at the 5ʹ-end (Section 1.5.2).  RtcB-mediated capping and ligation of DNA bearing 
the same terminals has also been demonstrated in vitro (Section 1.5.3).  Biochemical analysis 
of three of the six RtcB paralogues present in the bacterium Myxococcus xanthus revealed that 
two resembled the E. coli RtcB homologue, with both RNAL and DNA guanylylation 
activities and weak DNA ligase activity, while the third was only capable of DNA 
guanylylation (Maughan and Shuman, 2015).  This raises the possibility that some RtcB 
proteins they may have acquired functional specialisation for one or more of the range of 
activities identified in vitro. 
The first in vivo indication of bacterial RtcB function was the observation that recombinant 
RtcB from E. coli complemented the normally lethal deletion of S. cerevisiae RNAL Trl1 
(Tanaka et al., 2011b).  This suggested it was capable of performing all essential RNA 
ligations in this organism, despite the difference in mechanism of the two ligases.  
Specifically, RtcB sealed tRNA halves following intron excision and cleaved XBP-1 mRNA 
during the UPR, demonstrating RtcB-mediated ligation of both tRNA and mRNA substrates.  
Moreover, RtcB could also protect cells against the activity of fungal ribotoxin PaT, which, 
like γ-toxin, targets the anticodon loop of a specific tRNA (Tanaka et al., 2011b; Tanaka and 
Shuman, 2011). 
Despite demonstrating the same functional capabilities as its eukaryotic homologues, RtcB 
must fulfil a different function in bacteria because bacterial introns are ribozymes capable of 
self-splicing (Hausner et al., 2014; Toro et al., 2007).  Further, no introns are present in tRNA 
in E. coli (Chan and Lowe, 2009).  Therefore, RtcB in E. coli and other bacteria is postulated 
to function as a repair response to stress-mediated RNA damage (Tanaka and Shuman, 2011).  
The regulation of rtcBA transcription in E. coli by alternative σ factor σ54 supports this notion, 
suggesting that RtcR detects damaged RNA or other stress signals resulting from RNA 
damage via its CARF-like regulatory domain, and initiates a response by activating rtcBA 
transcription.   
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Consistent with the hypothesis that RtcB catalyses the repair of stress-induced damage of 
cellular RNAs, a role for RtcB was recently identified in the response to RNA cleavage by the 
endoribonuclease MazF in E. coli (Temmel et al., 2016).  MazF is the toxin component of the 
mazEF toxin-antitoxin (TA) system and is neutralised by interaction with its cognate antitoxin 
MazE (Pedersen et al., 2002).  Degradation of labile MazE in stressful conditions, such as 
amino acid starvation and antibiotic treatment, permits the toxic effect of stable MazF 
(Christensen et al., 2003; Hazan et al., 2004; Sat et al., 2001).  MazF is a ribosome-
independent endoribonuclease, cleaving single-stranded RNA at ACA sites, resulting in 
inhibition of translation (Zhang et al., 2003; Zhang et al., 2005). However, Vesper et al. 
(2011) discovered that selective translation of a subset of mRNAs was still permitted during 
MazF induction. The translated mRNAs were characterised by the presence of ACA sites in 
the vicinity of the start codon, which, upon MazF cleavage, generated leaderless mRNAs 
lacking the Shine-Dalgarno (SD) sequence.  Specialised ‘stress’ ribosomes lacking the anti-
Shine-Dalgarno (aSD) sequence usually required to interact with the SD sequence of 
incoming mRNA and mediate translation initiation, were found to be responsible for 
translating the leaderless mRNAs.  Moreover, the stress ribosomes were themselves created as 
a result of the endoribonuclease activity of MazF, which cleaved an ACA site at the 3ʹ-
terminal of 16S rRNA, removing the final 43 nucleotides including the aSD sequence.  Thus, 
the authors considered the global changes in translation elicited by MazF to be a novel post-
transcriptional stress response mechanism.  Further investigation to elucidate the MazF 
regulon by polysome profiling followed by RNA deep sequencing revealed that rtcB mRNA 
was one of the selectively translated transcripts during MazF expression (Sauert et al., 2016).  
The generation of leaderless rtcB mRNA via MazF-cleavage at an ACA five nucleotides 
upstream of the start codon was verified by primer extension analysis.   
There was no apparent functional clustering of the products of the 330 leaderless mRNAs 
identified in the MazF regulon to suggest an overall function for the proposed stress response 
mechanism (Sauert et al., 2016).  However, Temmel et al. (2016) were able to demonstrate a 
role for RtcB.  As the 43 nucleotide fragment of 16S rRNA cleaved by MazF remained stable 
and associated with the 30S ribosome subunit during MazF induction, this suggested that the 
16S rRNA may be repaired and as a member of the MazF regulon, RtcB was an attractive 
candidate ligase.  As such, RtcB was found to mediate the recovery of cells from MazF 
induction.  Northern blot analysis revealed that the cleaved 43 nucleotide fragment was 
detectable for a longer period in an rtcB deletion strain compared to wild-type E. coli during 
recovery, while levels of intact 16S rRNA were lower.  Furthermore, a reporter system in 
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which 16S rRNA was engineered to contain an SD sequence in place of the aSD to enable 
specific translation of modified gfp preceded by the aSD sequence, demonstrated in vivo that 
RtcB was responsible for ligating 16S rRNA fragments after MazF expression and that the 
resulting ribosomes were functional for translation of canonical mRNAs. 
Other functions of RtcB in bacteria have been proposed in recent months by Engl et al. 
(2016).  Surprisingly, they found that deletion of the rtcBA operon in E. coli produced a 
phenotype in standard laboratory conditions, contrary to previously published data (Englert et 
al., 2011; Genschik et al., 1998)  Cells lacking rtcB had a reduced growth rate compared to 
wild-type cells and accordingly, RNA deep sequencing demonstrated changes in the 
transcriptome of the two strains.  Over 570 genes were differentially expressed by over four-
fold, of which the biggest functional grouping was genes associated with translation, which 
led the authors to propose a link between RtcB and the translation apparatus.  Further 
investigation revealed changes in the ribosome profile of the rtcB deletion strain, indicative of 
increased rRNA degradation, which was complemented by expression of RtcB from a 
plasmid.  RNA sequencing data in combination with qPCR showed that 16S rRNA was more 
unstable in the absence of RtcB but no difference in 23S or 5S rRNA was observed.  This led 
to the suggestion that RtcB functions in ribosome homeostasis in E. coli (Engl et al., 2016).  
Although Temmel et al. (2016) also defined a role for RtcB in repair of 16S rRNA, their 
findings do not corroborate those of Engl et al. (2016), as they did not observe any difference 
in 16S rRNA stability upon rtcB deletion in the absence of MazF induction. 
In addition, the RNA sequencing data showed that genes involved in chemotaxis and motility 
were upregulated in the rtcB deletion (Engl et al., 2016).  Motility assays confirmed that the 
spread of cells increased in the absence of RtcB, while complementation reversed this effect, 
suggesting that the activity of RtcB negatively regulates cell motility under standard growth 
conditions.  Although the mechanism behind this phenotype is unclear, this is in line with the 
finding that human RtcB is involved in mediating cell-cell interactions and migration (Hu et 
al., 2008; Ma et al., 2014). 
1.6.4 Genes commonly associated with rtcB in bacteria 
1.6.4.1 The RNA cyclase RtcA 
In E. coli, rtcB is localised in an operon with rtcA that is transcriptionally regulated by the 
σ54-RNAP holoenzyme in an RtcR-dependent manner (Genschik et al., 1998).  RtcA belongs 
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to a family of 3ʹ-terminal phosphate cyclases, which are also highly conserved with 
homologues in the eukaryal, archaeal and bacterial domains (Genschik et al., 1997).  
Bioinformatic analysis identified 32 bacteria that share the genetic arrangement of an rtcBA 
operon with a neighbouring rtcR gene, which in the majority of cases appeared in the same 
orientation as in E. coli (Das and Shuman, 2013a).  While this is a relatively small proportion 
of the bacteria known to have an RtcB homologue, suggesting that rtcB and rtcA are not 
generally genetically linked, the rtcR-rtcBA gene cluster is conserved across four different 
phyla, namely Proteobacteria, Acidobacteria, Chlamydiae and Planctomycetes.  The presence 
of an adjacent rtcR gene implies that, as demonstrated in E. coli, the rtcBA operon is 
transcriptionally regulated by RtcR from a σ54-dependent promoter in these bacteria.   
The activity of RtcA was first characterised in HeLa cell extracts and found to catalyse ATP-
dependent conversion of a 3ʹ-terminal phosphate to a 2ʹ,3ʹ-cyclic phosphates at the 3ʹ-terminal 
of RNA (Filipowicz et al., 1983; Filipowicz et al., 1985).  This activity was found to be 
conserved in human and E. coli RtcA and was specific to RNA and not DNA (Genschik et al., 
1997; Genschik et al., 1998).  The nucleotidyltransferase steps of the RtcA cyclisation 
pathway are analogous to the mechanism of action of RtcB.  First, RtcA is adenylylated on a 
conserved histidine residue by ATP, coordinated by a divalent metal cofactor (Mn
2+
 or Mg
2+
), 
forming an RtcA-AMP intermediate (Chakravarty et al., 2011; Tanaka et al., 2010).  Next, the 
RtcA-AMP is hydrolysed, transferring AMP to the 3ʹ-phosphate group of substrate RNA to 
generate an RNA-ppA intermediate (Desai et al., 2014a; Reinberg et al., 1985).  Finally, 
nucleophilic attack of the activated phosphoanhydride bond of the intermediate by the 
terminal 2ʹ-hydroxyl group of the RNA produces a 2ʹ,3ʹ-cyclic phosphodiester at the RNA 3ʹ-
terminal, releasing AMP (Filipowicz et al., 1985). 
In addition to its 3ʹ-terminal phosphate cyclase activity, the repertoire of RtcA has been 
expanded.  Chakravarty and Shuman (2011) established that RtcA has activity as a 5ʹ-
adenylyltransferase, transferring of AMP from RtcA to a 5ʹ-phosphate group of RNA or DNA 
in a manner similar to 5ʹ-3ʹ RNALs and DNA ligases (Cherepanov and de Vries, 2002; El 
Omari et al., 2006).  Das and Shuman (2013a) demonstrated that RtcA also had 2ʹ-terminal 
phosphate cyclase activity, albeit at a five-fold slower rate than the 3ʹ-phosphate cyclase 
activity. 
The genetic linkage of rtcB and rtcA led to initial speculation that they are also 
mechanistically linked, with E. coli RtcA postulated to provide or maintain 2ʹ,3ʹ-cyclic 
phosphate terminals for RtcB-mediated RNA repair (Englert et al., 2011; Filipowicz et al., 
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1983).  However, Tanaka and Shuman (2011) found that inclusion of RtcA did not augment 
ligation of broken synthetic tRNA stem loops by RtcB in vitro and further elucidation of the 
substrate specificity of RtcB showed that it can use 3ʹ-phosphate RNA terminals for ligation 
directly, precluding the need for RtcA-mediated 3ʹ-phosphate cyclisation (Chakravarty et al., 
2012).  Although the 3ʹ-terminal phosphate cyclase activity of RtcA would appear to be 
redundant in the case of RtcB, its ability to also catalyse the conversion of a 2ʹ-phosphate to a 
2ʹ,3ʹ-cyclic phosphate provides an RtcB-ligatable substrate and represents a plausible scenario 
for activity of RtcA and RtcB in the same pathway.   
Although three in vitro activities have been reported for RtcA, the function in vivo is unclear.  
Engl et al. (2016) observed the same increased motility phenotype as described for an rtcB 
deletion strain with an rtcA deletion, which could be complemented by RtcA expression from 
a plasmid.  However, no evidence was presented to suggest that RtcA was also implicated in 
16S rRNA maintenance and repair (Engl et al., 2016; Temmel et al., 2016).  Thus it is unclear 
whether RtcB and RtcA are involved in the same reaction pathways or act independently in 
vivo.  Co-transcription of rtcBA from the σ54-dependent promoter indicates that RtcB and 
RtcA at least function in the same cellular conditions, if not the same reactions.   
1.6.4.2 Ro, an RNA scavenger 
In other bacterial species, the rtcBA operon often includes extra genes.  The most common 
addition is ro, which was found in the rtcBA locus in ten bacteria across three phyla, out of 
the 32 with rtcBA and an adjacent rtcR (Das and Shuman, 2013a).  As observed in E. coli, 
transcription of the ro-rtcBA operon of S. Typhimurium was activated by expression of 
constitutively active RtcR lacking the N-terminal regulatory domain (Chen et al., 2013), 
confirming this as a conserved feature of the rtcBA operon.   
Ro is a ring-shaped protein that associates with two to four small non-coding RNAs known as 
Y RNAs to form a functional ribonucleoprotein (Wolin et al., 2013).  It is conserved in most 
metazoa and found in approximately 5% of bacterial species but is absent in E. coli (Sim and 
Wolin, 2011).  The Ro ribonucleoprotein forms a complex with exoribonuclease 
polynucleotide phosphorylase (PNPase), which increases the RNA degradation activity of 
PNPase for structured RNAs, but not single-stranded RNAs (Chen et al., 2013).  Ro 
ribonucleoprotein interacts with other exoribonucleases involved in RNA metabolism during 
environmental stress (Chen et al., 2007b).  As Ro binds misfolded RNAs in addition to Y 
RNAs (Sim and Wolin, 2011), this suggests that it scavenges cellular RNAs and directs their 
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degradation, altering the specificity and activity of various RNA degrading proteins via Y 
RNA-mediated tethering. 
1.6.4.3 The RtcB cofactor archease 
The archease gene is found in all domains of life and has a strikingly conserved genomic 
context, commonly positioned adjacent to genes encoding proteins that function in RNA or 
DNA processing, such as rtcB (Canaves, 2004).  Although not widely distributed in bacteria 
(it is absent from E. coli), archease is often found in an operon with rtcB in bacteria and also 
in archaea (Desai et al., 2014b). 
As discussed, archease is a confirmed cofactor of RtcB in animals and is necessary for its full 
activity in tRNA and XPB-1 ligation by mediating guanylylation of RtcB (Jurkin et al., 2014; 
Popow et al., 2014).  In contrast, archease from archaeon P. horikoshii accelerated both 
guanylylation of the 3ʹ-end phosphate of the 5ʹ-RNA substrate and attack of the guanylylated 
3ʹ-end by the 5ʹ-hydroxyl group of the 3ʹ-substrate (Desai et al., 2014b).  Further, P. 
horikoshii archease reduced the specificity of RtcB for GTP, enabling the use of other NTPs 
efficiently.  Archease is also a cofactor of bacterial RtcB: the RNA ligase activity of RtcB 
from bacterium T. thermophilus was significantly enhanced in the presence of endogenous 
archease and archease from P. horikoshii (Desai et al., 2015).  However, the addition of 
archease had no effect on the activity of RtcB from Thermobifida fusca, a bacterial species 
that does not encode archease (Desai et al., 2015).  Therefore, RtcB homologues can be 
catagorised as archease-dependent or –independent and it appears that coevolution of RtcB 
and archease is necessary to enable a functional interaction.  Archease has also been 
characterised as an accessory protein of 5-methylcytosine tRNA methytransferase, increasing 
its specificity for methylation of a specific cytosine in archaeon Pyrococcus abyssi (Auxilien 
et al., 2007).  Therefore, archease may function as a general modulator of proteins involved in 
RNA metabolism. 
As demonstrated with archease, the genomic context of RtcB supports its proposed function 
in RNA repair in bacteria, where it is localised and often co-transcribed with other genes 
encoding enzymes involved in RNA metabolism, as exemplified here by RtcA, Ro and 
archease. 
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 Aims of this work 1.7
As discussed in this chapter, the rtcB gene was first annotated by Genschik et al. (1998) as 
part of the σ54–dependent rtcBA operon of E. coli.  Since then, the activity of the highly 
conserved RtcB family as 3ʹ-5ʹ RNA ligases has been characterised in vitro (Chakravarty and 
Shuman, 2012; Chakravarty et al., 2012; Tanaka et al., 2011a; Tanaka and Shuman, 2011).  
Furthermore, functional roles for RtcB in tRNA maturation and the UPR in metazoa (Jurkin et 
al., 2014; Kosmaczewski et al., 2014; Lu et al., 2014; Popow et al., 2011) and in ribosome 
homeostasis and repair of MazF-induced stress ribosomes in E. coli (Engl et al., 2016; 
Temmel et al., 2016) have been reported.  However, at the outset of this project there was no 
published information regarding the role of RtcB in bacteria, and to date the extent of its 
function remains unclear.  Further, the regulation of σ54–dependent rtcBA transcription by 
RtcR has yet to be fully characterised. 
Therefore, the objective of this project was to understand the regulation and biological 
function of RtcB in E. coli K-12.  Specifically, we aimed to characterise the roles of RtcR and 
IHF as regulators of the rtcBA operon, to identify conditions where transcription of rtcBA is 
activated by RtcR in vivo and to identify the natural RNA substrates of RtcB. 
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Chapter 2 Materials and methods 
 Bacterial strains, media and growth conditions 2.1
E. coli strains used in this study (Table 1) were cultured at 37°C and 160 rpm in LB media 
(1% tryptone, 1% NaCl, 0.5% yeast extract, pH 7.5).  Nutrient agar (NA; 0.5% peptone, 0.2% 
yeast extract, 0.1% Lab-Lemco powder, 1.5% agar; 0.5% NaCl) was used for bacterial growth 
on solid media at 37°C for 14 to 18 hours, unless otherwise stated.   
Growth media was supplemented as required with 25 µg/ml kanamycin (kan), 30 µg/ml or 
100 µg/ml ampicillin (amp; for low- and high-copy-number plasmids respectively) and 50 
µg/ml chloramphenicol (cml).  Growth media was supplemented with 20 µg/ml L-glutamine 
as indicated to allow good growth in the absence of σ54.  Transcription from LacI-regulated 
promoters was induced by the addition of 0.1 to 1 mM isopropyl-β-D-1-thiogalactopyranoside 
(IPTG) as indicated.  Transcription from AraC-regulated promoters was induced by 0.2% 
arabinose.  40 µg/ml 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) was used to 
detect β-galactosidase activity on solid medium. 
 Standard DNA procedures 2.2
Molecular cloning to construct plasmids used in this study (Table 2) was conducted using 
standard methods (Sambrook et al., 1989).  Q5 High-Fidelity DNA polymerase was used to 
amplify DNA fragments for cloning by PCR according to the manufacturer’s instructions 
(NEB).  PCR amplifications for colony PCR and arbitrary PCR were performed using GoTaq 
DNA polymerase (Promega) or DreamTaq DNA polymerase (Thermo Fisher Scientific) and 
in accordance with the instructions of the respective manufacturer’s.  Oligonucleotides used 
are listed in Table 3.  DNA fragments were resolved by gel electrophoresis on a 1% TAE (40 
mM Tris-base, 20 mM acetic acid, 1 mM EDTA) agarose gel containing 0.5 μg/ml Ethidium 
bromide (Sigma-Aldrich) using 10X Orange G (25% ficoll, 0.4% Orange G dye) loading dye 
and a 1 kb ladder (GeneRuler, Thermo Fisher Scientific) at 125 V for 30 minutes.  DNA was 
purified from gels and enzymatic mixtures using the QIAquick Gel Extraction or QIAquick 
PCR Purification kits (both Qiagen) according to the provided instructions. 
PCR products and plasmids were digested with the relevant Fast-Digest restriction 
endonucleases from Thermo Fisher Scientific and ligated using the compatible T4 DNA 
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ligase, according to the manufacturer’s recommendations.  Digested plasmids were treated 
with Fast Alkaline Phosphatase (Thermo Fisher Scientific) before ligation to minimise self-
ligation.  Plasmid DNA was purified from bacterial culture using the QIAprep Spin Miniprep 
kit (Qiagen) or Untergasser’s rapid boiling plasmid extraction protocol (Untergasser, 2006).  
With the exception of the low-copy temperature sensitive (ts) R1 plasmids (Table 2), which 
were diluted from overnight (ON) culture into fresh LB medium grown exponentially then 
cultured for 2-4 hours at 42°C to induce uncontrolled plasmid replication, all plasmids were 
purified from ON culture. All cloned inserts were sequenced using DNA Sequencing & 
Services, Dundee, Scotland or Eurofins Genomics, Ebersberg, Germany. 
 
Table 1  Strains used in this study 
 
Strain 
 
Genotype 
Keio collection 
strain (if 
applicable) 
Source or 
reference 
MG1655 
E. coli K-12 MG1655 F
–
 λ– ilvG– rfb-50 
rph-1 
 
Laboratory 
collection 
TB28 MG1655ΔlacIZYA  
Laboratory 
collection 
C41 
E. coli BL21 B F
-
 ompT gal dcm lon 
hsdSB(rB-mB-) λ(DE3 [lacI lacUV5-
T7p07 ind1 sam7 nin5]) [malB
+
]K-12(λ
S
) 
 
(Miroux and 
Walker, 1996) 
DH5α λpir 
E. coli K-12 DH5α pir+ F-endA1 glnV44 
thi-1 recA1 gyrA96 relA1 deoR nupG 
purB20 φ80dlacZΔM15 Δ(lacZYA-
argF)U169 hsdR17(rK-mK
+) λ– 
 
Laboratory 
collection 
SC28 E. coli  K-12 MC1000ΔmazEF  
(Pedersen et 
al., 2002) 
GH01 MG1655ΔrpoN  This study 
GH02 TB28ΔrpoN  This study 
GH03 TB28rtcBA-lacZ  This study 
GH04 TB28rtcBA-lacZΔihfA::kan JW1702 This study 
GH05 TB28rtcBA-lacZΔihfB::kan JW0895 This study 
GH06 MG1655ΔrtcR  This study 
GH07 TB28ΔrtcR  This study 
GH08 MG1655ΔrtcB JW3384 This study 
GH09 MG1655ΔrtcA JW5688 This study 
GH10 MG1655ΔrtcBA  This study 
GH11 MG1655ΔrtcBAR  This study 
GH12 MG1655rtcR
M1X 
 This study 
GH13 TB28rtcR
M1X
  This study 
GH14 SC28ΔrtcB JW3384 This study 
 
 
41 
 
Table 2  Plasmids used in this study 
 
Plasmid 
 
Description 
Source or 
reference 
pOU254 mini-R1 ts, lacZYA transcriptional fusion, Amp
R Laboratory 
collection 
pOU254K mini-R1 ts, lacZYA transcriptional fusion, Kan
R
 
Laboratory 
collection 
pGH254 pOU254 terrrnB This study 
pGH254K pOU254K terrrnB This study 
pGH254BA0 pGH254 PrtcBA
BA0
::lacZYA This study 
pGH254BA1 pGH254 PrtcBA
BA1
::lacZYA This study 
pGH254BA2 pGH254 PrtcBA
BA2
::lacZYA This study 
pGH254BA3 pGH254 PrtcBA
BA3
::lacZYA This study 
pGH254BA3-IRM1 pGH254BA3 IRM1 mutation This study 
pGH254BA3-IRM2 pGH254BA3 IRM2 mutation This study 
pGH254BA3-IRM3 pGH254BA3 IRM3 mutation This study 
pGH254BA3-IRM4 pGH254BA3 IRM4 mutation This study 
pGH254BA3-IRM5 pGH254BA3 IRM5 mutation This study 
pGH254BA3-IRM6 pGH254BA3 IRM6 mutation
 
This study 
pGH254BA3-IRM7 pGH254BA3 IRM7 mutation This study 
pGH254BA3-IRM8 pGH254BA3 IRM8 mutation This study 
pGH254BA3-IRM9 pGH254BA3 IRM9 mutation
 
This study 
pGH254BA3-IRM10 pGH254BA3 IRM10 mutation This study 
pGH254BA3-IHFM1 pGH254BA3 IHFM1 mutation This study 
pGH254BA3-IHFM2 pGH254BA3 IHFM2 mutation This study 
pGH254BA3-IHFM3 pGH254BA3 IHFM3 mutation This study 
pGH254BA3-IHFM4 pGH254BA3 IHFM4 mutation This study 
pGH254BA3-IHFM5 pGH254BA3 IHFM5 mutation This study 
pGH254BA3-IHFM6 pGH254BA3 IHFM6 mutation This study 
pGH254BA3-IHFM7 pGH254BA3 IHFM7 mutation This study 
pGH254R0 pGH254 PrtcR
R0
::lacZYA This study 
pGH254R1 pGH254 PrtcR
R1
::lacZYA
 
This study 
pGH254R2 pGH254 PrtcR
R2
::lacZYA
 
This study 
pGH254R3 pGH254 PrtcR
R3
::lacZYA
 
This study 
pGH254R3mut10 pGH254R3 -10 mutation This study 
pGH254KR3 pGH254K PrtcR
R3
::lacZYA This study 
pGH254KBA2 pGH254K PrtcBA
BA2
::lacZYA
 
This study 
pBR322 pMB1, Amp
R
 Tet
R (Bolivar et al., 
1977) 
pGH10 pBR322::yaeP-rof-tilS This study 
pGH12 pBR322::yaeP-rof-tilS-yaeR This study 
pGH13 pBR322::yaeP-rof-tilS This study 
pBAD322K pBR322, araC PBAD, Kan
R 
(Cronan, 2006) 
pGH322R pBAD322K PBAD::SDopt::rtcR This study 
pGH322RΔN pBAD322K PBAD::SDopt::rtcRΔN This study 
pBAD322C pBR322, araC PBAD, Cml
R 
(Cronan, 2006) 
pGH322CR pBAD322C PBAD::SDopt::rtcR This study 
pGH322CRΔN pBAD322C PBAD::SDopt::rtcRΔN This study 
pMG25 pUC, lacI
q
 PA1/O4/O3, Amp
R Laboratory 
collection 
pGH25rpoN pMG25 PA1/O4/O3::SDopt::rpoN This study 
pGH25rtcBA pMG25 PA1/O4/O3::SDopt::rtcBA This study 
pGH25H6RC pMG25 PA1/O4/O3::SDopt::H6-rtcRC-term This study 
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Plasmid 
 
Description 
Source or 
reference 
pGH251 pMG25 rtcR-rtcBA intergenic sequence This study 
pGH252 pMG25 rtcR-rtcBA intergenic sequence, - rtcO This study 
pBAD33 p15, araC PBAD, Cml
R (Guzman et al., 
1995) 
pSC3326 pBAD33 PBAD:: mazF 
(Pedersen et al., 
2002) 
pKW82 pBAD33 PBAD::vapC 
(Winther and 
Gerdes, 2009) 
pKP3035 pBAD33 PBAD::relE 
(Pedersen et al., 
2002) 
pKP3065 pBAD33 PBAD::yafQ 
Laboratory 
collection 
pMCD8 pBAD33 PBAD::parE 
Laboratory 
collection 
pGH33H6R pBAD33 PBAD::SDopt::H6-rtcR This study 
pGH33H6RΔN pBAD33 PBAD::SDopt::H6-rtcRΔN This study 
pGH33H6IHF pBAD33 PBAD::SDopt::H6-ihfA::SDopt::ihfB This study 
pGH33rof pBAD33 PBAD::SDopt::rof This study 
pGH33rofext pBAD33 PBAD::rof (extended) This study 
pGH33yaeP pBAD33 PBAD::SDopt::yaeP This study 
pGH33yaeP-rof pBAD33 PBAD::yaeP-rof This study 
pGH33tilS pBAD33 PBAD::SDopt::tilS This study 
pNDM220 mini-R1 ts, lacI
q
 PA1/O4/O3, Amp
R
 
Laboratory 
collection 
pSC228 pNDM220 PA1/O4/O3::mazE 
(Pedersen et al., 
2002) 
pKW220 
mini-R1 ts, lacI
q
 PO5/O4, N-terminal FLAG-TEV-
H6 tag, Amp
R 
Laboratory 
collection 
pKW220rtcB pKW220, PO5/O4::FTH-rtcB 
Kristoffer 
Winther 
pNKBOR R6K, mini-Tn10::kan, Kan
R (Rossignol et al., 
2001) 
pMiniHimar R6K, mini-mariner::kan, Kan
R (Rubin et al., 
1999) 
pMG25::frt::kan::frt pMG25, frt::kan::frt 
Laboratory 
collection 
pGH25lacZ pMG25::lacZ::frt::kan::frt This study 
pKD3 R6K, Cml
R
, Amp
R (Datsenko and 
Wanner, 2000) 
pKD46 pSC101 ts, ParaB::γ-β-exo (λ red), Amp
R
 
(Datsenko and 
Wanner, 2000) 
pWRG100 pKD3, I-SceI recognition site, Cml
R
, Amp
R
 
(Blank et al., 
2011) 
pWRG99 pKD46, PtetA::I-SceI, Amp
R (Blank et al., 
2011) 
pCP20 Rep ts, λ PR::flp, λ cI857, Amp
R
 Cml
R 
(Cherepanov and 
Wackernagel, 
1995) 
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Table 3  Oligonucleotides used in this study 
Oligonucleotide 
name 
 
Sequence (5ʹ  3ʹ) 
 
CLONING 
GH-ter-mfeI-cw CCCCCCAATTGGGCATCAAATAAAACGAAAGGC 
GH-ter-ecoRI-
ccw 
CCCCCGAATTCAGTTTGTAGAAACGCAAAAAGG 
GH-ter-eagI-cw 
CCCCCCGGCCGCTTTTGACGTCTTTGGCATCAAATAAAACGAAAGGCT
C 
RTCR1-optSD-f 
CCCCCGGTACCGAATTCAAAATAAGGAGGAAAAAAAAATGCGTAAAA
CAGTGGCTTTTGG 
RTCR2 CCCCCGAATTCAAGCTTCAGGTGCTGACGGACCACC 
RTCR1-optSD-
trunc-f 
CCCCCGGTACCGAATTCAAAATAAGGAGGAAAAAAAAATGACCATGA
TTACCCCGCTTGATTTTCTTAAGTCCGG 
GH-optSD-rpoN 
CCCCCGGATCCGGTACCAAAATAAGGAGGAAAAAAAAATGAAGCAAG
GTTTGCAAC 
GH-rpoN-ccw CCCCCGAATTCAAGCTTTCAAACGAGTTGTTTACGCTGGTTTG 
rtcB-NcoI-
BamHI-f 
CCCCCCCATGGGGATCCAAAATAAGGAGGAAAAAAAAATGAATTACG
AATTACTG 
rtcA-SalI-XhoI-
rv 
CCCCCGTCGACCTCGAGTCATTCAATGCTC 
RTCB1 CCCCCGAATTCAGACGATATTTCATTATCGG 
RTCB2 CCCCCGGATCCATTTTCAGTGGTCAGTAATTCG 
RTCB4 CCCCCGAATTCTTCATTATCGGTAAATTGG 
RTCR6 CCCCCGAATTCGCATAAACAGAGTGTCGG 
RTCR11 CCCCCGAATTCGCATCTTAGATATCCTTATAAAAG 
RTCBmut9-f GTTTTACGCATCTTAGGCGCTCTTATAAAAGACGAT 
RTCBmut9-rv ATCGTCTTTTATAAGAGCGCCTAAGATGCGTAAAAC 
RTCBmut10-f GTTTTACGCATCTTAGGTGTTCTTATAAAAGACGAT 
RTCBmut10-rv ATCGTCTTTTATAAGAACACCTAAGATGCGTAAAAC 
RTCBmut11-f GTTTTACGCATCTTAGTTTTGCTTATAAAAGACGAT 
RTCBmut11-rv ATCGTCTTTTATAAGCAAAACTAAGATGCGTAAAAC 
RTCBmut3-f ATCCTTATAAAAGACAGCGCTTCATTATCGGTAAA 
RTCBmut3-rv TTTACCGATAATGAAGCGCTGTCTTTTATAAGGAT 
RTCBmut4-f ATCCTTATAAAAGACAACACTTCATTATCGGTAAA 
RTCBmut4-rv TTTACCGATAATGAAGTGTTGTCTTTTATAAGGAT 
RTCBmut5-f ATCCTTATAAAAGACCAAAATTCATTATCGGTAAA 
RTCBmut5-rv TTTACCGATAATGAATTTTGGTCTTTTATAAGGAT 
RTCBmut6-f TTACGCATCTTAGGTGTTCTTATAAAAGACAACACTTCATTATCGGTA 
RTCBmut6-rv TACCGATAATGAAGTGTTGTCTTTTATAAGAACACCTAAGATGCGTAA 
RTCBmut7-f TTACGCATCTTAGGTGTTCTTATAAAAGACTAGAGTTCATTATCGGTA 
RTCBmut7-rv TACCGATAATGAACTCTAGTCTTTTATAAGAACACCTAAGATGCGTAA 
RTCBmut8-f TTACGCATCTTAGGTAGCCTTATAAAAGACGGTAGTTCATTATCGGTA 
RTCBmut8-rv TACCGATAATGAACTACCGTCTTTTATAAGGCTACCTAAGATGCGTAA 
RTCBmut2-f CTTAGATGGCCTTATAAAAG 
RTCBmut2-rv ACCGATAATGAAATCCCGTC 
RTCBmutIHF1-f AGATATAATCTTTTTTGAAACAATGAATTAAA 
RTCBmutIHF1-
rv 
TTTAATTCATTGTTTCAAAAAAGATTATATCT 
RTCBmutIHF2-f CAATGAATTAAAAAATCAAGCTGCTTATTTAA 
RTCBmutIHF2-
rv 
TTAAATAAGCAGCTTGATTTTTTAATTCATTG 
RTCBmutIHF7-f CTTTTTTAAAACAATGAATTGCAAAACCCAGCTGCTTATTTAAT 
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Oligonucleotide 
name 
 
Sequence (5ʹ  3ʹ) 
 
RTCBmutIHF7-
rv 
ATTAAATAAGCAGCTGGGTTTTGCAATTCATTGTTTTAAAAAAG 
RTCBmutIHF3-f CTTTTTTAAAACAATGAACTAAAAAATTAAGCTG 
RTCBmutIHF3-
rv 
CAGCTTAATTTTTTAGTTCATTGTTTTAAAAAAG 
RTCBmutIHF4-f 
AGATATAATCTTTTTTGAAACAATGAATTAAAAAATCAAGCTGCTTAT
TTAAT 
RTCBmutIHF4-
rv 
ATTAAATAAGCAGCTTGATTTTTTAATTCATTGTTTCAAAAAAGATTAT
ATCT 
RTCBmutIHF5-f 
AGATATAATCTTTTTTGAAACAATGAACTAAAAAATCAAGCTGCTTAT
TTAAT 
RTCBmutIHF5-
rv 
ATTAAATAAGCAGCTTGATTTTTTAGTTCATTGTTTCAAAAAAGATTAT
ATCT 
RTCBmutIHF8-f 
AGATATAATCTTTTTGGGAACAGCAAGTTGCAAAACCCAGCTGCTTAT
TTAAT 
RTCBmutIHF8-
rv 
ATTAAATAAGCAGCTGGGTTTTGCAACTTGCTGTTCCCAAAAAGATTA
TATCT 
GH-optSD-his6-
rtcR-cw 
CCCCGGTACCGAATTCAAAATAAGGAGGAAAAAAAAATGCATCACCA
TCACCATCACCGTAAAACAGTGGCTTTTGG 
GH-optSD-his6-
rtcR-trunc-cw 
CCCCCGGTACCGAATTCAAAATAAGGAGGAAAAAAAAATGCATCACC
ATCACCATCACCTTGATTTTCTTAAGTCCGG 
GH-optSD-his6-
rtcR-Cterm-cw 
CCCCCGGTACCGAATTCAAAATAAGGAGGAAAAAAAAATGCATCACC
ATCACCATCACTTTGCCACTAGCGGACGC 
GH-optSD-his6-
ihfA-cw 
CCCCCGGTACCGAATTCAAAATAAGGAGGAAAAAAAAATGCATCACC
ATCACCATCACGCGCTTACAAAAGCTGA 
GH-ihfA2-ccw CCCCCTCTAGAGGATCCTTACTCGTCTTTGGGCGAAG 
GH-optSD-
ihfB2-cw 
CCCCCTCTAGAGGATCCAAAATAAGGAGGAAAAAAAAATGACCAAGT
CAGAATTGA 
GH-ihfB2-ccw CCCCCCTGCAGGTCGACTTAACCGTAAATATTGGCGCG 
pRTCR12 CCCCCGAATTCGAAATATCGTCTTTTATAAG 
pRTCR3 CCCCCGGATCCGACAAAGCCAAAAGCCACTG 
pRTCR7 CCCCCGAATTCAAGCCAATTTACCGATAATG 
pRTCR6 CCCCCGAATTCGATTATATCTTTACGTCCG 
pRTCR1 CCCCCGAATTCTGTTTGCTGTCCTGATAATTG 
pRTCRmut1-f CAAAGCCAATTTACCGGGAAGGAAATATCGTCTTTT 
pRTCRmut1-rv AAAAGACGATATTTCCTTCCCGGTAAATTGGCTTTG 
GH-optSD-rof-
cw 
CCCCCGGATCCGGTACCAAAATAAGGAGGAAAAAAAAATGAATGATA
CGTATCAACC 
GH-rof-ccw CCCCCGAATTCAAGCTTTCAGGATTCGCTTACCACC 
GH-rof-cw CCCCCGGATCCGGTACCCATACGCTGCGGCAAAC 
GH-rof-rep15-
ccw 
CCCCCGAATTCAAGCTTGGCGAAACGCTGATTG 
GH-optSD-yaeP-
cw 
CCCCCGGATCCGGTACCAAAATAAGGAGGAAAAAAAAGTGGAAAAAT
ATTGTGAG 
GH-yaeP-ccw CCCCCGGATCCGGTACCAGTGCTGACAGGAGGGCA 
GH-yaeP-cw CCCCCGAATTCAAGCTTTCATTCATTGACATAATCGC 
GH-optSD-tilS-
cw- 
CCCCCGGATCCGGTACCAAAATAAGGAGGAAAAAAAAATGACACTCA
CGCTCAATAG 
GH-tilS-ccw CCCCCGAATTCAAGCTTCCTGCCAGCATCATTTAAT 
RECOMBINATION 
GH-pWRG100-
rpoN-f 
AAGTTTGCGACGTTTTAGCAGGAGAGTACGATTCTGAACCGCCTTACG
CCCCGCCCTGC 
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Oligonucleotide 
name 
 
Sequence (5ʹ  3ʹ) 
 
GH-pWRG100-
rpoN-rv 
GTAATGTTGAGCTGCATAGTGTCTTCCTTATCGGTTGGGCTAGACTATA
TTACCCTGTT 
GH-rpoN-
scarless-1 
GAAGTTTGCGACGTTTTAGCAGGAGAGTACGATTCTGAACCCCAACCG
ATAAGGAAGACACTATGCAGCTCAACATTACC 
GH-rpoN-
scarless-2 
GGTAATGTTGAGCTGCATAGTGTCTTCCTTATCGGTTGGGGTTCAGAAT
CGTACTCTCCTGCTAAAACGTCGCAAACTTC 
GH-lacZ-SD4-
ecoRI-cw 
CCCCCGAATTCAAGGAGGATAAATGACCATGATTACGGATTC 
GH-lacZ-bamHI-
ccw 
CCCCCGGATCCTTATTTTTGACACCAGACC 
GH-rtcBA-
SD4lacZ-cw 
TTAGTTTGATAGAAACAGATGGCGTAACGCGGGTGAGCATTGAATGAT
GCAAGGAGGATAAATGACCATG 
GH-rtcBA-lacZ-
ccw 
ACGGCGTGTAAGTTTAGCCGGATAACGCGCCAGATCCGGCTTACATCT
CTCCTCCTTAGTTCCTATTCC 
GH-pWRG100-
rtcR-f 
ACCGATAATGAAATATCGTCTTTTATAAGGATATCTAAGCGCCTTACG
CCCCGCCCTGC 
GH-pWRG100-
rtcR2-rv 
CTTTGCCTGGCGGCAGATAGCGATAACGTGTTCCAGTTGCTAGACTAT
ATTACCCTGTT 
GH-rtcR2-
scarless-1 
AAGCCAATTTACCGATAATGAAATATCGTCTTTTATAAGGATATCTAA
GCAACTGGAACACGTTATCGCTATCTGCCGCCAGGCAAAGTCGCTTTC
CGC 
GH-rtcR2-
scarless-2 
GCGGAAAGCGACTTTGCCTGGCGGCAGATAGCGATAACGTGTTCCAGT
TGCTTAGATATCCTTATAAAAGACGATATTTCATTATCGGTAAATTGGC
TT 
GH-pKD3-
rtcBA-f 
ATTAAAAAATTAAGCTGCTTATTTAATTTTCTGGCACGACGTGTAGGCT
GGAGCTGCTTC 
GH-pKD3-
rtcBA-rv 
TTAGCCGGATAACGCGCCAGATCCGGCTTACATCTCTGCACATATGAA
TATCCTCCTTAG 
GH-pKD3-
rtcBAR-f 
AAGCTGGCGTCCGGCTGCGGAAAGCGACTTTGCCTGGCGGGTGTAGGC
TGGAGCTGCTTC 
GH-pWRG100-
rtcRmut-rv 
CAGTACGGTACCGACAAAGCCAAAAGCCACTGTTTTACGCTAGACTAT
ATTACCCTGTT 
GH-rtcRmut-1 
AAGCCAATTTACCGATAATGAAATATCGTCTTTTATAAGGATATCTAA
GTAGCGTAAAACAGTGGCTTTTGGCTTTGTCGGTACCGTACTGGATTA
TGC 
GH-rtcRmut-2 
GCATAATCCAGTACGGTACCGACAAAGCCAAAAGCCACTGTTTTACGC
TACTTAGATATCCTTATAAAAGACGATATTTCATTATCGGTAAATTGGC
TT 
COLONY PCR AND SEQUENCING 
GH-rtcA-orf-cw  GAGGTGGTTGCGGCACAG 
GH-rtcA-flank-rv ACAACACGCCCAGCAATTGC 
pGH254amp-cw TAGGGGTTCCGCGCACATTTCCC 
pGH254-ccw GCGATTAAGTTGGGTAAC 
pGH254kan-cw TTGAATATGGCTCATAACAC 
pBAD-fw CGCAACTCTCTACTGTTTCTC 
pBAD-rv CCGCTTCTGCGTTCTG 
pMG25-f GAGTGTTGACTTGTGAGCGG 
pMG25-rv GGAGTTCTGAGGTCATTACTGG 
GH-ihfA-cw GATTCCAGGCATCATTGAGG 
GH-ihfA-ccw GCAGAGCGGCCTTTTTAG 
GH-ihfB-cw ATTTGCCTTTAAGGAACCGG 
GH-ihfB-ccw GTGCTTTTCTCTCGTTCAAG 
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Oligonucleotide 
name 
 
Sequence (5ʹ  3ʹ) 
 
GH-rpoN-flank-
cw 
CACGCCTACAGAAATCTTAC 
GH-rpoN-flank-
ccw 
GAACAACATAGACCTGGTTGATTC 
RTCR1 CCCCCGGATCCGGTACCTACCGATAATGAAATATCGTC 
delta-rtcB-f ACGGTTGCAATTATCAGG 
delta-rtcB-rv CGCCATCCAGCGCAATC 
Seq-rtcB-f2 GTAATGAGCCGAACTAAAG 
GH-rtcR-flank-
end-f 
GCATGGTAGATGCCGTCTAC 
pBR322-cw CACTATCGACTACGC 
pBR322-ccw CGATGCGTCCGGCGT 
pEG25-f GCGTATCACGAGGCCCTTTC 
ARBITRARY PCR 
OR7 GTGACACAGGAACACTTAACGGCTGACATGG 
OR8 GTCGACGTCATATGGATCCG 
OR9 CATTAAACGCGTATTCAGGCTGACCCTGCG 
OR10 CCGGATTACAGGGATCGATC 
ARB1A CCACGCGTCGACTAGTACNNNNNNNNNNNGATAT 
ARB2A CCACGCGTCGACTAGTAC 
EMSA 
RTCR9-f CAGTACGGTACCGACAAAG 
RTCB1-f AGACGATATTTCATTATCGG 
RTCB3-rv GTTTGCTGTCCTGATAATTG 
hicA-f2 CTGGAATCTTCCTTCCTGAT 
hicA-rv CTCGCTTTGTTTCACATCGCC 
CRAC 
miRCat-33 linker rApp-TGGAATTCTCGGGTGCCAAGG-ddC 
L5Aa linker InvddT-ACACrGrArCrGrCrUrCrUrUrCrCrGrArUrCrUrNrNrNrUrArArGrC 
L5Ab linker InvddT-ACACrGrArCrGrCrUrCrUrUrCrCrGrArUrCrUrNrNrNrArUrUrArGrC 
L5Ad linker 
InvddT-
ACACrGrArCrGrCrUrCrUrUrCrCrGrArUrCrUrNrNrNrCrGrCrUrUrArGrC 
L5Bb linker InvddT-ACACrGrArCrGrCrUrCrUrUrCrCrGrArUrCrUrNrNrNrGrUrGrArGrC 
miRCat RT CCTTGGCACCCGAGAATT 
PE_miRCat  
CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGGCCTTGG
CACCCGAGAATTCC 
P5 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCT
CTTCCGATCT 
(A denotes adenosine; T denotes thymidine; C denotes cytidine; G denotes guanosine; U denotes 
uridine; N denotes random nucleotides; r denotes a ribonucleotide rather than a deoxyribonucleotide; 
App denotes an activated A; ddC denotes a di-deoxycytidine; InvddT denotes an inverted di-
deoxythymidine) 
 Strain construction 2.3
GH01 (MG1655ΔrpoN), GH02 (TB28ΔrpoN).  A scarless rpoN deletion was made in the 
chromosome of E. coli strains MG1655 and TB28 using the phage λ red recombination and 
mutagenesis method outlined in Blank et al. (2011).  First, primers GH-pWRG100-rpoN-f and 
GH-pWRG100-rpoN-rv were used with plasmid pWRG100 as a template to generate a PCR 
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product with 40 bp homology extensions flanking the chloramphenicol resistance gene and 
the I-SceI restriction endonuclease recognition site.  200 ng of PCR product were 
electroporated (Section 2.6) into the relevant strain of E. coli and recombined into the 
chromosome by inducing expression of the phage λ red recombinase genes from pWRG99 
with 0.2% arabinose.  Successful recombinants were selected by growing on NA 
supplemented with 50 µg/ml chloramphenicol.  In the second step, the chloramphenicol 
resistance gene and the I-SceI recognition site were replaced by double-stranded (ds)DNA 
fragments, which were generated by annealing equal amounts (500 nM) of oligonucleotides 
GH-rpoN-scarless-1 and GH-rpoN-scarless-2 in the presence of 150 mM NaCl at 95°C for 15 
minutes, cooling to RT then desalting the resultant dsDNA on Illustra MicroSpin G-25 
columns (GE Healthcare).  The resulting dsDNA fragment consists of 40 bp of homologous 
sequence immediately upstream and 40 bp of homologous sequence immediately downstream 
of rpoN and, as with the first step of recombination, was introduced into the chromosome by 
expressing phage λ red recombinase genes from pWRG99.  Successful recombinants with a 
large colony phenotype indicative of resistance to I-SceI were selected on NA supplemented 
with 100 µg/ml ampicillin (to maintain pWRG99) and 0.5 µg/ml anhydrotetracycline (to 
induce expression of I-SceI from pWRG99).  Correct insertion of the chloramphenicol 
resistance marker and I-SceI site and subsequent generation of a scarless and markerless rpoN 
deletion was verified by colony PCR and sequencing using primers GH-rpoN-flank-cw and 
GH-rpoN-flank-ccw. 
GH03 (TB28rtcBA-lacZ).  The lacZ gene was recombined into the E. coli TB28 chromosome 
by phage λ red recombination as described by Datsenko and Wanner (2000).  Primers GH-
lacZ-SD4-ecoRI-cw and GH-lacZ-bamHI-ccw were used to amplify the lacZ gene with 
Shine-Dalgarno sequence AAGGAGGATAA (SD4) from genomic MG1655 template DNA.  
The PCR product was digested with EcoRI and BamHI and ligated into pMG25::frt::kan::frt, 
a pMG25 variant carrying a kanamycin resistance gene flanked by frt sites, generating 
pGH25lacZ.  Primers GH-rtcBA-SD4lacZ-cw and GH-rtcBA-lacZ-ccw were used with 
pGH25lacZ as template DNA to amplify the SD4-lacZ::frt::kan::frt cassette flanked by 40 bp 
homology extensions for the end of the rtcA gene.  100 ng of PCR product was electroporated 
(Section 2.6) into E. coli strain TB28 and recombined into the chromosome by inducing 
expression of the phage λ red recombinase genes from pKD46 with 0.2% arabinose.  
Successful recombination events were screened for by growing selectively on NA with 25 
µg/ml kanamycin.  Subsequently, the antibiotic resistance marker was removed by frt site 
recombination using pCP20 (Cherepanov and Wackernagel, 1995).  Correct insertion of lacZ 
48 
 
into the end of the rtcBA operon and subsequent removal of the antibiotic resistance gene was 
verified by colony PCR and sequencing using primers GH-rtcA-orf-cw and GH-rtcA-flank-rv. 
GH04 (TB28rtcBA-lacZΔihfA::kan).  The ihfA gene was deleted from the chromosome of 
TB28rtcBA-lacZ (recipient strain) by P1 transduction, using the relevant strain of the Keio 
collection (Baba et al., 2006) as donor.  Donor strain JW1702 was diluted from an ON culture 
into fresh LB medium containing 25 µg/ml kanamycin, 10 mM MgSO4 and 10 mM CaCl2 and 
grown exponentially at 37°C with aeration.  The culture was incubated for 1 hour at 37°C 
upon addition of 100µl of stock P1 phage then transferred to 37°C with aeration until cell 
lysis occurred.  The lysate was incubated for 10 minutes at room temperature (RT) with 0.1 
volume of chloroform then centrifuged for 5 minutes at 5000 rpm and the supernatants (P1 
lysates) collected.  A single colony of recipient strain TB28rtcBA-lacZ was grown at 37°C 
with aeration to stationary phase.  25 mM CaCl2 was added to the culture and incubated at 
37°C with aeration for 20 minutes.  100 µl donor P1 lysate was mixed with 1 ml recipient 
culture and incubated at 37°C for 10 minutes, after which 500 µl LB supplemented with 10 
mM sodium citrate was added.  Following 60 minutes incubation at 37°C, cells were 
harvested, plated on NA containing 25 µg/ml kanamycin and 10 mM sodium citrate and 
incubated overnight at 37°C.  The resulting colonies carry the kanamycin resistance gene in 
place of the ihfA gene.  Insertion of the kanamycin resistance gene at the correct position was 
verified by colony PCR using primers GH-ihfA-cw and GH-ihfA-ccw.  
GH05 (TB28rtcBA-lacZΔihfB::kan).  The ihfB gene was deleted from the chromosome of 
recipient strain TB28rtcBA-lacZ using donor strain JW0895 from the Keio collection by P1 
phage transduction, as described for GH04.  Insertion of the kanamycin resistance gene at the 
ihfB locus was verified by colony PCR using primers GH-ihfB-cw and GH-ihfB-ccw. 
GH06 (MG1655ΔrtcR), GH07 (TB28ΔrtcR).  A scarless rtcR deletion was made in MG1655 
and TB28 using the phage λ red recombination and mutagenesis method outlined in Blank et 
al. (2011).  The details of the two-step recombination are the same as described for GH01 and 
GH02.  Primers GH-pWRG100-rtcR-f and GH-pWRG100-rtcR2-rv were used with template 
pWRG100 to generate a PCR product for step 1.  For step 2, dsDNA was generated using 
primers GH-rtcR2-scarless-1 and GH-rtcR2-scarless-2, containing 40 bp of homologous 
sequence immediately upstream and 40 bp of homologous sequence at the 3ʹ-end of rtcR 
(leaving the transcription terminator which overlaps the 3ʹ-end of rtcR intact).  Correct 
insertion of the chloramphenicol resistance marker and I-SceI site (step 1) and subsequent 
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generation of a scarless and markerless deletion (step 2) was verified by colony PCR and 
sequencing using primers RTCR1 and RTCR2. 
GH08 (MG1655ΔrtcB).  The rtcB gene was deleted from the chromosome of recipient strain 
MG1655 using donor strain JW3384 from the Keio collection by P1 phage transduction, as 
described for GH04.  The antibiotic resistance marker replacing rtcB in the resulting colonies 
was removed by transformation of pCP20 and culturing according to the protocol described in 
Cherepanov and Wackernagel (1995).  Insertion of the kanamycin resistance gene at the rtcB 
locus and its subsequent removal was verified by colony PCR using primers delta-rtcB-f and 
delta-rtcB-rv. 
GH09 (MG1655ΔrtcA).  The rtcA gene was deleted from the chromosome of recipient strain 
MG1655 using donor strain JW5688 from the Keio collection by P1 phage transduction, as 
described for GH04.  The antibiotic resistance marker replacing rtcA in the resulting colonies 
was removed by transformation of pCP20 (Cherepanov and Wackernagel, 1995).  Insertion of 
the kanamycin resistance gene at the rtcA locus and its subsequent removal was verified by 
colony PCR using primers Seq-rtcB-f2 and GH-rtcA-flank-rv. 
GH10 (MG1655ΔrtcBA).  The rtcBA operon was deleted from MG1655 by phage λ red 
recombination as described by Datsenko and Wanner (2000).  Primers GH-pKD3-rtcBA-f and 
GH-pKD3-rtcBA-rv were used with plasmid pKD3 as a template to generate a PCR product 
with 40 bp homology extensions flanking a chloramphenicol resistance gene.  100 ng of PCR 
product was electroporated (Section 2.6) into the relevant strain of E. coli and recombined 
into the chromosome by inducing expression of the phage λ red recombinase genes from 
pKD46 with 0.2% arabinose.  Successful recombination events were screened for by growing 
selectively on NA containing 50 µg/ml chlorampheniol.  Subsequently, the antibiotic 
resistance marker was removed using pCP20 (Cherepanov and Wackernagel, 1995).  Correct 
insertion and subsequent removal of the antibiotic resistance gene was verified by colony 
PCR and sequencing using primers delta-rtcB-f and GH-rtcA-flank-rv. 
GH11 (MG1655ΔrtcBAR).  The rtcBAR locus was deleted from MG1655 by phage λ red 
recombination as described for GH10, using primers GH-pKD3-rtcBAR-f and GH-pKD3-
rtcBA-rv with template pKD3 to generate the PCR product.   Correct insertion and subsequent 
removal of the antibiotic resistance gene was verified by colony PCR and sequencing using 
primers GH-RtcR-flank-end-f and GH-rtcA-flank-rv. 
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GH12 (MG1655rtcR
M1X
), GH13 (TB28rtcR
M1X
).  Site-directed mutations of the rtcR start 
codon were made in the chromosome of MG1655 and TB28 using the phage λ red 
recombination and mutagenesis method outlined in Blank et al. (2011).  The details of the 
two-step recombination are the same as described for GH01 and GH02.  Primers GH-
pWRG100-rtcR-f and GH-pWRG100-rtcRmut-rv were used with template pWRG100 to 
generate a PCR product for step 1.  For step 2, primers GH-rtcRmut-1 and GH-rtcRmut-2 
were used to generate dsDNA containing 40 bp of homologous sequence immediately 
upstream of rtcR, followed by the nucleotides to replace the rtcR start codon and 40 bp of 
homologous sequence immediately downstream of the rtcR start codon, producing an in-
frame and scarless substitution of the rtcR start codon to a stop codon (ATGTAG; M1X).  
Correct insertion of the chloramphenicol resistance marker and I-SceI site (step 1) and 
subsequent generation of a scarless and markerless deletion (step 2) was verified by colony 
PCR and sequencing using primers RTCR1 and RTCR2. 
GH14 (SC28ΔrtcB).  The rtcB gene was deleted from the chromosome of recipient strain 
SC28 using donor strain JW3384 from the Keio collection by P1 phage transduction, as 
described for GH04.  The antibiotic resistance marker replacing rtcB in the resulting colonies 
was removed by transformation of pCP20 (Cherepanov and Wackernagel, 1995).  Insertion of 
the kanamycin resistance gene at the rtcB locus and its subsequent removal was verified by 
colony PCR using primers delta-rtcB-f and delta-rtcB-rv. 
 Plasmid construction 2.4
2.4.1 Transcriptional fusions 
All transcriptional fusion plasmids were verified by colony PCR and sequencing using 
primers pGH254amp-cw and pGH254-ccw for ampicillin-resistant derivatives of pOU254 and 
primers pGH254kan-cw and pGH254-ccw for kanamycin-resistant derivatives of pOU254K. 
pGH254.  Transcription terminators of the rrnB operon (terrrnB) were amplified from genomic 
E. coli K-12 MG1655 template DNA using primers GH-ter-mfeI-cw and GH-ter-ecoRI-ccw.  
The PCR product was digested with MfeI and EcoRI and ligated into the EcoRI-digested 
lacZYA transcriptional fusion vector pOU254.  The resulting ampicillin resistant plasmid has 
two terminators upstream of the multiple cloning site (MCS). 
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pGH254K.  Transcription terminators of the rrnB operon (terrrnB) were amplified using 
primers GH-ter-eagI-cw and GH-ter-ecoRI-ccw.  The PCR product and lacZYA transcriptional 
fusion vector pOU254K was digested with EagI and EcoRI and ligated. The resulting 
kanamycin resistant plasmid has two terminators upstream of the MCS.  
pGH254BA0.  A fragment starting at -133 bp relative to the rtcBA transcription start site (+1) 
and containing the first 30 bp of rtcB was amplified with primers RTCB4 and RTCB2 using 
genomic E. coli MG1655 template DNA.  The PCR product and pGH254 were digested with 
EcoRI and BamHI and ligated.  The resulting plasmid carries a transcriptional rtcBA-lacZYA 
fusion known as BA0. 
pGH254BA1.  Primers RTCB1 and RTCB2 were used to amplify a fragment starting at -142 
bp relative to the rtcBA transcription start site (+1) and containing the first 30 bp of rtcB from 
genomic E. coli MG1655 template DNA.  The PCR product and pGH254 were digested with 
EcoRI and BamHI and ligated.  The resulting plasmid carries a transcriptional rtcBA-lacZYA 
fusion known as BA1. 
pGH254BA2.  A fragment starting at -164 bp relative to the rtcBA transcription start site (+1) 
and containing the first 30 bp of rtcB was amplified with primers RTCR11 and RTCB2 using 
genomic E. coli MG1655 template DNA.  The PCR product and pGH254 were digested with 
EcoRI and BamHI and ligated.  The resulting plasmid carries a transcriptional rtcBA-lacZYA 
fusion known as BA2. 
pGH254KBA2.  As described for pGH254BA2, except the PCR product was ligated into 
pGH254K. 
pGH254BA3.  Primers RTCR6 and RTCB2 were used to amplify a fragment starting at -262 
bp relative to the rtcBA transcription start site (+1) and containing the first 30 bp of rtcB from 
genomic E. coli MG1655 template DNA.  The PCR product and pGH254 were digested with 
EcoRI and BamHI and ligated.  The resulting plasmid carries a transcriptional rtcBA-lacZYA 
fusion known as BA3. 
pGH254BA3-IRM1.  To introduce mutations into the putative RtcR binding site rtcO, primers 
RTCBmut9-rv and RTCBmut9-f carrying mutations in the inverted repeat (IR) were 
combined with primers RTCR6 and RTCB2 respectively, using pGH254BA3 template DNA.  
0.2 pmol of each of the PCR fragments, which are homologous at the terminals carrying 
mutations, were combined as templates for a second PCR reaction with primers RTCR6 and 
RTCB2.  The PCR product and pGH254 were digested with EcoRI and BamHI and ligated.  
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The resulting plasmid carries a transcriptional rtcBA-lacZYA fusion known as BA3-IRM1, 
which has ATATC to GCGCT substitutions in the first half of the rtcO. 
pGH254BA3-IRM2.  As described for pGH254BA3-IRM1, except that primers RTCBmut10-rv 
and RTCBmut10-f carrying mutations in rtcO were combined with primers RTCR6 and 
RTCB2 respectively in the first round of PCR.  The resulting plasmid carries a transcriptional 
rtcBA-lacZYA fusion known as BA3-IRM2, which has substitutions at the 1
st
 (A to G), 3
rd
 (A 
to G) and 5
th
 (C to T) positions in the first half of the IR. 
pGH254BA3-IRM3.  As described for pGH254BA3-IRM1, except that primers RTCBmut11-rv 
and RTCBmut11-f carrying mutations in rtcO were combined with primers RTCR6 and 
RTCB2 respectively in the first round of PCR.  The resulting plasmid carries a transcriptional 
rtcBA-lacZYA fusion known as BA3-IRM3, which has substitutions at the 1
st
 (A to T), 3
rd
 (A to 
T) and 5
th
 (C to G) positions in the first half of the IR. 
pGH254BA3-IRM4.  As described for pGH254BA3-IRM1, except that primers RTCBmut3-rv 
and RTCBmut3-f carrying mutations in rtcO were combined with primers RTCR6 and 
RTCB2 respectively in the first round of PCR.  The resulting plasmid carries a transcriptional 
rtcBA-lacZYA fusion known as BA3-IRM4, which has GATAT to AGCGC substitutions in the 
second half of the IR. 
pGH254BA3-IRM5.  As described for pGH254BA3-IRM1, except that primers RTCBmut4-rv 
and RTCBmut4-f carrying mutations in rtcO were combined with primers RTCR6 and 
RTCB2 respectively in the first round of PCR.  The resulting plasmid carries a transcriptional 
rtcBA-lacZYA fusion known as BA3-IRM5, which has substitutions at the 1
st
 (G to A), 3
rd
 (T to 
C) and 5
th
 (T to C) positions in the second half of the IR. 
pGH254BA3-IRM6.  As described for pGH254BA3-IRM1, except that primers RTCBmut5-rv 
and RTCBmut5-f carrying mutations in rtcO were combined with primers RTCR6 and 
RTCB2 respectively in the first round of PCR.  The resulting plasmid carries a transcriptional 
rtcBA-lacZYA fusion known as BA3-IRM6, which has substitutions at the 1
st
 (G to C), 3
rd
 (T to 
A) and 5
th
 (T to A) positions in the second half of the IR. 
pGH254BA3-IRM7.  As described for pGH254BA3-IRM1, except that primers RTCBmut6-rv 
and RTCBmut6-f carrying mutations in rtcO were combined with primers RTCR6 and 
RTCB2 respectively in the first round of PCR.  The resulting plasmid carries a transcriptional 
rtcBA-lacZYA fusion known as BA3-IRM7, which has substitutions at the 1
st
 (A to G), 3
rd
 (A 
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to G) and 5
th
 (C to T) positions in the first half and at the 1
st
 (G to A), 3
rd
 (T to C) and 5
th
 (T to 
C) positions in the second half of the IR. 
pGH254BA3-IRM8.  As described for pGH254BA3-IRM1, except that primers RTCBmut7-rv 
and RTCBmut7-f carrying mutations in rtcO were combined with primers RTCR6 and 
RTCB2 respectively in the first round of PCR.  The resulting plasmid carries a transcriptional 
rtcBA-lacZYA fusion known as BA3-IRM8, which has substitutions at the 1
st
 (A to G), 3
rd
 (A 
to G) and 5
th
 (C to T) positions in the first half and at the 1
st
 (G to T), 3
rd
 (T to G) and 5
th
 (T to 
G) positions in the second half of the IR. 
pGH254BA3-IRM9.  As described for pGH254BA3-IRM1, except that primers RTCBmut8-rv 
and RTCBmut8-f carrying mutations in rtcO were combined with primers RTCR6 and 
RTCB2 respectively in the first round of PCR.  The resulting plasmid carries a transcriptional 
rtcBA-lacZYA fusion known as BA3-IRM9, which has substitutions at the 1
st
 (A to G) and 4
th
 
(T to G) positions in the first half and at the 2
nd
 (A to G) and 5
th
 (T to G) positions in the 
second half of the IR. 
pGH254BA3-IRM10.  As described for pGH254BA3-IRM1, except that primers RTCBmut2-rv 
and RTCBmut2-f carrying mutations in rtcO were combined with primers RTCR6 and 
RTCB2 respectively in the first round of PCR.  The resulting plasmid carries a transcriptional 
rtcBA-lacZYA fusion known as BA3-IRM10, which has substitutions at the 3
rd
 (A to G) and 4
th
 
(T to G) positions in the first half and at the 2
nd
 (A to G) and 3
rd
 (T to G) positions in the 
second half of the IR. 
pGH254BA3-IHFM1.  To introduce mutations into the putative IHF binding sites, primers 
RTCBmutIHF1-rv and RTCBmutIHF1-f carrying a mutation in IHF site 1 (ihf1) were 
combined with primers RTCR6 and RTCB2 respectively, using pGH254BA3 template DNA.  
0.2 pmol of each of the PCR fragments, which are homologous at the terminals carrying the 
mutation, were combined as templates for a second PCR reaction with primers RTCR6 and 
RTCB2.  The PCR product and pGH254 were digested with EcoRI and BamHI and ligated.  
The resulting plasmid carries a transcriptional rtcBA-lacZYA fusion known as BA3-IHFM1, 
which has an A to G substitution in ihf1. 
pGH254BA3-IHFM2.  As described for pGH254BA3-IHFM1, except that primers 
RTCBmutIHF2-rv and RTCBmutIHF2-f carrying mutations in IHF site 2 (ihf2) were 
combined with primers RTCR6 and RTCB2 respectively in the first round of PCR.  The 
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resulting plasmid carries a transcriptional rtcBA-lacZYA fusion known as BA3-IHFM2, which 
has an T to C substitution in ihf2. 
pGH254BA3-IHFM3.  As described for pGH254BA3-IHFM1, except that primers 
RTCBmutIHF7-rv and RTCBmutIHF7-f carrying mutations in ihf2 were combined with 
primers RTCR6 and RTCB2 respectively in the first round of PCR.  The resulting plasmid 
carries a transcriptional rtcBA-lacZYA fusion known as BA3-IHFM3, which has AA----TTA to 
GC----CCC substitutions in ihf2.  
pGH254BA3-IHFM4.  As described for pGH254BA3-IHFM1, except that primers 
RTCBmutIHF3-rv and RTCBmutIHF3-f carrying mutations in the IHF binding sites were 
combined with primers RTCR6 and RTCB2 respectively in the first round of PCR.  The 
resulting plasmid carries a transcriptional rtcBA-lacZYA fusion known as BA3-IHFM4, which 
has a T to C substitution in the overlapping region of ihf1 and ihf2. 
pGH254BA3-IHFM5.  As described for pGH254BA3-IHFM1, except that primers 
RTCBmutIHF4-rv and RTCBmutIHF4-f carrying mutations in the IHF binding sites were 
combined with primers RTCR6 and RTCB2 respectively in the first round of PCR.  The 
resulting plasmid carries a transcriptional rtcBA-lacZYA fusion known as BA3-IHFM5, which 
has an A to G substitution in ihf1 and a T to C substitution in ihf2.   
pGH254BA3-IHFM6.  As described for pGH254BA3-IHFM1, except that primers 
RTCBmutIHF5-rv and RTCBmutIHF5-f carrying mutations in the IHF binding sites were 
combined with primers RTCR6 and RTCB2 respectively in the first round of PCR.  The 
resulting plasmid carries a transcriptional rtcBA-lacZYA fusion known as BA3-IHFM6, which 
has an A to G substitution in ihf1, a T to C substitution in ihf2 and a T to C substitution in the 
overlapping region of ihf1 and ihf2. 
pGH254BA3-IHFM7.  As described for pGH254BA3-IHFM1, except that primers 
RTCBmutIHF8-rv and RTCBmutIHF8-f carrying mutations in the IHF binding sites were 
combined with primers RTCR6 and RTCB2 respectively in the first round of PCR.  The 
resulting plasmid carries a transcriptional rtcBA-lacZYA fusion known as BA3-IHFM7, which 
has TAA----ATG--T-AA----TTA to GGC----GCA--C-GC----CCC substitutions in ihf1 and 
ihf2. 
pGH254R0.  A fragment beginning 30 bp upstream of the start codon of rtcR and containing 
the first 30 bp of rtcR was amplified with primers pRTCR12 and pRTCR3 using genomic E. 
coli MG1655 template DNA.  The PCR product and pGH254 were digested with EcoRI and 
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BamHI and ligated.  The resulting plasmid carries a transcriptional rtcR-lacZYA fusion known 
as R0. 
pGH254R1.  A fragment starting 49 bp upstream of rtcR and containing the first 30 bp of rtcR 
was amplified with primers pRTCR7 and pRTCR3 using MG1655 template DNA.  The PCR 
product and pGH254 were digested with EcoRI and BamHI and ligated.  The resulting 
plasmid carries a transcriptional rtcR-lacZYA fusion known as R1. 
pGH254R2.  A fragment starting 87 bp upstream of rtcR and containing the first 30 bp of rtcR 
was amplified with primers pRTCR6 and pRTCR3 using MG1655 template DNA.  The PCR 
product and pGH254 were digested with EcoRI and BamHI and ligated.  The resulting 
plasmid carries a transcriptional rtcR-lacZYA fusion known as R2. 
pGH254R3.  A fragment starting 169 bp upstream of rtcR and containing the first 30 bp of 
rtcR was amplified with primers pRTCR1 and pRTCR3 using MG1655 template DNA.  The 
PCR product and pGH254 were digested with EcoRI and BamHI and ligated.  The resulting 
plasmid carries a transcriptional rtcR-lacZYA fusion known as R3. 
pGH254KR3.  As described for pGH254R3, except the PCR product was ligated into 
pGH254K. 
pGH254R3mut10.  To introduce mutations into the hypothetical -10 site of rtcR, primers 
pRTCRmut1-rv and pRTCRmut1-f were combined with primers pRTCR1 and pRTCR3 
respectively, using pGH254R3 template DNA.  0.2 pmol of each of the PCR fragments, 
which are homologous at the terminals carrying the mutation, were combined as templates for 
a second PCR reaction with primers pRTCR1 and pRTCR3.  The PCR product and pGH254 
were digested with EcoRI and BamHI and ligated.  The resulting plasmid carries a 
transcriptional rtcR-lacZYA fusion known as R3mut10, which has GATAAT to GGGAAG 
substitutions in the hypothetical -10 of rtcR. 
2.4.2 Overexpression of rtc genes 
All genes were expressed from an optimal Shine-Dalgarno sequence (UAAGGAGG) with a 
spacing of 8 nucleotides as described by Ringquist et al. (1992), which was encoded in the 
forward primer, unless otherwise stated. 
pGH332R.  The complete open reading frame (ORF) of rtcR was PCR amplified using 
genomic E. coli MG1655 template DNA with primers RTCR1-optSD-f and RTCR2.  The 
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PCR product was digested with EcoRI and HindIII and ligated into pBAD322K, producing a 
plasmid expressing wild-type (WT) RtcR with an optimised Shine-Dalgarno (SDopt) sequence 
from the AraC-regulated PBAD promoter.  Correct clones were verified by colony PCR and 
sequencing using pBAD-fw and pBAD-rv. 
pGH332CR.  As described for pGH332R, except the PCR product was ligated into 
pBAD322C. 
pGH332RΔN.  Oligonucleotides RTCR1-optSD-trunc-f and RTCR2 were used to amplify a 
truncated form of rtcR (rtcRΔN), which lacks the first 534 nucleotides of rtcR (Genschik et 
al., 1998), from MG1655 template DNA.  The PCR product was digested with EcoRI and 
HindIII and ligated into pBAD322K.  The resulting plasmid expresses an N-terminally 
truncated RtcR with an SDopt sequence from AraC-regulated PBAD promoter.  Correct clones 
were verified by colony PCR and sequencing using pBAD-fw and pBAD-rv. 
pGH332CRΔN.  As described for pGH332R, except the PCR product was ligated into 
pBAD322C. 
pGH25rtcBA.  Oligonucleotides rtcB-NcoI-BamHI-f and rtcA-SalI-XhoI-rv were used to 
amplify rtcBA from MG1655 template DNA.  The PCR product and vector pMG25 were 
digested with BamHI and SalI and ligated.  The resulting plasmid expresses RtcB and RtcA 
from the LacI-regulated PA1/O4/O3 promoter.  Correct clones were verified by colony PCR and 
sequencing using pMG25-f and pMG25-rv. 
2.4.3 Expression of tagged rtc genes 
All genes were expressed from an optimal Shine-Dalgarno sequence (UAAGGAGG) with an 
optimal spacing of 8 nucleotides as described by Ringquist et al. (1992), which was encoded 
in the forward primer, unless otherwise stated. 
pGH33H6R.  Primers GH-optSD-his6-rtcR-cw and RTCR2 were used to amplify rtcR from 
genomic E. coli MG1655 template DNA.  The PCR product and vector pBAD33 were 
digested with KpnI and HindIII and ligated.  The resulting plasmid expresses His6-tagged 
RtcR with an SDopt sequence from the AraC-regulated PBAD promoter.  Correct clones were 
verified by colony PCR and sequencing using pBAD-fw and pBAD-rv. 
pGH33H6RΔN.  Primers GH-optSD-his6-rtcR-trunc-cw and RTCR2 were used to amplify 
rtcRΔN from MG1655 template DNA.  The PCR product and vector pBAD33 were digested 
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with KpnI and HindIII and ligated.  The resulting plasmid expresses His6-tagged RtcRΔN 
with an SDopt sequence from the AraC-regulated PBAD promoter.  Correct clones were verified 
by colony PCR and sequencing using pBAD-fw and pBAD-rv. 
pGH25H6RC.  Primers GH-optSD-his6-rtcR-Cterm-cw and RTCR2 were used to amplify 
truncated rtcR lacking the first 1272 bp (rtcRC-term) from MG1655 template DNA.  The PCR 
product and vector pMG25 were digested with EcoRI and HindIII and ligated.  The resulting 
plasmid expresses His6-tagged RtcRC-term with an SDopt sequence from the LacI-regulated 
PA1/O4/O3 promoter.  Correct clones were verified by colony PCR and sequencing using 
pMG25-f and pMG25-rv. 
2.4.4 Others 
All genes were expressed from an optimal Shine-Dalgarno sequence (UAAGGAGG) with an 
optimal spacing of 8 nucleotides as described by Ringquist et al. (1992), which was encoded 
in the forward primer unless otherwise stated. 
pGH25rpoN.  Primers GH-optSD-rpoN-cw and GH-rpoN-ccw were used to ampify the rpoN 
gene from genomic E. coli MG1655 template DNA.  The PCR product and vector pMG25 
were digested with BamHI and HindIII and ligated.  The resulting plasmid expresses σ54 with 
an SDopt sequence from the LacI-regulated PA1/O4/O3 promoter.  Correct clones were verified 
by colony PCR and sequencing using pMG25-f and pMG25-rv. 
pGH33H6IHF.  Oligonucleotides GH-optSD-his6-ihfA-cw and GH-ihfA2-ccw were used to 
amplify the ihfA gene from MG1655 template DNA.  The PCR product and vector pBAD33 
were digested with KpnI and XbaI and ligated.  Next, primers GH-optSD-ihfB2-cw and GH-
ihfB2-ccw were used to amplify ihfB from MG1655 template DNA.  The PCR product was 
digested with XbaI and PstI and ligated into pBAD33::PBAD::SDopt::H6-ihfA digested with the 
same restriction enzymes.  The resulting plasmid expresses His6-tagged IHFα with an SDopt 
sequence and IHFβ with an SDopt sequence from the AraC-regulated PBAD promoter.  Correct 
clones were verified by colony PCR and sequencing using pBAD-fw and pBAD-rv. 
pGH251.  Primers pRTCR1 and RTCR11 were used to amplify the rtcBA-rtcR intergenic 
sequence from MG1655 template DNA.  The PCR product and vector pMG25 were digested 
with BamHI and EcoRI and ligated.  Correct clones were verified by colony PCR and 
sequencing using pMG25-f and pMG25-rv. 
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pGH252.  Primers pRTCR1 and RTCB4 were used to amplify the rtcBA-rtcR intergenic 
sequence excluding rtcO from MG1655 template DNA.  The PCR product and vector pMG25 
were digested with BamHI and EcoRI and ligated.  Correct clones were verified by colony 
PCR and sequencing using pMG25-f and pMG25-rv. 
pGH33rof.  Oligonucleotides GH-optSD-rof-cw and GH-rof-ccw were used to amplify the rof 
gene from MG1655 template DNA.  The PCR product and vector pBAD33 were digested 
with KpnI and HindIII and ligated.  The resulting plasmid expresses Rof with an SDopt 
sequence from the AraC-regulated PBAD promoter.  Correct clones were verified by colony 
PCR and sequencing using pBAD-fw and pBAD-rv. 
pGH33rofext.  Primers GH-rof-cw and GH-rof-rep15-ccw were used to amplify the rof gene 
and the intergenic region between rof and tilS from MG1655 template DNA.  The PCR 
product and vector pBAD33 were digested with KpnI and HindIII and ligated.  The plasmid 
produced expresses Rof with its native SD sequence from the AraC-regulated PBAD promoter.  
Correct clones were verified by colony PCR and sequencing using pBAD-fw and pBAD-rv. 
pGH33yaeP.  Primers GH-optSD-yaeP-cw and GH-yaeP-ccw were used to amplify the yaeP 
gene from MG1655 template DNA.  The PCR product and vector pBAD33 were digested 
with KpnI and HindIII and ligated.  The resulting plasmid expresses YaeP with an SDopt 
sequence from the AraC-regulated PBAD promoter.  Correct clones were verified by colony 
PCR and sequencing using pBAD-fw and pBAD-rv. 
pGH33yaeP-rof.  Primers GH-yaeP-cw and GH-rof-ccw were used to amplify the yaeP and 
rof genes from MG1655 template DNA.  The PCR product and vector pBAD33 were digested 
with KpnI and HindIII and ligated.  The resulting plasmid expresses YaeP and Rof with their 
native SD sequences from the AraC-regulated PBAD promoter.  Correct clones were verified 
by colony PCR and sequencing using pBAD-fw and pBAD-rv. 
pGH33tilS.  Oligonucleotides GH-optSD-tilS-cw and GH-tilS-ccw were used to amplify the 
tilS gene from MG1655 template DNA.  The PCR product and vector pBAD33 were digested 
with KpnI and HindIII and ligated.  The resulting plasmid expresses TilS with an SDopt 
sequence from the AraC-regulated PBAD promoter.  Correct clones were verified by colony 
PCR and sequencing using pBAD-fw and pBAD-rv. 
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 Preparation and transformation of TSB chemically competent cells 2.5
The protocol was adapted from (Chung and Miller, 1988).  An ON culture inoculated from a 
single colony of an appropriate bacterial strain was diluted into fresh LB medium and grown 
at 37°C with aeration until OD600 0.3-0.4.  Cells were harvested by centrifugation for 5 
minutes at 5000 rpm and resuspended in 0.2 volume cold sterile TSB (10% polyethylene 
glycol 3350, 5% dimethylsulphoxide, 20 mM MgCl2 solution, diluted in LB broth).  20-200 
ng plasmid DNA was mixed with a 200 µl aliquot of TSB chemically-competent cells and 
incubated on ice for 30 minutes.  Cells were heat-shocked at 42°C for 45 seconds and 
recovered by addition of 800 µl LB media, followed by phenotypic expression at 37°C for 60 
minutes.  Cells were centrifuged and pellets resuspended in approximately 150 µl of 
supernatant, plated on NA containing appropriate selection and incubated overnight at 37°C. 
 Preparation and electroporation of competent cells 2.6
An ON bacterial culture was diluted into fresh media and grown at 37°C with aeration until 
reaching OD600 0.4-0.5.  Cells were rapidly chilled in ice-water slurry for 5-10 minutes then 
harvested at 5000 rpm and 4°C for 5 minutes.  The pellet was washed three times with the 
original culture volume of sterile ice-cold H2O.  The pellet was finally resuspended in a small 
volume of ice-cold H2O (1 ml per 50 ml original culture) and separated into 50 µl aliquots.  
10-200 ng DNA was mixed with an aliquot of electrocompetent cells on ice.  The mixture was 
added to a pre-cooled 0.2 cm Gene Pulser cuvette (BioRad), pulsed for a few seconds (2.5 kV; 
200 ohms; 25 μF) and recovered by addition of 800 µl LB media, followed by phenotypic 
expression at 37°C with aeration for 60 minutes.  Cells were harvested and the pellet was 
resuspended in approximately 150 µl of supernatant, plated on NA containing appropriate 
selection and incubated overnight at 37°C. 
 Genomic DNA purification 2.7
100 ml of ON culture of the relevant strain was centrifuged at 5000 rpm for 20 minutes.  The 
cell pellet was washed once with 25 ml 0.9% NaCl then resuspended in 20 ml lysis buffer (50 
mM Tris-HCl (pH 8), 20 mM EDTA (pH 8), 400 µg/ml lysozyme, 10 µg/ml RNase A) and 
incubated at 37°C for 10 minutes.  Following addition of 1ml of 10% SDS, the lysate was 
incubated at 37°C for a further 20 minutes.  An equal volume of phenol (pH 8) was added, 
vortexed thoroughly and centrifuged at 5000 rpm for 10 minutes.  The aqueous phase of the 
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biphasic mixture was transferred to a fresh vessel and phenol extraction repeated twice, 
followed by two chloroform extractions.  DNA was precipitated upon addition of 0.6 volume 
of 2-propanol with gentle mixing then 20 minutes incubation at RT.  DNA was harvested by 
centrifugation at 5000 rpm for 20 minutes at 4°C.  The DNA pellet was washed twice with 5 
ml ice-cold 70% ethanol and once with 5 ml ice-cold 96% ethanol after which the pellet was 
air dried and dissolved in an appropriate volume of distilled (d)H2O. 
Rapid, small-scale chromosomal DNA extraction was performed according to the method 
developed by Cheng and Jiang (2006), following the recommendations for Gram-negative 
bacteria.  The Bacterial Genomic DNA Purification kit (EdgeBio) was also routinely used for 
chromosomal DNA purification, following the instructions provided by the manufacturer. 
 Genomic DNA library construction 2.8
Chromosomal DNA from E. coli K-12 TB28 was partially digested with Sau3AI (Thermo 
Fisher Scientific) using a protocol optimised from Sambrook et al. (1989).  First, a scaled-up 
digest mix of 40 µg of DNA, 20 µl of Sau3AI digest buffer and dH2O to a total volume of 200 
µl was made.  1 µl of 0.25 U/µl stock Sau3AI was added to a 40 µl aliquot of the digest mix 
and two-fold serial dilutions were made using 20 µl aliquots of the digest mix.  The final 20 
µl aliquot was used as a control lacking Sau3AI.  The digests were incubated at 37°C for 50 
minutes then Sau3AI was inactivated according to the manufacturer’s instructions.  Partially 
digested DNA was resolved on a 1% agarose gel stained with ethidium bromide and DNA 
between 2 and 6 Kb was purified as described in Section 2.2.  The 2-6 Kb fragments were 
ligated at a 4:3 insert to vector ratio into 100 ng BamH1-digested and Alkaline Phosphatase-
treated pBR322 and incubated ON at 4°C.  T4 DNA ligase was inactivated according to the 
manufacturer’s instructions (Thermo Fisher Scientific).  1 µl of the resulting pBR322 library 
was used per 200 µl transformation reaction (see Section 2.5).  Equivalent amounts of 
pBR322 ligated alone were also transformed in parallel, to gauge to digestion and ligation 
efficiency. 
 Mapping transposon insertion sites 2.9
Arbitrary PCR was used to map mini-Tn10 transposon insertion sites.  The method was 
optimised from (Das et al., 2005).  In the first round of PCRs, transposon-specific primers 
(Table 3; OR7 and 9) were paired in separate reactions with an arbitrary primer (ARB1A), 
and a small amount of colony providing template DNA.  ARB1A binds promiscuously and 
61 
 
any annealing in the region of the transposon insertion produced an amplicon with the 
transposon-specific primers, which was purified.  In the second round, nested primers for the 
transposon-specific primers (OR8 and OR10 respectively) and a primer for the non-arbitrary 
flanking sequence at the 5ʹ-end of ARB1A (ARB2A) were paired to specifically amplify PCR 
product from the first round.  The resulting PCR products were purified and sequenced. 
Another method used for mapping transposition sites exploited the self-cloning properties of 
the transposon (Rossignol et al., 2001).  Briefly, genomic DNA was extracted from each 
strain (Cheng and Jiang, 2006), digested with a restriction enzyme unable to cut within the 
transposon (MfeI and EcoRI were used) and ligated, producing a collection of circular 
genomic DNA from each strain.  This was transformed into E. coli DH5α λpir and plated 
selectively with kanamycin.  Resulting colonies carried circularised DNA containing the 
transposon, which were stably propagated owing to the presence of a conditional origin of 
replication, R6K, in the transposon and R6K π replicase in DH5α λpir (Rossignol et al., 
2001).  Subsequently, plasmids were purified and sequenced with transposon-specific primers 
OR8 and OR10. 
 Beta-galactosidase assay 2.10
ON cultures inoculated from single bacterial colonies were diluted to OD600 0.05 in fresh LB 
media supplemented as appropriate with antibiotics and cultured at 37°C with aeration to 
OD600 0.5.  The cultures were again diluted to OD600 0.05 in supplemented LB medium and 
cultured at 37°C with aeration.  0.5 ml samples of culture were generally taken between 
OD600 0.1 and 1 as stated and diluted as necessary.  Where appropriate, protein expression 
from various plasmids was induced by addition of 0.2% arabinose or 0.1-1 mM IPTG as 
indicated.  β-galactosidase activity of the lacZ fusions in the samples taken were assayed as 
described by Miller (1972) using the chloroform and SDS protocol variant.  Experiments were 
carried out in triplicate with two technical repeats per sample. 
 Total RNA purification 2.11
Total RNA purification was performed using the RNeasy Mini kit (Qiagen).  The 
manufacturer’s recommendations were adapted to optimise RNA extraction from bacteria.  5 
ml bacterial culture was harvested and lysed by addition of 100 µl TE buffer (10 mM Tris-
HCl (pH 8), 1 mM EDTA (pH 8) containing 1 mg/ml lysozyme.  Following 3 minutes 
incubation at RT, 350 µl buffer RLT (Qiagen) supplemented with 1% β-mercaptoethanol was 
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added to the sample, vortexed for 1 minute and centrifuged at 13,000 rpm for 2 minutes.  The 
supernatant was transferred to a fresh tube and 250 µl of ice-cold 100% ethanol was added 
and thoroughly homogenised by vortexing.  The mixture was added to an RNeasy Spin 
column, centrifuged for 30 seconds and washed twice with 500 µl buffer RW1 (Qiagen).  
RNA was treated on the column with RNase-free DNase I (Qiagen) according to the 
manufacturer’s instructions for 60 minutes at RT.  The column was washed once with 350 µl 
buffer RW1 and twice with 500 µl buffer RPE and RNA was eluted in 50 µl RNase-free H2O.  
The integrity of purified RNA was verified on a 1% agarose gel stained with ethidium 
bromide and quantified using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher 
Scientific). 
 Quantitative PCR 2.12
Following total RNA extraction from cell samples (Section 2.11), 1 µg of RNA was reverse 
transcribed to cDNA using the High Capacity cDNA Reverse Transcription kit (Applied 
Biosystems) according the provided instructions.  The resulting cDNA was diluted 100-fold 
in sterile dH2O, of which 6 µl was added to 10 µl 2X GoTaq qPCR Master Mix (Qiagen) and 
2 µl each of forward and reverse primers from a 10 µM stock.  The oligonucleotides used for 
quantitative (q)PCR are listed in Table 1Table 4.  cDNA was amplified using either a Rotor-
Gene Q Real-Time PCR Cycler (Qiagen) or a C1000 Thermal Cycler (BioRad) in 40 cycles of 
95°C for 10 seconds and 60°C for 30 seconds, preceded by 3 minutes at 95°C.  Quantification 
was performed by the associated software and the data analysed using the Pfaffl method of 
relative quantification (Pfaffl, 2001).  The reference genes used for normalisation were tatA, 
rpoB, tus and gyrA.  Primer efficiencies required for accurate relative quantification were 
calculated by amplification of 10-fold serial dilutions of cDNA and were between 91 and 
104%. 
Table 4  Oligonucleotides used in this study for qPCR 
 
Oligonucleotide name 
 
Sequence (5ʹ  3ʹ) Target gene 
qRtcB2-f TGGCCGTTGTAAACGTGATA 
rtcB 
qRtcB2-rv CAGCGTTCCCAGGTGTTTAT 
qRtcA-f GACCAACTGGTGCTACCGAT 
rtcA 
qRtcA-rv GCGTTACGCCATCTGTTTCT 
qRpoN-f GCAACTCAGGCTTAGCCAAC 
rpoN 
qRpoN-rv TCCAGCGTTTCACTGTCTTG 
qTatA-f TGAGCGATGATGAACCAAAG 
tatA 
qTatA-rv TCGCGTCTTCTGTTTTAGCC 
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Oligonucleotide name 
 
Sequence (5ʹ  3ʹ) Target gene 
qRpoB-f TCCGTATTCCCGATTCAGAG 
rpoB 
qRpoB-rv TCACCAGACGCAGTTTAACG 
qTus-f TACCTTTCGCCAGATGGAAC 
tus 
qTus-rv GCGATTTTCGGACTGTTGTT 
qGyrA-f TGATGGAAGTGATCCGTGAA 
gyrA 
qGyrA-rv AACGTAGCCCTGGTGAGAGA 
qRplL-f GGCGCTAACAAAGTTGCTGT 
rplL 
qRplL-rv CTTTGCTCACGCCTTCTTTC 
qRplD-f CCGAACTGGTACGTCAGGAT 
rplD 
qRplD-rv ATGCCAGCATCTCCTCAACT 
qRplM-f GGCAACAAGCGTACTGACAA 
rplM 
qRplM-rv CGTTACCCGCGTAAACTTTC 
qRpmA-f GGTAGCATCATCGTTCGTCA 
rpmA 
qRpmA-rv GGTTTTTCGGGCCTTTAACT 
qRplU-f GAAGTGCTGATGATCGCAAA 
rplU 
qRplU-rv CAGTGAACCACTGACGATGG 
qRpsB-f AAACCGTTCGTCAGTCCATC 
rpsB 
qRpsB-rv ACCGCCCATGTCTTTGATAC 
qRpsJ-f TCCGTACTCACTTGCGTCTG 
rpsJ 
qRpsJ-rv GGCTGATCTGCACGTCTACA 
qGcvB-f GAATGCGTGTTCTGGTGAACT 
gcvB 
qGcvB-rv GCAATTAGGCGGTGCTACAT 
qGlmY-f GACTTATGTCAGCCCCTTCG 
glmY 
qGlmY-rv CCCGGCTTTGTTATGGAATA 
qIlvL-f ATGACAGCCCTTCTACGAG 
ilvL 
qIlvL-rv AAGCCTTTCCTCGTCCAAGT 
qRraA-f GGTTGCTGTACGATCTGCTC 
rraA 
qRraA-rv TGCCGATATCCAACTCTTCC 
 
 Protein purification of His6-tagged RtcR and IHF 2.13
E. coli strain C41 carrying either pGH33H6R, pGH33H6RΔN, pGH25H6RC or pGH33H6IHF, 
which express N-terminally His6-tagged RtcR, RtcRΔN, RtcRC-term and IHF respectively (see 
Sections 2.4.3 and 2.4.4), were diluted from ON cultures into 1 l fresh LB media 
supplemented with 100 µg/ml ampicillin or 50 µg/ml chloramphenicol as required and 
incubated at 37°C with aeration.  At OD600 0.3, protein expression was induced by addition of 
1 mM IPTG or 0.2% arabinose as appropriate and cultures were incubated for a further 1-4 
hours as indicated.  Cells were harvested at 6000 rpm and 4°C for 20 minutes and 
resuspended in 40 ml ice-cold lysis buffer (50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 10 mM 
imidazole, 5 mM β-mercaptoethanol, “complete” EDTA-free protease inhibitor (Roche)).  
Cells were lysed by sonication (Digital Sonifier, Branson) for 2 seconds followed by 2 
seconds rest at 60 % amplification for 2.5 minutes.  Sonication was repeated following 2.5 
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minutes on ice.  Cell lysates were centrifuged at 16,000 rpm and 4°C for 20 minutes and the 
supernatants were incubated with washed 0.75 ml Ni-NTA agarose beads (Qiagen) for 1 hour 
at 4°C with gentle aeration.  The mixture was then applied to a Poly-Pre Chromatography 
column (BioRad) which was subsequently washed several times with ice-cold wash buffer (50 
mM Tris-HCl (pH 7.5), 300 mM NaCl, 35 mM imidazole, 1 mM β-mercaptoethanol).  Protein 
was eluted from the Ni-NTA agarose by step-wise addition of 5 ml ice-cold elution buffer (50 
mM Tris-HCl (pH 7.5), 300 mM NaCl, 1 mM β-mercaptoethanol) containing increasing 
concentrations of imidazole (62.5-250 mM).  Small samples from each elution, along with 
samples from the culture, lysate and washing steps, were mixed with 4X NuPAGE LDS 
sample buffer (Thermo Fisher Scientific) according to the manufacturer’s instructions and 
resolved on a NuPAGE Novex 4-12% Bis-Tris protein gel (Invitrogen) by SDS-PAGE, using 
Precision Plus Protein Dual-Xtra Prestained Protein Standards (BioRad) as a marker of 
protein size.  Gels were stained using Instant Blue (Expedeon) stain for 1 hour and destained 
using dH2O.  Elution fractions containing protein of the correct size and purity were pooled 
and concentrated if necessary using Centrifugal Filter Units (Amicon) according to the 
manufacturer’s recommendations.  Proteins were then dialysed ON at 4°C in Slide-A-Lyzer 
Dialysis Cassettes (Thermo Fisher Scientific) with 5 l dialysis buffer 1 (50 mM Tris-HCl (pH 
7.5), 300 mM NaCl, 2 mM β-mercaptoethanol).  Finally, dialysis cassettes were transferred 
into 1 l dialysis buffer 2 (50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 5 mM dithiothreitol 
(DTT), 50% glycerol) for 6 hours at 4°C and the dialysed proteins stored at -20°C.  The 
concentration of dialysed proteins was assessed using a Bradford assay (Bradford, 1976) with 
Protein Assay Dye Reagent Concentrate (BioRad). 
 Electrophoretic mobility shift assay 2.14
DNA fragments were prepared by PCR using E. coli MG1655 template DNA with 
oligonucleotides RTCR9-f and RTCB3-rv for electrophoretic mobility shift assays (EMSAs) 
with H6-RtcR (DNARtcR) and with oligonucleotides RTCB1-f and RTCB3-rv for EMSAs with 
H6-IHF (DNAIHF) .  Mutations in the predicted IHF binding sites were introduced by PCR 
with primers RTCBmutIHF5-f and RTCBmutIHF5-rv (DNAIHF-M5) and RTCBmutIHF8-f and 
RTCBmutIHF8-rv (DNAIHF-M8).  Control DNA (DNAcontrol) was amplified using primers 
hicA-f2 and hicA-rv (kindly provided by Kathryn Turnbull).  2-5 pmol DNA were then 
labelled with [γ-32P]ATP using T4 polynucleotide kinase (PNK; Thermo Fisher Scientific) 
according to the manufacturer’s protocol and purified on Illustra MicroSpin G-25 columns 
(GE Healthcare). 
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3 nM labelled DNA was mixed with purified protein or an equivalent volume of dialysis 
buffer 2 as a control and binding buffer (20 mM Tris-HCl (pH 8), 100 mM KCl, 2 mM MgCl, 
1mM DTT, 50 µg/ml BSA, 100 µg/ml sheared salmon sperm DNA (Ambion)) to a total 
volume of 10 µl.  The binding reaction was then incubated at 37°C for 20 minutes, mixed 
with 3X loading buffer (0.01% bromophenol blue, 0.01% xylene cyanol, 50% glycerol) and 5 
µl loaded onto a running native acrylamide gel, which was electrophoresed at 200 V for 90 
minutes.  Gels consisted of either 6% or 8% acrylamide from a 40% Acrylamide/Bis-
Acrylamide 19:1 stock (Sigma), 374 mM Tris-HCl (pH 8) 1X Tris-Glycine (Thermo Fisher 
Scientific), 0.08% ammonium persulphate and 0.08% tetramethylethylenediamine and the 
running buffer was 1X Tris-Glycine.  Following electrophoresis, the gel was fixed (40% 
methanol, 20% acetic acid), dried and incubated at RT in a phosphor cassette for imaging. 
 CRAC analysis 2.15
Crosslinking and analysis of cDNA (CRAC) of RtcB was performed by comparison of four 
samples: E. coli MG1655ΔrtcB carrying pKW220rtcB; E. coli MG1655ΔrtcB carrying 
pKW220rtcB and treated with chloramphenicol; E. coli MG1655ΔrtcB carrying pKW220rtcB 
and pSC3326 (pBAD33::mazF) and E. coli MG1655ΔrtcB carrying empty pKW220 as a 
control.  See Table 2 for details of the plasmids used.  ON cultures from single bacterial 
colonies were diluted to OD600 0.005 in 1 l of LB supplemented with 30 µ/ml ampicillin and, 
for the sample carrying pSC3326, 50 µg/ml chloramphenicol and cultured at 37°C with 
aeration.  At OD600 0.25, 100 µM IPTG was added to the cultures to induce expression of N-
terminally FLAG-TEV-His6 (FTH)-tagged RtcB from pKW220rtcB.  After 10 minutes 
incubation at 37°C with aeration, the relevant cultures were treated with 50 µg/ml 
chloramphenicol or 0.2% arabinose for induction MazF expression from pSC3326.  
Following 30 minutes at 37°C with aeration, the cultures were irradiated with 1800 mJ of UV-
C for 100 seconds (Van Remmen UV Techniek), harvested at 5000 rpm and 4°C for 15 
minutes and washed in ice-cold phosphate-buffered saline (PBS).  Pellets were snap frozen in 
liquid nitrogen and stored at -80°C. 
The protocol used to purify FTH-RtcB, ligate linkers to the crosslinked RNA and generate 
libraries from cDNA is described in detail by Tree et al. (2014) in the supplementary 
information, including buffer recipes and timescales.  Briefly, the cell pellets collected were 
lysed and FTH-RtcB was harvested from the lysates using M2 anti-FLAG resin (Sigma).  The 
FLAG tag was removed by Halo-TEV protease cleavage (Promega) and RNA crosslinked to 
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H6-RtcB was trimmed with RNaceIT Ribonuclease Cocktail (Agilent).  H6-RtcB-RNA 
complexes were immobilised on Ni-NTA resin (Qiagen) and alkaline phosphatase (Promega) 
treated to dephosphorylate the 5ʹ RNA ends prior to linker ligation.  The 3ʹ miRCat-33 RNA 
linker (Integrated DNA Technologies) was ligated to 3ʹ-ends of crosslinked RNA using T4 
RNA Ligase I (New England Biolabs), then the 5ʹ-ends were phosphorylated with [γ-32P]ATP 
using T4 PNK (Thermo Fisher Scientific) and subsequently ligated to the 5ʹ L5 RNA linker.  
Four L5 linkers were used, each with a unique barcode at the 3ʹ-end and assigned to one of the 
four samples tested (L5Aa, L5Ab, L5Ad and L5Bb).  H6-RtcB-RNA complexes were eluted 
from Ni-NTA agarose, resolved by SDS-PAGE (Section 2.13) and transferred to a Hybond C-
Extra nitrocellulose membrane (Amersham) using a Trans-Blot Cell wet transfer system 
(BioRad).  The membrane was imaged by autoradiography using a Carestream Biomax MS 
film (Sigma Aldrich.) and Glogos II Autorad Chemi-luminescent Markers (for alignment; 
Agilent).  Smears of H6-RtcB-RNA were cut out of the membrane from just above the 
molecular weight of RtcB alone, by aligning the membrane and autoradiograph with the 
Glogos markers.  H6-RtcB was digested with Proteinase K and RNA was extracted by 
phenol:chloroform:isoamylalcohol and chloroform and precipitated with ice-cold ethanol.  
Purified RNA was reverse transcribed (SuperScript III, Thermo Fisher Scientific) with primer 
miRCat RT and cDNA was PCR amplified using Takara LA Taq polymerase (Clontech) with 
primers P5 and PE_miRCat.  PCR products were separated on a 2% MetaPhor agarose gel 
(Lonza) dissolved and ran in 1X TBE buffer (5X stock: 54 g Tris base, 27.5 g boric acid, 20 
ml 0.5 M EDTA (pH 8) in 1 l) and stained with SYBR Safe (Thermo Fisher Scientific).  The 
smear of amplicons between 150-300 bp, according to the GeneRuler 50 bp DNA ladder 
(Thermo Fisher Scientific) and above primer dimers also detectable in the control sample 
were extracted using the MinElute Gel Extraction kit (Qiagen), generating CRAC cDNA 
libraries.  Primers used for 5ʹ and 3ʹ linkers, reverse transcription and PCR amplification are 
listed in Table 3. 
The quality of the cDNA libraries were assessed by cloning with the TOPO TA Cloning kit 
(Invitrogen) and sequencing five clones per sample.  The libraries for each sample were 
pooled and sent for high throughput sequencing on the illumina MiSeq platform at GATC 
Biotech.  The sequencing output was analysed by Dr Kristoffer Winther (Gerdes Laboratory, 
University of Copenhagen) using the pyCRAC software (Webb et al., 2014). 
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 Western blot analysis 2.16
A Western blot of the culture and lysate samples collected for CRAC analysis of RtcB 
(Section 2.15) was conducted to detect FTH-RtcB.  SDS-PAGE of the samples was 
performed as described in Section 2.14 then proteins were transferred onto a PVDF 
membrane (GE Healthcare) using the semi-dry transfer method.  The membrane was first 
soaked in 100% methanol then in semi-dry transfer buffer (25 mM Tris, 192 mM glycine, 
0.1% SDS, 20% methanol) for 5 mins and the gel was equilibrated in transfer buffer for 5 
minutes.  The membrane and gel were then assembled on the TE70X semi-dry transfer unit 
(Hoefer) in the correct orientation, sandwiched between four sheets of transfer buffer-soaked 
blotting paper.  Protein transfer was carried out for 1 hour at 115 mA.  The membrane was 
blocked at RT for 1 hour in PBS-T (PBS with 0.1% Tween-20) containing 5% milk powder 
and subsequently incubated at RT for 1 hour with mouse Penta-His monoclonal antibodies 
(Qiagen) diluted 1:2000 in PBS-T containing 5% milk powder.  Next, the membrane was 
incubated at RT for 1 hour with horseradish peroxidase-conjugated rabbit anti-mouse 
antibodies (Sigma Aldrich) diluted 1:20,000 in PBS-T containing 5% milk powder, then 
washed three times for 5 minutes with PBS-T.  Finally, the blot was detected by assaying 
horseradish peroxidase activity using the Pierce ECL Western Blotting Substrate (Thermo 
Fisher Scientific; see manufacturer’s instructions) followed by chemiluminescent imaging. 
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Chapter 3 Regulation of the rtcBA 
operon 
 Introduction 3.1
The rtcBA operon of E. coli was previously demonstrated to be regulated by σ54-associated 
RNAP (Genschik et al., 1998).  In the same publication, rtcR, the gene adjacent to the rtcBA 
operon, was found to encode a protein able to activate rtcBA transcription, consistent with the 
requirement of σ54-regulated promoters for a bEBP.  Although the general features of the 
rtcBA promoter are consistent with that of σ54-dependent promoters, rtcBA regulation has not 
been characterised in detail. 
bEBPs generally initiate σ54-dependent transcription from a binding site 150 to 200 bp 
upstream of the transcription start site, known as a UAS.  DNA binding is mediated by the C-
terminal DNA binding domain of bEBPs, which binds as a dimer to an IR of variable length 
and spacing (Leonhartsberger et al., 2001; Porter et al., 1993; Tucker et al., 2005).  The UAS 
of RtcR in the rtcBA promoter is presently unknown. 
Furthermore, although sequences with high similarity to the consensus sequence for IHF 
binding were previously identified in the rtcBA promoter (Genschik et al., 1998), a role for 
IHF in rtcBA transcription has not been described.  IHF is well known to mediate 
transcription from σ54-dependent promoters by changing the topology of DNA between the 
UAS and the -12/-24 σ54 binding elements to favour a more stable interaction between bEBPs 
and σ54 (Huo et al., 2006). 
Finally, there is no published information concerning the regulation of rtcR itself.  The rtcR 
promoter is unmapped and the mode of transcription of rtcR is unknown.  As a transcriptional 
activator of rtcBA, any regulatory mechanism affecting the levels of RtcR would also have 
consequences for rtcBA expression. 
In this chapter, we address unanswered questions concerning the regulation of the rtcBA 
operon, including the location of the RtcR binding site in the rtcBA promoter, the role of IHF 
in transcription of rtcBA and the regulation of rtcR transcription. 
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 Results 3.2
3.2.1 The rtcBA operon behaves as a typical σ54-dependent promoter 
3.2.1.1 Confirmation of RtcR-dependency of rtcBA transcription 
To confirm transcriptional activation of the rtcBA operon by RtcR, a similar method to that 
used by Genschik et al. (1998) was adopted, in which transcription of rtcBA from the E. coli 
chromosome was compared during expression of wild-type RtcR and a truncated form of 
RtcR lacking the N-terminal regulatory domain (RtcRΔN).  As described in Chapter 1, the 
ATPase activity of the central domain of bEBPs is generally negatively regulated by 
interaction with the regulatory domain in the absence of an activating signal (Fernández et al., 
1995).  Signal detection by the regulatory domain relieves repression of the central domain, 
which is then able to activate transcription.  Therefore, RtcRΔN should be constitutively 
active due to the unrestricted activity of the central domain in the absence of the regulatory 
domain. 
E. coli MG1655 carrying pGH322R (RtcR), pGH322RΔN (RtcRΔN) and pBAD322K (empty 
plasmid control) were cultured exponentially then overexpression of RtcR and RtcRΔN was 
induced for 30 minutes.  Samples were collected and analysed by qPCR using rtcB and rtcA-
specific primers to assess the relative levels of rtcBA mRNA in the strains.  Figure 10A shows 
that levels of both rtcB and rtcA RNA are significantly increased in cells expressing RtcRΔN 
but not full-length RtcR, relative to the plasmid control, confirming the role of RtcR as a 
transcriptional activator of the rtcBA promoter. 
3.2.1.2 Confirmation of σ54-dependency of rtcBA transcription 
Levels of rtcBA mRNA in a strain lacking σ54 were also analysed by qPCR, in order to 
confirm the σ54-dependency of the rtcBA operon.  For this purpose, E. coli MG1655 with a 
scarless deletion of the rpoN gene, which encodes σ54, was constructed.  During the 
recombination process, it was observed that MG1655ΔrpoN exhibited a slower rate of growth 
than wild-type MG1655.  In order to ensure that this phenotype was due to deletion of rpoN 
and not a side-effect of recombination, σ54 was expressed from plasmid pGH25rpoN and the 
growth of the strains measured by optical density (Figure 11A).  Complementation recovered 
the growth rate of MG1655ΔrpoN to that of wild-type MG1655, even without IPTG-induction 
of rpoN transcription from pGH25rpoN.  Leaky transcription of rtcBA from plasmid 
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pGH25rtcBA was unable to complement the deletion of rpoN, indicating that the phenotype 
observed was unrelated to rtcBA transcription.  This was also the case when rtcBA 
transcription was induced from pGH25rtcBA with 1 mM IPTG (data not shown).  However, 
supplementation of LB with increasing concentrations of L-glutamine resulted in a 
concomitant increase in the growth rate of MG1655ΔrpoN, with a concentration of 20 µg/ml 
sufficient to fully recover wild-type growth (Figure 11B).  This suggests that insufficient 
glutamine synthetase is produced in the absence of σ54 in the media used (Schaefer et al., 
2015).  Therefore, LB media was supplemented with L-glutamine in experiments involving 
MG1655ΔrpoN where relevant, to allow comparable growth with wild-type MG1655.  
Using the MG1655ΔrpoN, the σ54-dependency of rtcBA transcription was determined.  As for 
wild-type MG1655, RtcR and RtcRΔN expression was induced from pGH322R and 
pGH322RΔN respectively.  Whereas MG1655 showed a marked increase in the level of 
rtcBA transcription during RtcRΔN expression, qPCR analysis detected no change in rtcBA 
mRNA in any rpoN deletion strain (Figure 10B).  This confirms that RtcR-dependent rtcBA 
transcription in E. coli occurs from a σ54-regulated promoter as previously reported (Genschik 
et al., 1998).  As expected, rpoN transcripts were only detectable in MG1655 and not in 
MG1655ΔrpoN, confirming the specific deletion of rpoN. 
3.2.2 Identification of an RtcR binding region in the rtcBA promoter 
3.2.2.1 Identification of minimal promoter requirements for rtcBA transcription 
To further investigate rtcBA promoter activity, plasmid-based rtcBA transcriptional fusions 
with the lacZ reporter gene were constructed.  The lacZYA transcriptional fusion plasmid 
pOU254 available in the laboratory collection was found to have high levels of β-
galactosidase activity even without a promoter.  Therefore, Rho-independent terminators of 
the ribosomal rrnB operon were inserted upstream of the lacZ gene in pOU254, generating 
pGH254 (Figure 12A).  Comparison of the β-galactosidase activity of E. coli strain TB28 
(MG1655ΔlacIZYA) carrying pOU254 and pGH254 revealed that the terminators were 
sufficient to reduce β-galactosidase activity from approximately 110 to 5 Miller units (Figure 
12B).  This suggests that the higher β-galactosidase activity exhibited by pOU254 is due to 
spurious transcription of lacZ from upstream sequences. 
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Figure 10  Expression of a mutant form of RtcR, RtcRΔN, activates rtcBA transcription. 
E. coli MG1655 (A) and MG1655ΔrpoN (B) carrying pGH332R (RtcR), pGH322RΔN (RtcRΔN) or 
pBAD322K (corresponding empty plasmid) were grown exponentially in LB medium containing 25 
µg/ml kanamycin and expression of RtcR and RtcRΔN was induced for 30 minutes with 0.2% 
arabinose.  RNA was extracted from each sample, reverse transcribed and the fold change in the 
transcript levels of rtcB, rtcA and rpoN in strains expressing RtcR or RtcRΔN relative to strains 
carrying the empty plasmid were determined by qPCR.  qPCR data were analysed using the Pfaffl 
method and normalised against the tatA gene.  Data from three independent experiments are shown as 
the mean relative fold change ± standard deviation. 
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Figure 11  Deletion of rpoN reduces the growth rate of E. coli MG1655. 
(A) E. coli MG1655 (black line) and MG1655ΔrpoN (dashed line) carrying pGH25rpoN (σ54 
expression), pGH25rtcBA (RtcB and RtcA expression) or pMG25 (corresponding empty plasmid) 
were cultured in LB medium containing 100 µg/ml ampicillin and OD600 measured at regular intervals.  
(B) MG1655ΔrpoN was also cultured in LB medium supplemented with increasing concentrations of 
L-glutamine (1-20 µg/ml) and OD600 measured at regular intervals.  
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Figure 12  Construction of transcriptional lacZ fusions. 
(A) Schematic organisation of pGH254 at the region used to generate transcriptional lacZ fusions (not 
to scale).  A DNA fragment containing the promoter of interest is amplified and cloned into the 
multiple cloning site (MCS) of pGH254 between the rrnB terminators (terrrnB) and the lacZ Shine-
Dalgarno (SD) and gene.  The lacZ gene is thus transcribed under the control of the promoter of 
interest and translationally regulated by the lacZ SD.  (B) E. coli TB28 (MG1655ΔlacZYA) carrying 
pGH254 or original plasmid pOU254 lacking rrnB terminators were cultured exponentially in LB 
medium supplemented with 30 µg/ml ampicillin.  Samples were taken and β-galactosidase activity 
was measured.  β-galactosidase activity is expressed in Miller units and the values are an average of 
three independent experiments ± standard deviation. 
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Having established the use of RtcR and RtcRΔN expression as a method for assaying rtcBA 
promoter activity (Section 3.2.1), a series of transcriptional rtcBA-lacZ fusions (BA0-3) were 
made using pGH254 with the aim of determining the minimal promoter requirement for 
activation of rtcBA transcription by RtcRΔN (Figure 13A).  The levels of lacZ expression as a 
reporter for rtcBA transcriptional activation from each fusion was then monitored by β-
galactosidase assay in E. coli TB28 carrying pGH322R (RtcR), pGH322RΔN (RtcRΔN) and 
empty pBAD322K.  Following arabinose-induced expression from the pBAD322K variants, 
fusion BA3 (spanning from -262 bp relative to the rtcBA transcription start site (+1) to 30 bp 
into the rtcB open reading frame (ORF), with a transcriptional fusion to lacZ) was active in 
the presence of RtcRΔN but not RtcR (Figure 13B).  Further rtcBA-lacZ fusions were 
constructed by successive deletion of 20-30 bp from the -262 position (including BA2 and 
BA0, data for the rest not shown).  BA2, which starts at -164 bp relative to the transcription 
start site, was found to be the shortest fusion made that showed significant increase in β-
galactosidase activity in the presence of RtcRΔN, whereas BA0, a 31 bp truncation of BA2, 
showed no increase in activity with RtcRΔN compared to RtcR and empty pBAD322K. 
This indicated that a regulatory DNA element necessary for RtcR-dependent transcription of 
rtcBA was located between the start of BA2 and the start of BA0 (-164 and -133 relative to 
+1).  As bEBPs usually bind around this region in σ54-dependent promoters, the palindrome 
application on EMBOSS (Rice et al., 2000) was used to search for candidate IRs for RtcR 
binding.  The longest perfect IRs identified were ATATC-N12-GATAT positioned at -155 to -
133 and CGATA-N6-TATCG at -139 to -123.  Thus, a further rtcBA-lacZ fusion starting at -
142 was constructed (BA1) that truncates the upstream IR while the downstream remains 
intact.  Similarly to BA0, RtcRΔN failed to activate lacZ transcription from BA1 (Figure 
13B), which supports the upstream IR as the putative RtcR UAS, known as rtcO. 
3.2.2.2 Mutagenesis reveals an inverted repeat important for RtcR-dependent rtcBA 
transcription 
Following the identification of candidate UAS rtcO (ATATC-N12-GATAT) in the rtcBA 
promoter, mutations in the transcriptional BA3 rtcBA-lacZ fusion were made to disrupt the 
the IR of rtcO.  Figure 14A illustrates the organisation of the BA3 rtcBA-lacZ fusion 
(pGH254BA3) and the substitutions made to rtcO in ten mutated versions of the fusion, BA3-
IRM1 to BA3-IRM10 (carried on plasmids pGH254BA3-IRM1-10).  The effect of the mutations 
on rtcBA transcription was assessed by β-galactosidase activity on solid NA supplemented 
with X-gal and arabinose in E. coli TB28 carrying pGH322R (RtcR), pGH322RΔN (RtcRΔN) 
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and empty pBAD322K (Figure 14B).  As observed with fusions BA0 to BA3, fusions BA3-
IRM1 to BA3-IRM10 demonstrated very low β-galactosidase activity in strains carrying 
pBAD322K and pGH332R, as indicated by the presence of white colonies only (Figure 14B; 
top and middle rows of each panel respectively).  However, there were observable differences 
between the activity of the fusions during expression of RtcRΔN (Figure 14B; bottom row of 
each panel).  Despite substitutions of two or more bases to disrupt rtcO, strains carrying 
fusions BA3-IRM1, BA3-IRM2, BA3-IRM3, BA3-IRM8 and BA3-IRM10 produced blue colonies 
similar to those of BA3 when grown on X-gal-containing plates, indicative of transcriptional 
activation of the rtcBA promoter.  In other cases, including BA3-IRM4, BA3-IRM5, BA3-IRM6 
and BA3-IRM9, expression of RtcRΔN produced pale blue colonies, indicative of reduced β-
galactosidase activity from these strains, while BA3-IRM7 colonies appeared white, similar to 
BA0, in which rtcO is absent. 
To gain further insight into the activity of each of the rtcBA-lacZ fusions carrying mutations 
in rtcO, β-galactosidase assays in liquid culture were performed in E. coli TB28 carrying 
pGH322RΔN, following 30 minutes of arabinose-induced RtcRΔN expression (Figure 14C).  
Consistent with the results observed on solid medium, fusion BA3-IRM7 showed the most 
significant reduction in β-galactosidase activity compared to BA3, from 168 to 10.6 Miller 
units.  This fusion carried three substitutions in each half of the IR that changed the sequence 
but maintained the palindrome.  Further, fusion BA3-IRM9, with two substitutions in each half 
site, also demonstrated a significant reduction in β-galactosidase activity to 50.0 units.  
Fusions where mutations were made in the second half site of the IR only, exhibited reduced 
activity to varying extents compared to BA3.  Mutation of GATAT to CAAAA in fusion 
BA3-IRM6 produced the greatest decrease to 68.4 units.  Intriguingly, BA3-IRM4, in which β-
galactosidase activity was 120 units, had substitutions in all five bases and thus may have 
been predicted to be the most affected.  However, in accordance with observations on solid 
media, all fusions with mutations in the first half of the IR (BA3-IRM1, BA3-IRM2 and BA3-
IRM3) showed similar β-galactosidase activity to BA3 during RtcRΔN expression (Figure 
14C).  In addition, fusions BA3-IRM8 and BA3-IRM10, which carried three and two 
substitutions in each half site of the IR respectively, both demonstrated β-galactosidase 
activity comparable to that of BA3. 
3.2.2.3 Purification of RtcR and in vitro analysis of rtcBA promoter binding 
In order to further investigate the location and sequence of the RtcR binding site and 
particularly the role of rtcO, purification of RtcR was performed to allow in vitro analyses.  
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Figure 13  Promoter requirements for rtcBA transcription. 
(A) Schematic organisation of transcriptional rtcBA-lacZ fusions carried on pGH254BA3 (BA3), 
pGH254BA2 (BA2), pGH254BA1 (BA1) and pGH254BA0 (BA0) (not to scale).  Fragments 
consisting of the upstream sequences of rtcB were amplified and cloned into pGH254 to generate 
transcriptional fusions with the lacZ reporter gene.  The starting point for the fragments are as follows: 
the BA3 fusion begins at -262 bp relative to the +1 transcription start site of rtcB, BA2 begins at -164, 
BA1 at -142 and BA0 at -133.  All fragments end 30 bp (10 amino acids) into the rtcB open reading 
frame (ORF) and include the -12/-24 elements for σ54 recognition and the predicted IHF binding sites 
(ihf1 and ihf2).  (B) E. coli TB28 carrying pGH332R (RtcR), pGH322RΔN (RtcRΔN) or pBAD322K 
(corresponding empty plasmid) with pGH254BA3, pGH254BA2, pGH254BA1, pGH254BA0 or 
empty pGH254, in all combinations, were cultured exponentially in LB medium supplemented with 30 
µg/ml ampicillin and 25 µg/ml kanamycin.  Expression of RtcR and RtcRΔN was induced with 0.2% 
arabinose and samples taken 30 minutes later.  β-galactosidase activity of each sample was measured 
and the values for empty pGH254 with the pBAD322K variants were deducted.  β-galactosidase 
activity is expressed in Miller units and the values are an average of three independent experiments ± 
standard deviation.   
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Figure 14  Mutations in rtcO of the rtcBA promoter reduce transcription. 
(A) Schematic organisation of the transcriptional rtcBA-lacZ fusion carried on pGH254BA3 (BA3), as 
described in Figure 13, including the sequence around the inverted repeat (IR) rtcO (marked with 
arrows) predicted to be involved with RtcR binding.  A series of pGH254BA3 variants (pGH254BA3-
IRM1-10) with mutations in the inverted repeat (red), generating rtcBA-lacZ transcriptional fusions 
BA3-IRM1-10 respectively, are shown.  Plasmids pGH254BA0 (BA0, described in Figure 13) and 
pGH254 (corresponding empty plasmid) are also shown.  (B) E. coli TB28 carrying each fusion along 
with pBAD322K (top row of each panel), pGH332R (RtcR; middle row of each panel) or 
pGH322RΔN (RtcRΔN; bottom row of each panel) were plated in 100-fold serial dilutions on NA 
plates containing 30 µg/ml ampicillin, 25 µg/ml kanamycin, 40 µg/ml X-gal and 0.2% arabinose and 
incubated 12 hours at 37°C.  (C) E. coli TB28 carrying each fusion along with pGH322RΔN were 
cultured exponentially in LB medium supplemented with 30 µg/ml ampicillin and 25 µg/ml 
kanamycin and 0.2% arabinose was added to induce expression of RtcRΔN for 30 minutes.  Samples 
were taken and β-galactosidase activity from the transcriptional rtcBA-lacZ fusions was measured.  β-
galactosidase activity is expressed in Miller units and the values are an average of three independent 
experiments ± standard deviation, with the activity of pGH254 with pGH322RΔN deducted. 
 
RtcR was initially cloned onto high-copy-number plasmid pMG25 with an N-terminal His6-
tag, to enable affinity purification on nickel.  However, expression of H6-RtcR from pMG25 
in the E. coli strain C41 revealed that upon lysis the protein was found in the insoluble 
fraction (data not shown).  A range of culturing conditions were tested, to attempt to increase 
the amount of soluble protein including variation of temperature (37°C, 30°C and 16°C), 
variation of induction time (one hour to ON) and variation of amount of inductive agent (100 
µM to 1 mM IPTG).  These alterations produced no detectable increase in the amount of 
soluble H6-RtcR. 
Next, H6-RtcR was cloned in a lower-copy-number plasmid, pBAD33, producing pGH33H6R.  
A second plasmid, pGH33H6RΔN, expressing H6-RtcRΔN was also generated, to test whether 
removal of the regulatory domain of RtcR increased solubility.  E. coli C41 carrying 
pGH33H6R or pGH33H6RΔN was cultured exponentially at 37°C and protein expression 
induced with 0.2% arabinose for one hour.  H6-RtcR and H6-RtcRΔN were purified from the 
cell pellet as described in Chapter 2.  Cellular proteins detectable in the cultures, lysates and 
elutions during the purification process were resolved by SDS-PAGE and the stained gels are 
shown in Figure 15A (H6-RtcR) and Figure 15B (H6-RtcRΔN).  In both cases, although high 
levels of protein of the expected size, 60.3 kDa for RtcR and 40.7 kDa for RtcRΔN, were 
expressed (compare lanes 1 and 2 for each), the majority of overexpressed protein was 
insoluble (compare lanes 3 and 4).  However, weak bands corresponding to the approximate 
size of H6-RtcR and H6-RtcRΔN were detectable in the elution fractions (upper bands, lanes 
5-9), along with some unknown contaminants or degradation products (lower bands).  
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Therefore, elution fractions containing the most and purest H6-RtcR and H6-RtcRΔN were 
pooled for use in in vitro experiments. 
To attempt to increase the amount of soluble protein, the C-terminal DNA binding domain of 
RtcR was cloned onto pMG25 with an N-terminal His6-tag.  E. coli C41 carrying the resulting 
plasmid, pGH25H6RC, was cultured exponentially at 37°C and protein expression induced 
with 1 mM IPTG for four hours.  H6-RtcRC-term was purified and samples from cultures, 
lysates and elutions were resolved by SDS-PAGE (Figure 15C).  Clear bands corresponding 
to the size of H6-RtcRC-term at 13.2 kDa were visible after IPTG induction (lane 2 onwards) 
and indicate that, unlike H6-RtcR and H6-RtcRΔN, the DNA binding domain of RtcR is 
soluble in the absence of the other domains.  The elution fractions were pooled and used along 
with H6-RtcR and H6-RtcRΔN. 
Purified proteins were incubated with a DNA fragment containing the rtcBA promoter from -
203 bp to +8 relative to the rtcBA transcription start site +1 (DNARtcR) and analysed by 
EMSA (Figure 16).  Two-fold serial dilutions of H6-RtcR (lanes 1 to 3) and H6-RtcRΔN 
(lanes 4 to 6) and ten-fold serial dilutions of H6-RtcRC-term (lanes 7 to 9) were used in the 
binding reactions, however no DNA shift indicative of the formation of an RtcR-DNARtcR 
complex was detectable compared to the DNARtcR fragment alone (lane 10).  The range of 
protein concentrations used was increased and other parameters were changed, including the 
ratio of acrylamide used in the gels, the gel running time and the use of an alternative binding 
buffer (Pedersen and Valentin-Hansen, 1997).  However, none of the changes elicited a shift 
in the DNA fragment (data not shown). 
As a result of the inability to detect interaction between rtcBA promoter DNA and purified 
RtcR proteins, further EMSAs to examine the ability of RtcR to bind and shift DNA 
fragments with mutations in rtcO and DNase I footprinting analysis to determine which DNA 
sequences are protected by RtcR in vitro were not conducted. 
3.2.3 IHF-dependency of rtcBA transcription 
3.2.3.1 IHF is required for RtcR-dependent rtcBA transcription 
In order to ascertain the role of IHF in the transcription of rtcBA, strains carrying ihf deletions 
were constructed using the Keio collection of mutants, in which single genes are replaced by 
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Figure 15  Protein purification of RtcR. 
E. coli C41 carrying pGH33H6R, pGH33H6RΔN or pGH25H6RC were cultured exponentially and 
induced for 1 hour with 0.2% arabinose or 4 hours with 1 mM IPTG as indicated in the text and H6-
RtcR (A), H6-RtcRΔN (B) and H6-RtcRC-term (C) respectively were purified as described in Chapter 2.  
Samples from cultures before (lane 1) and after induction (lane 2), from lysates (lane 3) and lysate 
supernatants (lane 4) and from elution fractions (lanes 5 to 12) were resolved by SDS-PAGE and 
stained for analysis.  A protein ladder was included as a marker of protein size (indicated in kDa).  
Arrows () indicate the expected size of the protein purified. 
 
 
Figure 16  Purified RtcR is unable to bind promoter rtcBA DNA in vitro. 
Purified H6-RtcR, H6-RtcRΔN and H6-RtcRC-term were added to [γ-
32
P]ATP-labelled DNARtcR probe 
containing the rtcBA promoter (-203 to +8 relative to the rtcBA transcription start site +1) in the 
following concentrations: 150 nM, 75 nM and 37.5 nM H6-RtcR (lanes 1-3), 4 nM, 2 nM and 1 nM 
H6-RtcRΔN (lanes 4-6) and 400 nM, 40 nM and 4 nM H6-RtcRC-term (lanes 7-9).  A no protein control 
was included (lane 10).  An EMSA was performed on a 6% native polyacrylamide gel. 
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the kanamycin resistance gene (Baba et al., 2006).  IHF is a heterodimer of IHFα and IHFβ, 
encoded by ihfA and ihfB respectively at different loci of the E. coli genome.  Initially, the 
kanamycin resistance gene replacing ihfA was transduced from the relevant Keio strain into E. 
coli TB28.  In order to combine the Keio ihfB deletion into TB28ΔihfA::kan, creating a 
complete ihf deletion, the kanamycin resistance cassette needed to be removed from the ihfA 
locus.  However, TB28ΔihfA::kan was unable to tolerate transformation with pCP20, which 
encodes the flp gene required to remove the kanamycin gene.  Transformation with pGH254 
for the measurement of transcriptional rtcBA-lacZ activity was also not possible (data not 
shown).  This suggests that functional IHF plays a role in the maintenance or replication of 
some plasmids in E. coli. 
As a result, a different approach was used to investigate the involvement of IHF in rtcBA 
transcription.  ihfA and ihfB deletions from the KEIO collection were transduced separately 
into E. coli TB28 with a transcriptional rtcBA-lacZ fusion on the chromosome (TB28rtcBA-
lacZ; Figure 17A), creating TB28rtcBA-lacZΔihfA::kan and TB28rtcBA-lacZΔihfB::kan.  
Chloramphenicol resistant versions of the plasmids used in Sections 3.2.1 and 3.2.2 for RtcR 
and RtcRΔN expression were transformed successfully into TB28rtcBA-lacZ and the ihfA and 
ihfB deletion strains and each strain was plated onto NA containing X-gal and arabinose.  As 
illustrated in Figure 17B, the only strain with blue colonies, indicative of transcriptional 
activation of the rtcBA promoter, was in the wild-type strain expressing RtcRΔN.  Both ihf 
deletion strains expressing RtcRΔN had white colonies, as did all strains expressing RtcR and 
those carrying the empty plasmid.  This result was confirmed in liquid culture using a β-
galactosidase assay to assess the activity of the transcriptional rtcBA-lacZ fusion (Figure 
17C).  The lack of β-galactosidase activity in the ihfA and ihfB deletion strains demonstrates a 
requirement for functional IHF in the activation of RtcR-dependent rtcBA transcription.   
3.2.3.2 IHF binding sites are functional in mediating rtcBA transcription 
Global regulator IHF modifies DNA architecture by binding to specific DNA sequences and 
inducing bending (Xu and Hoover, 2001).  In the case of σ54-dependent transcription, this 
mediates interaction between σ54 and the bEBP bound upstream.  Two sites with high 
similarity to the asymmetric IHF consensus sequence were previously identified in the rtcBA 
promoter (Genschik et al., 1998), ihf1 (on the opposite strand to the rtcB coding sequence and 
orientated away from rtcB) and ihf2 (on the same strand and orientated towards rtcB) as 
shown in Figure 5.    
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Figure 17  Transcription of rtcBA is dependent on the presence of functional IHF. 
(A) Genetic organisation at the rtcBA locus in the E. coli strain TB28rtcBA-lacZ, which carries a 
transcriptional fusion of lacZ as part of the rtcBA operon.  (B) TB28rtcBA-lacZ, TB28rtcBA-
lacZΔihfA::kan and TB28rtcBA-lacZΔihfB::kan carrying pGH322CR (RtcR), pGH322CRΔN 
(RtcRΔN) or pBAD322C (the corresponding empty plasmid, -) were plated in 10-fold serial dilutions 
on NA plates containing 50 µg/ml chloramphenicol, 40 µg/ml X-gal and 0.2% arabinose.  (C) The 
same strains were cultured exponentially in LB medium supplemented with 50 µg/ml chloramphenicol 
and 0.2% arabinose was added to induce expression of RtcR and RtcRΔN for 30 minutes.  Samples 
were taken and β-galactosidase activity from the chromosomal rtcBA-lacZ transcriptional fusion was 
measured.  β-galactosidase activity is expressed in Miller units and the values are an average of two 
independent experiments ± standard deviation, with the activity of TB28 with the pBAD322K variants 
deducted. 
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Having established IHF-dependency of rtcBA transcription, the two putative IHF sites were 
mutated in the transcriptional BA3 rtcBA-lacZ fusion (pGH254BA3) to determine whether 
these DNA elements are required for rtcBA transcription (Figure 18A).  Mutations at highly 
conserved positions of the IHF consensus sequence were made in ihf1, ihf2 or both according 
to Hales et al. (1994), where the severity of different substitutions in the IHF binding sites of 
bacteriophage λ were assessed.  The resulting fusions, BA3-IHFM1 to BA3-IHFM7 (carried on 
plasmids pGH254BA3-IHFM1 to pGH254BA3-IHFM7), were evaluated for the effect on rtcBA 
transcription by β-galactosidase activity on NA supplemented with X-gal and arabinose in E. 
coli TB28 carrying pGH322R (RtcR), pGH322RΔN (RtcRΔN) and empty pBAD322K 
(Figure 18B).  Mutations in ihf1 (BA3-IHFM1) or ihf2 (BA3-IHFM2 and BA3-IHFM3) alone 
were insufficient to disrupt rtcBA transcription, as indicated by the presence of blue colonies 
on X-gal-supplemented plates during induction of RtcRΔN expression (bottom row of each 
panel).  Further, fusions with substitutions in one or two positions to mutate both IHF binding 
sites simultaneously (BA3-IHFM4 and BA3-IHFM5 respectively) also generated blue colonies.  
Fusion BA3-IHFM6, which combines mutations of BA3-IHFM4 and BA3-IHFM5, showed an 
intermediate phenotype when combined with RtcRΔN expression, while BA3-IHFM7, in 
which 12 conserved bases of ihf1 and ihf2 were substituted for alternative bases, produced 
white colonies, indicating that β-galactosidase activity was significantly reduced.  As 
observed for all other transcriptional rtcBA-lacZ fusions, BA3-IHFM1 to BA3-IHFM7 carrying 
pBAD322K and pGH322R produced white colonies (Figure 18B; top and middle rows of 
each panel respectively). 
The β-galactosidase activity of the transcriptional BA3 rtcBA-lacZ fusion was also compared 
to those with IHF binding site mutations in liquid culture following 30 minutes of RtcRΔN 
expression from pGH322RΔN by β-galactosidase assay (Figure 18C).  Consistent with 
observations on solid media, fusions BA3-IHFM1, BA3-IHFM2 and BA3-IHFM3, with 
mutations in ihf1 or ihf2 alone, retained high β-galactosidase activity.  Fusions BA3-IHFM4 to 
BA3-IHFM7 carrying mutations in both ihf1 and ihf2 showed a progressive decrease in β-
galactosidase activity compared to wild-type BA3 concomitant with increasing number of 
substitutions.  For example, BA3-IHFM4, which has a single substitution of T to C in the 
overlap between ihf1 and ihf2, had a moderate reduction in activity from 168 to 145 Miller 
units, whereas BA3-IHFM7, in which 12 conserved bases of ihf1 and ihf2 were substituted, 
displayed the greatest reduction to 18.4 Miller units, as indicated by the results on X-gal 
plates.  Therefore, the data suggests that the putative IHF binding sites are functional and 
84 
 
necessary regulatory elements of the rtcBA promoter that support RtcR-dependent 
transcription of rtcBA, likely as a result of IHF binding. 
3.2.3.3 IHF binds to rtcBA promoter DNA in vitro 
The findings of Sections 3.2.3.1 and 3.2.3.2 strongly imply that IHF mediates its effect on 
rtcBA transcription from the two putative IHF binding sites in the rtcBA promoter.  Therefore, 
to establish whether IHF can bind to ihf1 and ihf2 in vitro, purification of IHF was conducted.   
Nash et al. (1987) determined that IHFα was unstable and IHFβ was insoluble when 
overexpressed separately, but that co-expression of both subunits produced stable and soluble 
IHF.  Therefore, the ihfA and ihfB genes were sequentially cloned into pBAD33 to allow 
stoichiometric expression of the individual subunits.  E. coli C41 carrying the resulting 
plasmid, pGH33H6IHF, was cultured exponentially at 37°C and protein expression induced 
with 0.2% arabinose for four hours.  IHFα was His6-tagged at the N-terminal to enable co-
purification with untagged IHFβ by affinity chromatography, as described in Chapter 2.  
Samples of cellular proteins from the culture, lysate and elutions during purification were 
resolved by SDS-PAGE and the stained gel is shown in Figure 19.  Clear bands corresponding 
to the size of H6-IHFα and IHFβ, at 12.2 kDa and 10.7 kDa respectively, were visible 
following induction of protein expression (compare lane 1 with lane 2 onwards).  The 
presence of IHFβ in the elution fractions demonstrated that the subunits were purified in 
complex as IHF (lane 5 onwards).  The presence of contaminating protein in the elution 
fractions of the same size as observed during RtcR purifications (Figure 16), indicates that 
these bands are a general contaminant.  Elution fractions containing high amounts of IHF 
subunits were pooled and used for in vitro DNA binding experiments. 
Initially, ten-fold serial dilutions of purified H6-IHF were incubated with a DNA fragment 
containing the rtcBA promoter from -142 bp to +8 relative to the rtcBA transcription start site 
+1 (DNAIHF; data not shown).  Having established that H6-IHF could successfully form a 
complex with DNAIHF, further DNAIHF fragments were generated to ascertain whether 
binding was mediated via the putative IHF binding sites: DNAIHF-M7 had mutations in 12 
conserved sites of ihf1 and ihf2, as were made in the transcriptional BA3-IHFM7 rtcBA-lacZ 
fusion, and DNAIHF-M6 had 3 mutations spanning ihf1 and ihf2, as for fusion BA3-IHFM6 
(Figure 18A).  A DNA fragment of the same size from an unrelated part of the E. coli genome 
was also included as a control to assay for any non-specific DNA binding by H6-IHF 
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Figure 18  Mutations in IHF binding sites reduce rtcBA transcription. 
(A) Schematic organisation of the transcriptional rtcBA-lacZ fusion carried on pGH254BA3 (BA3), 
including the sequence around two putative IHF binding sites (ihf1 and ihf2; underlined).  Variants of 
pGH254BA3 (pGH254BA3-IHFM1-7) with mutations in ihf1 and/or ihf2 (red), generating rtcBA-lacZ 
transcriptional fusions BA3-IHFM1-7, are shown.  Plasmids pGH254BA0 (BA0) and pGH254 
(corresponding empty plasmid) are included as negative controls.  (B) E. coli TB28 carrying each 
fusion along with pBAD322K (top row of each panel), pGH332R (RtcR; middle row of each panel) or 
pGH322RΔN (RtcRΔN; bottom row of each panel) were plated in 100-fold serial dilutions on NA 
plates containing 30 µg/ml ampicillin, 25 µg/ml kanamycin, 40 µg/ml X-gal and 0.2% arabinose and 
incubated 12 hours at 37°C.  (C) E. coli TB28 carrying each fusion along with pGH322RΔN were 
cultured exponentially in LB medium supplemented with 30 µg/ml ampicillin and 25 µg/ml 
kanamycin and 0.2% arabinose was added to induce expression of RtcRΔN for 30 minutes.  Samples 
were taken and β-galactosidase activity from the transcriptional rtcBA-lacZ fusions was measured.  β-
galactosidase activity is expressed in Miller units as an average of three independent experiments ± 
standard deviation, with the activity of TB28 carrying pGH254 and pGH322RΔN deducted.  
86 
 
 
Figure 19  Protein purification of IHF. 
E. coli C41 carrying pGH33H6IHF was cultured exponentially and expression of H6-IHF induced for 4 
hours with 0.2% arabinose then purified as described in Chapter 2.  Samples from cultures before (lane 
1) and after induction (lane 2), from cell lysate (lane 3) and lysate supernatant (lane 4) and from 
elution fractions (lanes 5 to 13) were resolved by SDS-PAGE and stained for analysis.  A protein 
ladder was included as a marker of protein size (indicated in kDa).  Arrows () indicate the expected 
size of the IHFα and IHFβ subunits purified. 
 
 
 
Figure 20  Purified IHF binds to rtcBA promoter DNA in vitro. 
Purified H6-IHF was added to [γ-
32
P]ATP-labelled DNA probes in the following concentrations: 600 
mM (lanes 1, 5, 9 and 13), 300 nM (lanes 3, 6, 10 and 14) and 150 nM (lanes 2, 7, 11 and 15). No 
protein controls were included (lanes 4, 8, 12 and 16).  Four probes were used as indicated: DNAIHF (-
142 to +8 relative to the rtcBA transcription start site +1), DNAIHF-M7 (as DNAIHF but with mutations in 
the putative IHF binding sites as described in Figure 18A for IHFM7), DNAIHF-M5 (as DNAIHF but with 
mutations in the putative IHF binding sites as described in Figure 18A for IHFM5) and DNAcontrol (DNA 
from another part of the E. coli MG1655 genome).  An EMSA was performed on a 6% native 
polyacrylamide gel. 
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 (DNAcontrol).  The fragments were then incubated with two-fold serial dilutions of H6-IHF 
(Figure 20).  At a concentration of 600 nM H6-IHF, a shift indicative of DNA-protein 
interaction was detectable for DNAIHF (lane 1 compared to lane 4).  Smaller shifts were also 
observed with 300 nM and 150 nM H6-IHF (compare lanes 3 and 2 with 4 respectively).  
However, with DNAIHF-M7 and DNAIHF-M6, smaller migrations were detectable at 600 nM and 
300 nM H6-IHF and neither fragment was shifted by 150 nM of protein (lanes 5 to 8 and 9 to 
12).  No interaction was detected between H6-IHF and DNAcontrol (lanes 13 to 16), indicating 
that the shifts detected with the rtcBA promoter DNA were specific. 
This demonstrates that the affinity of H6-IHF for rtcBA promoter DNA is reduced when ihf1 
and ihf2 are mutated in vitro, therefore indicating that IHF binds to these sequences in order to 
mediate its effect on rtcBA transcription during RtcR activation, as indicated by Figure 17 and 
Figure 18. 
3.2.4 Regulation of rtcR transcription 
3.2.4.1 Mapping the rtcR promoter 
With the aim of investigating the regulation of rtcR transcription, plasmid-based 
transcriptional rtcR fusions were made with the lacZ reporter gene using pGH254.  As the 
location of the rtcR promoter is unknown, a series of rtcR-lacZ fusions were constructed 
containing sequentially less of the sequence upstream of rtcR and including the first 30 bp of 
the rtcR ORF (R3-0), as depicted in Figure 21A.  The β-galactosidase activity of each fusion 
as a reporter of rtcR transcription was assessed in E. coli TB28 on NA plates containing X-
gal.  As Figure 21B shows, strains carrying fusions R3 to R1 produced blue colonies, while 
fusion R0 produced white colonies.  This indicates that an essential element of the rtcR 
promoter is located in the 19 bp region between fusion R1, which begins 49 bp upstream of 
the first codon of rtcR, and R0, which starts 30 bp upstream of rtcR. 
The majority of bEBPs are constitutively transcribed at low levels under the control of the 
housekeeping sigma factor, σ70, however some are reported to also have a σ54-controlled 
promoter, for example the two component systems ZraRS and NtrBC (Leonhartsberger et al., 
2001; Magasanik, 1988).  To this end, the β-galactosidase activity of fusion R3 was compared 
in E. coli TB28 and an isogenic rpoN deletion strain (Figure 21C).  Colonies from 
TB28ΔrpoN were blue demonstrating that the presence or absence of σ54 does not affect rtcR 
transcription. 
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Unlike σ54, σ70 family-associated RNAP recognises and binds to DNA elements centred 
around -10 and -35 relative to the transcription start site, which is unknown for rtcR.  A search 
of the sequence upstream of rtcR identified sequences between 30 and 58 bp upstream of rtcR 
with similarity to and appropriate spacing of the σ70 consensus sequence (Shultzaberger et al., 
2006).  The R3 rtcR-lacZ fusion was mutated at the -10 element of the hypothetical rtcR 
promoter identified, as indicated in Figure 21D.  The resulting fusion, R3mut10, displayed 
reduced β-galactosidase activity on plates supplemented with X-gal compared to R3 to R1 
(Figure 21B).  However, the activity of R3mut10 did not decrease to the same extent as R0, 
suggesting that the substitutions made to the hypothetical -10 do not completely eliminate 
rtcR transcription.   
3.2.4.2 Evidence of negative auto-regulation of rtcR transcription 
Owing to the close proximity of the rtcR binding region rtcO to the rtcR promoter (Figure 
21A), it was hypothesised that RtcR may have a role in regulating its own expression.  To 
investigate this possibility, β-galactosidase activity of the transcriptional R3 rtcR-lacZ fusion 
was monitored in E. coli TB28 carrying pGH332R for arabinose-inducible expression of RtcR 
and empty pBAD322K (Figure 22A).  As observed in Figure 22A, strains carrying fusion R3 
produced blue colonies on NA plates supplemented with X-gal (left panel, top two rows).  
However, in the presence of arabinose, colonies became white in the strain expressing RtcR 
(right panel, compare first and second rows), suggesting that overexpression of RtcR initiates 
a negative feedback to reduce rtcR transcription.  E. coli TB28 carrying empty fusion plasmid 
pGH254 produced white colonies as expected (bottom two rows of each panel). 
To determine whether the IR of rtcO identified as a potential RtcR binding site for rtcBA 
transcriptional activation also mediates negative autoregulation by RtcR binding, a system 
was established to sequester RtcR from the rtcR promoter using the high-copy-number 
plasmid pMG25.  Three pMG25 variants were used for this purpose: pGH251, which 
contained the region upstream of rtcR including rtcO, pGH252, which was the same as 
pGH251 but lacked rtcO and empty pMG25.  If RtcR directly regulated rtcR transcription by 
binding to an element in the rtcR promoter, then the presence of pGH251 may titrate RtcR 
and enable rtcR transcription to resume, producing a blue colony phenotype in cells carrying 
transcriptional rtcR-lacZ fusions.  If RtcR binding were mediated via rtcO in this case, 
pGH252 would be unable to titrate RtcR and colonies would remain white, along with 
pMG25.  To test this hypothesis, E. coli TB28 carrying pGH251, pGH252 or pMG25 with a 
  
89 
 
 
 
  
90 
 
Figure 21  Promoter requirements for rtcR transcription. 
(A) Schematic organisation of transcriptional rtcR-lacZ fusions carried on pGH254R3 (R3), 
pGH254R2 (R2), pGH254R1 (R1), pGH254R0 (R0) and pGH254R3mut10 (R3mut10) (not to scale).  
Fragments consisting of the sequence upstream of rtcR were amplified and cloned into pGH254 to 
generate transcriptional fusions with the lacZ reporter gene.  The R3 and R3mut10 fusions begin 169 bp 
upstream of the rtcR start codon (ATG), R2 begins at 87 bp upstream, R1 at 49 bp and R0 at 30 bp, as 
indicated.  All fragments end 30 bp (10 amino acids) into the rtcR ORF.  The position of hypothetical -
10/-35 elements for σ70 recognition are indicated (red indicates mutation of the -10 element).  Features 
of the rtcBA promoter are shown in grey.  (B) E. coli TB28 carrying fusions R0 to R3, mutated fusion 
R3mut10 or empty pGH254 (-) were plated in 100-fold serial dilutions on NA plates containing 30 
µg/ml ampicillin and 40 µg/ml X-gal, with or without 0.2% arabinose as indicated, and incubated at 
37°C.  (C) E. coli TB28 and TB28ΔrpoN carrying pGH254R3 (R3) or pGH254 (-) were plated on NA 
plates containing 30 µg/ml ampicillin, 20 µg/ml L-glutamine and 40 µg/ml X-gal and incubated at 
37°C.  (D) A hypothetical -35/-10 element upstream of rtcR compared to a sequence logo for σ70 
binding (Shultzaberger et al., 2006).  Mutations were made in the -10 site (red), generating R3 variant 
R3mut10. 
 
kanamycin-resistant version of fusion R3 and pGH322CR for expression of RtcR were grown 
on X-gal plates (Figure 22B).  However, all strains maintained the white colony phenotype in 
the presence of arabinose.  Furthermore, a comparison of the β-galactosidase activity of R3 in 
wild-type TB28 and a scarless rtcR deletion strain by β-galactosidase assay revealed that there 
was no difference in activity of the fusion in the presence or absence of chromosomal rtcR 
(Figure 22C). 
 Discussion 3.3
In this chapter, the regulation of rtcBA transcription in E. coli was investigated.  Transcription 
of rtcBA was activated upon expression of RtcRΔN in a σ54-dependent manner, verifying the 
role of RtcR as the bEBP of the rtcBA operon as well as the function of the N-terminal 
regulatory domain in negatively regulating RtcR activity in the absence of an activating 
signal, as previously described by Genschik et al. (1998).  This property of RtcRΔN was used 
as a means to investigate DNA elements involved in rtcBA transcription including putative 
IHF binding sites and the unknown binding site of RtcR.   
A series of progressively truncated transcriptional rtcBA-lacZ fusions identified a region 
upstream of the rtcBA promoter that, when deleted, prevented RtcRΔN-mediated 
transcriptional activation of rtcBA.  Inspection of this region identified a candidate UAS of 
RtcR, rtcO, which was further investigated by mutagenising the IR and assessing the effect on 
rtcBA-lacZ transcription by RtcRΔN.  β-galactosidase activity on both solid and liquid media 
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Figure 22  Negative autoregulation of rtcR transcription. 
(A) E. coli TB28 carrying pGH254R3 (R3) or empty pGH254 (-) with pGH322R or pBAD322K 
(corresponding empty plasmid) for RtcR expression as indicated, were plated in 10-fold serial 
dilutions on NA plates containing 30 µg/ml ampicillin, 25 µg/ml kanamycin and 40 µg/ml X-gal, with 
or without 0.2% arabinose and incubated at 37°C.  (B)  E. coli TB28 carrying pGH254KR3 (R3) or 
empty pGH254K (-) with pGH322CR or pBAD322C (corresponding empty plasmid), for RtcR 
expression as indicated, and pGH251 (+rtcO), pGH252 (-rtcO) or pMG25 (-) were plated in all 
combinations on NA plates containing 25 µg/ml kanamycin, 50 µg/ml chloramphenicol, 100 µg/ml 
ampicillin and 40 µg/ml X-gal, with or without 0.2% arabinose as indicated and incubated at 37°C.  
(C) E. coli TB28 and TB28ΔrtcR carrying pGH254R3 (R3) or pGH254 were cultured in LB medium 
supplemented with 30 µg/ml ampicillin and sampled during exponential growth.  β-galactosidase 
activity of each sample was measured and the values for empty pGH254 were deducted.  β-
galactosidase activity is expressed in Miller units and the values are an average of two independent 
experiments ± standard deviation.  
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revealed that substitution of three bases in each half of the IR in fusion BA3-IRM7, which 
changed the sequence but maintained its palindromic nature, abolished transcription of rtcBA-
lacZ.  However, BA3-IRM2 and BA3-IRM5, which carried the same mutations in either the first 
or second half-site of the IR only, did not show similar reduction in β-galactosidase activity.  
Furthermore, substitution of all five bases in either the first or second half-site (fusions BA3-
IRM1 and BA3-IRM4 respectively) failed to reduce β-galactosidase activity to the same extent, 
implying that maintenance of one IR half-site is sufficient to retain rtcBA-lacZ transcription.  
In particular, mutation of the first half-site alone had no impact on β-galactosidase activity, 
which is inconsistent with the finding that fusion BA1, which carries the downstream half-site 
of the IR only, shows no detectable induction of rtcBA transcription by RtcRΔN. 
Taken together, the data suggests that rtcO is involved in mediating RtcR-dependent rtcBA 
transcription.  However, it is also notable that some of the mutations made in rtcO failed to 
affect β-galactosidase activity of the rtcBA-lacZ fusions, suggesting that the ability of RtcR to 
initiate rtcBA transcription is not compromised.  Moreover, based on the substitutions made in 
the IR, there is no clear pattern to indicate which bases would be likely to participate in an 
interaction with RtcR.  It is possible that other bases surrounding the IR of rtcO could 
contribute to an interaction with RtcR, creating an imperfect IR, which could explain why 
some substitutions failed to affect rtcBA transcription.  Another possibility is that RtcR has an 
additional UAS.  In this scenario, the extra UAS would be unable to activate rtcBA 
transcription when rtcO is completely abolished, as is the case with BA3-IRM7, but would be 
competent to mediate some degree of transcription when mutations in rtcO reduce but don’t 
eliminate RtcR binding at this site.  Therefore, while a potential UAS for RtcR has been 
identified, it is clear that further investigation is necessary to establish the extent of the role of 
the IR, whether other bases in the region also contribute to an extended rtcO and whether 
additional UASs are present. 
Owing to the inconclusive results obtained from mutagenesis of the candidate rtcO sequence, 
we attempted to analyse the location and sequence of the UAS of RtcR in vitro.  However, 
purified proteins RtcR, RtcRΔN and RtcRC-term were unable to form a complex with rtcBA 
promoter DNA including rtcO and the surrounding region.  RtcR and RtcRΔN were largely 
insoluble so may not be sufficiently concentrated in the native form to produce a shift in the 
assay.  The inability of RtcRC-term to elicit complex formation could indicate that the DNA 
binding domain of RtcR alone cannot form a stable dimer for DNA binding and that the major 
dimerisation determinants may be located in the regulatory or ATPase domains, as is the case 
for some bEBPs including NtrC1 and DctD (Sallai and Tucker, 2005; Vidangos et al., 2013).  
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In order to conduct in vitro analyses with RtcR, attempts to purify increased amounts of RtcR 
or RtcRΔN could be made by introducing denaturing and refolding steps into the purification 
protocol (Singh and Panda, 2005).  In addition, in vivo DNA footprinting could represent an 
alternative method to identify regions of DNA protected by RtcR. 
Transcriptional rtcBA-lacZ fusions were also used to investigate the role of IHF in rtcBA 
transcription.  Independent deletion of the α and β subunits of IHF abolished rtcBA-lacZ 
transcription during RtcRΔN expression, demonstrating that IHF is required for RtcR-
dependent rtcBA transcription.  As two putative IHF binding sites, ihf1 and ihf2, were 
previously identified upstream of the rtcBA operon (Genschik et al., 1998), we investigated 
whether one or both of these sites were necessary to mediate the IHF-dependency of rtcBA 
transcription during RtcRΔN expression.  Fusions carrying mutations in either ihf1 or ihf2 
alone remained competent for rtcBA-lacZ transcription.  However, simultaneous mutation of 
ihf1 and ihf2 with an increasing number of substitutions was accompanied by a gradual 
decrease in β-galactosidase activity.  In particular, fusions BA3-IHFM1 and BA3-IHFM2 had 
single base pair substitutions in ihf1 or ihf2 respectively and retained high β-galactosidase 
activity, while combination of both substitutions into BA3-IHFM5 reduced activity to 
approximately 73% of wild-type fusion BA3.  This suggests that one functional IHF site is 
sufficient for efficient rtcBA transcription, but that either ihf1 or ihf2 may be able to fulfil this 
role.  In support of this hypothesis, fusion BA3-IHFM3, which introduced five substitutions in 
ihf2, had similar activity to BA3, but in combination with mutation of ihf1 in fusion BA3-
IHFM7 produced a severe reduction in rtcBA transcription.  To verify this, a similar fusion 
with mutations in ihf1 only is required to confirm that ihf2 is sufficient for rtcBA transcription 
in the absence of ihf1. 
The greatest reduction in β-galactosidase activity during RtcRΔN expression was observed 
with BA3-IHFM7, which carried 12 substitutions across both ihf1 and ihf2.  Nevertheless, the 
activity was still higher than that of fusion BA0, which lacks rtcO, indicating that even when 
a substantial number of substitutions are introduced into ihf1 and ihf2, rtcBA transcription is 
not completely inhibited.  Accordingly, purified IHF was able to form a complex with rtcBA 
promoter DNA containing the same mutations as BA3-IHFM7 in vitro.  However, the complex 
formed between IHF and DNA containing wild-type ihf1 and ihf2 at equivalent protein 
concentrations appeared to be more stable in comparison and was maintained at lower 
concentrations of IHF.  This demonstrates that, while some IHF binding is still able to occur 
and mediate the low levels of rtcBA transcription observed for BA3-IHFM7, IHF has a greater 
affinity for wild-type ihf1 and ihf2 sequences. 
94 
 
Together, the data shows that RtcR-dependent rtcBA transcription requires functional IHF, 
which confers its effect in a DNA-dependent manner by binding to ihf1 and/or ihf2.  It would 
be of interest to ascertain whether the role of IHF in rtcBA transcription is solely to mediate 
correct interfacing between RtcR and the σ54-RNAP holoenzyme or if it has additional 
functions, as described for some other σ54-dependent promoters (Chapter 1.3.3).  For example, 
IHF is known to aid binding of the bEBP PspF to its UASs and in a reciprocal arrangement, 
PspF also facilitates IHF binding to DNA (Jovanovic and Model, 1997).  Cooperative binding 
of RtcR and IHF could provide another possible explanation for the lack of complex 
formation between RtcRC-term and rtcBA promoter DNA and could also explain the high 
concentrations of IHF necessary to detect complex formation here, compared to previous 
studies (Jovanovic and Model, 1997; Sze et al., 2001). 
Transcriptional regulation of rtcR was studied using a similar approach to that used to identify 
the RtcR binding region in the rtcBA promoter.  The transcriptional rtcR-lacZ fusion R3 was 
found to have moderate β-galactosidase activity in standard conditions, indicating that 
transcription may be regulated by the housekeeping σ70 factor.  As the fusion retained the 
same activity in an rpoN deletion strain, we were able to ascertain that the transcription 
observed from R3 was not σ54–dependent.  Upon inspection of the sequence upstream of the 
rtcR ORF, potential -35/-10 promoter elements were identified and, accordingly, mutation of 
the -10 motif was found to decrease β-galactosidase activity from the R3 variant R3mut10.  
However, rtcR-lacZ fusions containing successively less of the upstream sequence revealed 
that the shortest fusion retaining similar β-galactosidase activity to R3 and thus representing 
the minimal rtcR promoter, lacked the -35 element of the hypothetical promoter.  Combined 
with the fact that fusion R3mut10 does not reduce rtcR-lacZ transcription to the same extent as 
R0, the longest fusion lacking β-galactosidase activity, despite the introduction of three 
substitutions in the hypothetical -10, this suggests that the potential σ70 promoter identified 
here may be incorrect.  This could be resolved by using primer extension analysis to map the 
transcription start site of rtcR.   
Expression of RtcR from a plasmid was found to decrease the β-galactosidase activity of 
fusion R3, indicating that transcription of rtcR is negatively autoregulated.  This negative 
feedback mechanism of regulation has also been described for other bEBPs, including NtrC, 
PspF and CrbB, and is mediated via binding of the bEBPs to DNA sequences overlapping 
their σ70 promoter elements, enabling constant and relatively low levels to be maintained 
(Abdou et al., 2011; Jovanovic et al., 1997; Magasanik, 1988).  As rtcO is in close proximity 
to the start site of rtcR, we reasoned that a similar mechanism of transcriptional regulation 
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might exist for rtcR.  However, no difference was observed in the β-galactosidase activity of 
fusion R3 between wild-type E. coli and an rtcR deletion, indicating that the absence of RtcR 
does not result in derepression of the rtcR promoter.  Moreover, attempts to titrate RtcR using 
a high copy number plasmid carrying the sequence upstream of rtcR (including rtcO) did not 
recover the activity of fusion R3 during RtcR expression.  This suggests that either RtcR was 
insufficiently titrated by the plasmid, not able to be titrated by the sequence carried on the 
plasmid or that promoter DNA binding by RtcR is not involved in regulating rtcR 
transcription.  Therefore, at present it is unclear how the negative autoregulation of rtcR is 
mediated.  In order to establish whether the binding of RtcR to promoter DNA is involved in 
this regulatory feedback mechanism, truncated RtcR lacking the DNA binding domain could 
be expressed.  In the event that rtcR transcription was not inhibited by this RtcR variant, this 
would support the hypothesis that RtcR negatively regulates rtcR transcription by binding to 
rtcO (or another UAS of RtcR).  Alternatively, transcription of rtcR could be regulated 
indirectly by another protein, however the titration experiment would imply that this is also 
not mediated by DNA binding.   
In summary, the work presented in this chapter has further elucidated the transcriptional 
regulation of the rtcBA operon of E. coli K-12.  The minimal promoter required for RtcR-
dependent rtcBA transcription by the σ54-RNAP holoenzyme has been identified and putative 
RtcR binding region, rtcO has been characterised by mutagenesis.  Furthermore, an essential 
role for IHF in the activation of rtcBA transcription by RtcR has been confirmed and found to 
be dependent on interaction with at least one of the IHF binding sites in the rtcBA promoter.  
Finally, the minimal promoter required for rtcR transcription has been identified and is likely 
to be regulated by σ70-associated RNAP and may be subject to an autoregulatory feedback 
mechanism. 
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Chapter 4 Activation of rtcBA 
transcription in E. coli 
 Introduction 4.1
In the previous chapter, it was established that an N-terminally truncated version of RtcR 
(RtcRΔN) constitutively activates transcription from the rtcBA promoter, while wild-type 
RtcR does not, which is consistent with the findings of Genschik et al. (1998).  This suggests 
that, in accordance with other bEBPs, the N-terminal regulatory domain of RtcR has a sensory 
capacity and confers a level of control over rtcBA transcription that restricts the activity of 
RtcB to specific conditions. 
The regulatory domain of RtcR has no similarity with those of other bEBPs (Genschik et al., 
1998), suggesting that it detects a novel type of ligand or receives sensory information in a 
distinct way.  Instead, the regulatory domain was found to have similarity to the CARF 
domains of a group of CRISPR-cas-associated proteins, which are predicted to bind 
nucleotide or nucleotide-derived molecules (Makarova et al., 2014).  Although the CARF-like 
domain of RtcR has diverged from those associated with CRISPR-cas, this raises the 
possibility that the signal detected by RtcR could be single nucleotides or perhaps 
oligonucleotides released from damaged or cleaved RNA.  However, the conditions in which 
these or other activating signals might be created are unknown. 
In this chapter, we use genetic screening and quantitative PCR to identify conditions in which 
transcription of rtcBA is activated in E. coli. 
 Results 4.2
4.2.1 The rtc genes are non-essential for growth in laboratory conditions 
To establish whether the rtc genes are dispensible in E. coli under standard laboratory 
conditions, the growth of rtcB, rtcA, rtcR, rtcBA and rtcBAR deletion strains were compared 
to that of wild-type MG1655 in LB media at 37°C.  In contrast to a recent publication, which 
showed that deletion of rtcB or rtcA decreased the growth rate of E. coli (Engl et al., 2016), 
no difference in growth was observed between any of the strains (Figure 23).  This outcome is 
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supported by Temmel et al. (2016) and Genschik et al. (1998), who reported no difference in 
the growth rates of rtcB and rtcA null strains respectively in laboratory conditions.  The rtc 
deletion strains were also cultured in minimal media with glucose or glycerol as carbon 
sources and in the presence and absence of casamino acids.  In all cases, there was no 
difference in growth (data not shown).  In combination with the low levels of rtcBA 
transcription observed in the absence of RtcRΔN in standard laboratory conditions (Chapter 
3), this suggested a tightly-regulated function for RtcB activated in response to stress in E. 
coli, such as repair of stress-induced RNA damage.   
4.2.2 Genetic screening for regulators of rtcBA expression 
4.2.2.1 Screening for inhibitors of rtcBA transcription 
In order to investigate whether the disruption of any single genes in E. coli activate rtcBA 
transcription, transposon mutagenesis was performed using a kanamycin-resistant mini-Tn10 
transposon carried on suicide plasmid pNKBOR (Rossignol et al., 2001).  Initially, pNKBOR 
was electroporated into E. coli TB28 carrying pGH254BA2, encoding transcriptional rtcBA-
lacZ fusion BA2.  As shown in Chapter 3, β-galactosidase activity of BA2 was increased 
during RtcRΔN expression, suggesting it has all essential rtcBA promoter elements, but had 
low activity in its absence, suitable for use in genetic screening.  Thus, upon spreading of 
electroporated cells on X-gal-supplemented plates containing kanamycin for selection of 
transposition events, blue colonies were indicative of genetic disruption caused by mini-Tn10 
that activated the rtcBA-lacZ fusion.  Approximately 10,000 colonies were screened, of which 
twenty were blue.  However, plasmids purified from these strains were kanamycin resistant 
and remained blue when re-transformed into strain TB28, indicating that in all cases the 
transposon had integrated into pGH254BA2. 
To avoid the use of a reporter plasmid in genetic screening and circumvent associated 
problems including transposition into plasmid DNA and identification of genes involved in 
plasmid regulation as opposed to candidate rtcBA regulators, a transcriptional rtcBA-lacZ 
fusion on the E. coli chromosome was generated.  Having established that the resulting strain, 
TB28rtcBA-lacZ, was functional by expressing RtcRΔN (Chapter 3.2.3), a library of single 
gene mutants was generated and screened for blue colonies as described above.  Of 
approximately 35,000 colonies screened, 12 were blue.  P1 phage transduction was used to 
transfer the transposon from the 12 blue strains into clean TB28rtcBA-lacZ.  Four strains 
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retained the blue-colony phenotype, while the other eight produced white colonies, suggesting 
that the transposon from pNKBOR produced unstable phenotypes at high frequency. 
In order to map the site of transposon insertion in the four strains with stable phenotypes, 
arbitrary PCR was employed.  For those strains where arbitrary PCR was unsuccessful, the 
self-cloning properties of the transposon were exploited (Rossignol et al., 2001).  The PCR 
products or plasmids generated respectively were purified and sequenced with transposon-
specific primers.  All the transposition sites that stably activated the transcriptional rtcBA-
lacZ fusion were in ORFs and are listed in Table 5. 
For confirmation of the phenotypes observed with transposon mutagenesis, the relevant 
strains from the Keio collection of mutants (Baba et al., 2006) were used to generate single 
gene deletions of the four candidate genes in E. coli TB28 carrying pGH254BA2.  Deletions 
in ycfT and lpp produced white colonies on plates containing X-gal, comparable to the wild-
type strain carrying fusion BA2.  The only strains producing blue colonies were those with 
deletions of tolC and acrA.  However, when these deletions were combined with an rtcR 
deletion, colonies from TB28ΔrtcR-tolC and TB28ΔrtcR-acrA carrying pGH254BA2 
remained blue, indicating that transcription of the fusion was independent of RtcR (data not 
shown). 
As the genes identified in the screen were demonstrated to have either weak phenotypes (ycfT 
and lpp) or RtcR-independency (tolC and acrA) and their functions indicated no clear link 
with the activity of an RNA ligase (summarised in Table 5), they were not considered good 
candidates to further investigate the activation of rtcBA transcription.  To account for any 
transposition bias of the mini-Tn10 from pNKBOR and to ensure coverage of the genome was 
sufficiently saturated, a second transposon carried on suicide plasmid pMiniHimar (Rubin et 
al., 1999) was used to generate and screen a library of single gene mutants in the same way.  
However, no blue colonies were observed in this screen. 
4.2.2.2 Screening for activators of rtcBA transcription 
To search for proteins that induce rtcBA transcription, genetic screening of a genomic library 
of E. coli was performed.  The library was constructed by purifying genomic DNA from strain 
TB28 and partially digesting with restriction enzyme Sau3AI, which has approximately 
19,000 restriction sites in the E. coli genome.  DNA fragments of the appropriate size (2 to 6 
Kb) were cloned into BamHI-digested pBR322, as BamHI and Sau3AI produce compatible  
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Figure 23  Deletion of the rtc genes has no effect on growth of E. coli MG1655. 
E. coli strains MG1655, MG1655ΔrtcB, MG1655ΔrtcA, MG1655ΔrtcR, MG1655ΔrtcBA and 
MG1655ΔrtcBAR were cultured in LB medium and OD600 measured at regular intervals. 
 
 
Table 5  Candidate genes for inhibiting rtcBA transcription. 
Site of mini-
Tn10 insertion 
Gene function 
 
Colony 
phenotype 
 
Confirmation with 
Keio strain 
RtcR-dependency 
tolC 
Outer membrane 
channel 
 
5 
 
Yes No 
acrA Periplasmic protein 
 
3 
 
Yes No 
ycfT 
Inner membrane 
protein 
 
2 
 
No - 
lpp 
Outer membrane 
lipoprotein 
 
2 
 
No - 
(‘Gene functions’ were obtained from the EcoCyc database (Keseler et al., 2011). ‘Colony phenotype’ 
was ranked on a scale of 1 to 10 where 1 is the β-galactosidase activity of TB28rtcBA-lacZ alone and 
10 is the activity of TB28rtcBA-lacZ during overexpression of RtcRΔN.) 
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overhangs.  Strain TB28rtcBA-lacZ was transformed with the ligation mixture and cultured on 
plates containing ampicillin, for selection of the pBR322 library, and X-gal.  The resulting 
colonies were screened for multicopy activation of rtcBA-lacZ transcription.  Of the 
approximately 12,000 colonies screened, 27 were blue.  Plasmids were purified from the blue 
colonies (Untergasser, 2006), transformed into fresh TB28rtcBA-lacZ cells and plated onto X-
gal containing NA to assess the stability of the phenotypes.  Thirteen strains retained the blue-
colony phenotype and the plasmids from these strains (named pGH01 to pGH13) were 
sequenced with pBR322-specific primers to identify the genomic DNA fragments carried by 
each.  All the complete ORFs carried in pGH01 to pGH13 are listed in Table 6. 
To confirm the phenotypes observed from TB28rtcBA-lacZ carrying pGH01 to pGH13 and, 
in the case of plasmids carrying multiple ORFs, to attempt to identify the relevant gene 
responsible, the ASKA collection of plasmids was used (Kitagawa et al., 2005).  However, 
when expressed individually from the relevant ASKA plasmid, none of the candidate genes 
were able to activate the chromosomal rtcBA-lacZ fusion (data not shown).  The reason for 
this is unclear.  It may be that co-expression of some of the genes identified is required to 
activate the transcriptional fusion or the function of some proteins is altered by the presence 
of an N-terminal His6 tag from the ASKA plasmid. 
In order to determine whether the activation of the chromosomal rtcBA-lacZ fusion by pGH01 
to pGH13 was RtcR-dependent, TB28 and TB28ΔrtcR carrying pGH254KBA2 (a kanamycin-
resistant plasmid encoding transcriptional rtcBA-lacZ fusion BA2) in combination with 
pGH01 to pGH13 were plated on NA supplemented with X-gal.  In the majority of cases, both 
wild-type and rtcR deletion strains produced blue colonies, suggesting that transcription of the 
fusion was independent of RtcR.  However, deletion of rtcR in strains carrying pGH10, 
pGH12 or pGH13 changed the colony phenotype from blue to white, indicating that activation 
of the transcriptional BA2 fusion was RtcR-dependent (Figure 24B).  This was further 
confirmed with an rtcR null strain, MG1655rtcR
M1X
, in which the start codon of rtcR was 
mutated to a stop codon (Figure 24B).  As plasmids pGH10, pGH12 and pGH13 all contained 
a region of the E. coli genome encompassing the yaeP, rof and tilS genes (Figure 24A), these 
were considered promising candidates for further investigation. 
4.2.3 Rof overexpression activates rtcBA transcription 
Plasmids pGH10, pGH12 and pGH13 all contained complete ORFs of the yaeP, rof and tilS 
genes.  Because the relevant ASKA plasmids were not able to reproduce the phenotype 
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observed in the screen, yaeP, rof and tilS were cloned individually onto pBAD33, generating 
plasmids pGH33yaeP, pGH33rof, pGH33rofext and pGH33tilS respectively.  As annotation of 
yaeP and rof on the EcoCyc database (Keseler et al., 2011) indicates they are co-transcribed 
from the same promoter, a plasmid containing the yaeP-rof operon, pGH33rof-yaeP, was also 
constructed.  In order to establish which gene or combination of genes were responsible for 
activating transcription of the rtcBA-lacZ fusion, TB28rtcBA-lacZ carrying each plasmid was 
plated on NA supplemented with X-gal and arabinose to induce expression of the respective 
genes.  As Figure 25A shows, the plasmids encoding rof alone and yaeP-rof produced blue 
colonies with the same unusual appearance as produced from pGH10, pGH12 and pGH13 
(compare to Figure 24B).  The stronger phenotype observed from Rof expression from 
pGH33rof is due to the presence of an optimised SD sequence, whereas pGH33rofext and 
pGH33yaeP-rof expressed Rof from its native SD.  As the strains expressing TilS or YaeP 
alone were white on X-gal plates, this demonstrated that Rof was able to activate transcription 
of the rtcBA-lacZ chromosomal fusion. 
To further confirm this, the effect of Rof expression was compared in strain TB28 carrying 
transcriptional rtcBA-lacZ fusions BA2 and BA0 on plates supplemented with X-gal and 
arabinose.  Rof expression in the strain carrying fusion BA2 produced blue colonies, while 
BA0 produced colonies sick in appearance that remained white, indicating that the unusual 
colony appearance was associated with Rof rather than rtcBA transcription (Figure 25B).  The 
empty pBAD33 controls produced white colonies of normal appearance.  As fusion BA2 
included rtcO, the region of the rtcBA promoter necessary for RtcR responsiveness, whereas 
BA0 lacked rtcO, this established that Rof expression activated rtcBA transcription in an 
RtcR-dependent manner.  
Transcriptional regulation of the rtcBA operon by Rof was also investigated in liquid culture: 
E. coli TB28rtcBA-lacZ carrying pGH33rof or pBAD33 was cultured in the presence of 
arabinose and β-galactosidase activity was assayed over a period of five hours (Figure 26A).  
No difference in β-galactosidase activity from the rtcBA-lacZ fusion was observed after one 
hour of Rof expression compared to activity just prior to induction.  However, β-galactosidase 
activity progressively increased from 8.12 to 66.1 Miller units between two and five hours 
post-induction, when the cultures were entering stationary phase.  As a small increase in the 
activity of TB28rtcBA-lacZ carrying pBAD33 was also observed over five hours, β-
galactosidase activity was measured in a rof deletion strain to ascertain whether this was due 
to an increase in expression of Rof from the chromosome.  However, there was no difference 
detected between TB28rtcBA-lacZ and TB28rtcBA-lacZΔrof (data not shown).  
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Table 6  Candidate genes for inducing rtcBA transcription. 
Plasmid Gene(s) Gene function 
Colony 
phenotype 
Confirmation 
with ASKA 
plasmid 
RtcR-
dependency 
 
pGH01 
 
yraI Predicted fimbrial chaperone 2 No No 
 
pGH02 
 
yraK Predicted fimbrial protein 3 No No 
 
pGH03 
 
yhdV 
Predicted outer membrane 
lipoprotein 
3 No No 
pGH04 
ygiV Transcriptional repressor 
3 No No mqsR Toxin (mRNase) 
mqsA Antitoxin 
pGH05 
mreC Cell shape maintenance  
4 No No mreD Cell shape maintenance 
yhdE NTP pyrophosphatase 
pGH06 
tsgA Putative transporter 
4 No No ppiA Prolyl isomerase 
ficA Antitoxin 
 
pGH07 
 
yhdH Acrylyl-CoA reductase 6 No No 
 
pGH08 
 
panF Pantothenate/Na
+
 symporter 
5 No No 
yhdT Inner membrane protein 
 
pGH09 
 
yihV Sulfoquinovose kinase 
2 No No 
yihW Transcriptional regulator 
pGH10 
yaeP Unknown 
7 No Yes rof Antiterminator protein 
tilS tRNA
Ile
 synthetase 
 
pGH11 
 
yfaL Predicted adhesin 6 No No 
pGH12 
yaeP Unknown 
8 No Yes 
rof Antiterminator protein 
tilS tRNA
Ile
 synthetase 
yaeR Predicted lyase 
pGH13 
yaeP Unknown 
8 No Yes rof Antiterminator protein 
tilS tRNA
Ile
 synthetase 
(‘Gene functions’ were obtained from the EcoCyc database (Keseler et al., 2011).  ‘Colony phenotype’ 
was ranked on a scale of 1 to 10 where 1 is the β-galactosidase activity of TB28rtcBA-lacZ alone and 
10 is the activity of TB28rtcBA-lacZ during overexpression of RtcRΔN.) 
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Figure 24  Activation of the transcriptional rtcBA-lacZ fusion by the yaeP-rof-tilS locus 
is RtcR dependent. 
(A) Schematic organisation of the regions of the E. coli genome carried on pGH10, pGH12 and 
pGH13.  Complete genes in all three plasmids are shaded.  (B) E. coli TB28 and TB28ΔrtcR carrying 
reporter plasmid pGH254KBA2 (transcriptional rtcBA-lacZ fusion BA2) with pBR322 or variants 
pGH10, pGH12 or pGH13 identified by genetic screening were plated on NA containing 25 µg/ml 
kanamycin, 100 µg/ml ampicillin and 40 µg/ml X-gal and incubated at 37°C for 24 hours. 
  
104 
 
 
 
 
 
Figure 25  Expression of Rof induces transcription of the rtcBA-lacZ fusion in an RtcR-
dependent manner. 
(A) E. coli TB28rtcBA-lacZ carrying pGH33yaeP (YaeP expression), pGH33rof (Rof expression), 
pGH33rofext (Rof and rof-tilS intergenic region), pGH33yaeP-rof (YaeP and Rof expression) 
pGH33tilS (TilS expression) or pBAD33 (corresponding empty plasmid) were plated on NA 
supplemented with 50 µg/ml chloramphenicol, 40µg/ml X-gal and 0.2% arabinose.  Plates were 
incubated at 37°C for 24 hours.  (B) E. coli TB28 carrying pGH254BA2 or pGH254BA0 (containing 
transcriptional rtcBA-lacZ fusions BA2 and BA0 respectively) with pGH33rof (Rof) or pBAD33 (-) in 
all combinations were plated on NA supplemented with 30 µg/ml ampicillin, 50 µg/ml 
chloramphenicol, 40µg/ml X-gal and 0.2% arabinose.  Plates were incubated at 37°C for 24 hours. 
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The growth of E. coli strains MG1655, MG1655ΔrtcBA and MG1655ΔrtcB carrying 
pGH33rof or pBAD33 was monitored over the same timescale as the β-galactosidase assay 
(Figure 26B).  This showed that, while no difference in growth was observed between the 
wild-type strain and the rtcBA and rtcB deletions, Rof expression reduced the rate of growth 
and led to early entry into stationary phase.  Furthermore, the onset of the gradual decline in 
growth occurred approximately two hours after induction of Rof, coinciding with the 
activation of rtcBA transcription by Rof in Figure 26A.   
To investigate whether RtcB was involved in mediating recovery following Rof expression, 
cells were reseeded in fresh media without the inductive agent after 120 and 240 minutes of 
Rof expression.  Although the cells previously exposed to Rof expression had an extended lag 
phase compared to empty pBAD33 controls, wild-type, rtcB or rtcBA deletion strains resumed 
growth at the same time (data not shown).  When Rof was expressed from a higher-copy-
number plasmid pGH25rof (a variant of pMG25) the growth rate decreased more rapidly than 
observed from pGH33rof and again coincided with an increase in rtcBA-lacZ transcription.  
However, even following exposure to higher levels of Rof, the outgrowth of strains in fresh 
media failed to reveal any difference in recovery between MG1655 and the isogenic rtcB and 
rtcBA deletions (data not shown). 
4.2.4 Agents that target translation induce rtcB transcription 
4.2.4.1 Chloramphenicol treatment activates rtcB transcription 
In the search for conditions where RtcB is expressed and thereby possibly functional in E. 
coli, strain MG1655 was treated with a range of antibiotics for 30 minutes and relative 
changes in expression of the rtcBA operon were assessed by qPCR using rtcB-specific 
primers.  Figure 27A shows that antibiotics targeting translation more than doubled the levels 
of rtcB mRNA, compared to untreated cells.  The greatest increase of approximately 6.5-fold 
was observed following chloramphenicol treatment, which inhibits translation by binding to 
23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation (Schlunzen et 
al., 2001).  Tetracycline and kanamycin, which both target 16S rRNA of the 30S subunit 
(Brodersen et al.; François et al., 2005), resulted in an approximate 4-fold and 2.5-fold 
increase in rtcB transcript levels respectively.  By comparison, treatment with ampicillin, 
which inhibits cell wall synthesis (Drawz and Bonomo, 2010), did not significantly change 
rtcB transcription.  
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Figure 26  Transcription of the rtcBA-lacZ fusion increases concurrently with a 
reduction in growth of E. coli strains during Rof expression. 
(A) E. coli TB28rtcBA-lacZ carrying pGH33rof (Rof) or pBAD33 (corresponding empty plasmid; -) 
were cultured in LB medium containing 50 µg/ml chloramphenicol and 0.2% arabinose.  Samples 
were taken just prior to inoculation of cultures in medium containing arabinose (-2 minutes) and over a 
period of five hours (60, 120, 180 and 300 minutes) and β-galactosidase activity was measured.  β-
galactosidase activity is expressed in Miller units and the values are an average of three independent 
experiments ± standard deviation.  (B) E. coli MG1655, MG1655ΔrtcBA and MG1655ΔrtcB carrying 
pGH33rof or pBAD33 were cultured in LB medium containing 50 µg/ml chloramphenicol and 0.2% 
arabinose and OD600 measured at regular intervals.  The values are an average of three independent 
experiments. 
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Figure 27  Levels of rtcB mRNA increase during treatment with chloramphenicol. 
(A) E. coli MG1655 was grown exponentially in LB medium then treated with 50 µg/ml 
chloramphenicol (cml), 10 µg/ml tetracycline (tet), 25 µg/ml kanamycin (kan) or 30 µg/ml ampicillin 
(amp) for 30 minutes.  RNA was extracted from each sample, reverse transcribed and the fold change 
in transcript levels of rtcB in MG1655 treated with antibiotic relative to untreated MG1655 (-) was 
determined by qPCR.  qPCR data were analysed using the Pfaffl method and normalised against the 
tatA gene.  Data from three independent experiments are shown as the mean relative fold change ± 
standard deviation.  (B) Exponentially growing MG1655 (WT), MG1655rtcR
M1X
 (rtcR
M1X
) and 
MG1655ΔrpoN (ΔrpoN) were treated with 50 µg/ml chloramphenicol (cml) for 30 minutes and rtcB 
transcription was analysed by qPCR as described for (A).   
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Having been confirmed with two additional reference genes for normalisation of qPCR data 
(Appendix A), further analysis of the effect of chloramphenicol treatment on RtcB was 
undertaken.  Treatment of an rtcR null strain MG1655rtcR
M1X
 revealed similar increases in 
rtcB mRNA to that observed in wild-type MG1655, indicating that transcription of rtcB is 
independent of RtcR (Figure 27B).  Furthermore, levels also increased in MG1655ΔrpoN 
during chloramphenicol treatment, suggesting that it was not transcribed by σ54-associated 
RNAP.  In the absence of chloramphenicol, the rtcR null and rpoN deletion strains had similar 
levels of rtcB mRNA to wild-type as expected.  qPCR analysis with rtcA-specific primers 
showed that rtcA mRNA levels also increased during chloramphenicol treatment in wild-type, 
rtcR null and rpoN deletion strains (data not shown).   
To ascertain whether RtcB produced an observable growth phenotype during 
chloramphenicol-mediated inhibition of translation, recovery was monitored following 30 and 
120 minutes of chloramphenicol treatment, in a similar manner to that described in Section 
4.2.3.  No difference in growth was observed between rtcBA deletion strains and wild-type 
strains, either during chloramphenicol treatment or recovery (data not shown).  In addition, 
counting the colony forming units (CFU) of wild-type and rtcB deletion strains during five 
hours of chloramphenicol treatment indicated that cell viability was unaffected by RtcB in 
these conditions (data not shown). 
4.2.4.2 MazF activates rtcB transcription 
The effect of various toxin components of TA modules on rtcB transcription was also 
assessed.  E. coli MG1655 carrying pSC3326, pKW82, pKP3035, pKP3065, pMCD8 or 
pBAD33 (empty plasmid control) were cultured exponentially and expression of toxins MazF, 
VapC, RelE, YafQ or ParE respectively were induced for 30 minutes upon addition of 
arabinose.  Samples were analysed by qPCR with rtcB-specific primers.  As shown in Figure 
28, expression of MazF, a sequence-specific endoribonuclease that cleaves mRNA 
independently of the ribosome and thereby inhibits translation (Zhang et al., 2003), increased 
rtcB mRNA levels approximately five-fold relative to the plasmid control.  Other mRNA 
interferases RelE and YafQ, which are both ribosome-dependent endoribonucleases (Pedersen 
et al.; Prysak et al., 2009), did not show similar increases in rtcB transcription.  Expression of 
VapC, a site-specific endoribonuclease of Shigella flexneri 2a virulence plasmid pMYSH6000 
that targets initiator tRNA
fMet 
(Winther and Gerdes, 2011), produced an approximate 3.5-fold 
increase in rtcB mRNA.  Meanwhile, ParE, a toxin that targets DNA gyrase to inhibit DNA 
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replication (Jiang et al., 2002), did not change the levels of rtcB compared to the plasmid 
control. 
The increase in rtcB transcription in the presence of MazF was confirmed by qPCR analysis 
using additional reference genes (Appendix B).  Comparison of strains MG1655rtcR
M1X 
and 
MG1655ΔrpoN with MG1655 revealed that, like chloramphenicol treatment, MazF 
expression produced similar increases of around five-fold in rtcB mRNA levels in all strains 
relative to wild-type cells carrying empty pBAD33, regardless of the presence or absence of 
RtcR or σ54 (Figure 28B).  This was also observed when samples were analysed with rtcA-
specific primers (data not shown). 
To determine whether RtcB had a functional role during or after MazF expression in E. coli, 
growth of strains MG1655 and MG1655ΔrtcB were compared.  As expected, Figure 29A 
shows induction of mazF from pSC3326 rapidly reduced growth as a result of translation 
inhibition.  However, there was no difference between the wild-type and rtcB deletion strains 
during MazF expression.  Following 30 and 120 minutes of MazF-induced translation 
inhibition, cells were inoculated in fresh medium to remove arabinose and prevent further 
production of MazF, in order to monitor the recovery of growth in the two strains.  Strains 
carrying empty pBAD33 and thus not experiencing inhibition of translation in the original 
cultures grew normally upon reseeding, while those exposed to MazF had a longer lag phase.  
Following 30 minutes of MazF expression, cells began to resume growth after approximately 
90 minutes, with those with rtcB deleted displaying a slightly slower recovery compare to 
wild-type (Figure 29B).  The delayed recovery of the rtcB deletion strain was more 
pronounced following 120 minutes of MazF expression, with cells resuming growth around 
150 minutes after reseeding, compared to 120 minutes for the wild-type strain (Figure 29C).  
However, the extent of the difference between the wild-type and rtcB strain in recovery was 
not consistent, as indicated by the large error bars in Figure 29B and C.  In the three 
experiments conducted, a clear difference was observed in one, while less defined in the other 
two.  
To investigate whether RtcB mediated cell survival during growth inhibition as a result of 
MazF expression, cell viability was assessed.  For this purpose, E. coli strain SC28, which 
carries a deletion of the mazEF TA locus, and an isogenic rtcB deletion strain were used to 
allow controlled expression of MazF from pSC3326 and antitoxin MazE from pSC228, as 
described by Pedersen et al. (2002).  SC28 and SC28ΔrtcB carrying pSC228 and pSC3326 or 
pBAD33 were cultured exponentially and MazF expression induced with arabinose for a 
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period of five hours.  Every hour, samples from each culture were plated on NA supplemented 
with glucose to prevent further MazF production and IPTG to induce the cognate antitoxin 
MazE and subsequently, the CFU counted.  As previously demonstrated, MazE was able to 
resuscitate MazF-inhibited cells and allow colonies to form, while lack of MazE induction 
reduced the viable counts of MazF-inhibited cells (Figure 30).  However, no difference was 
observed between wild-type and rtcB deletion strains, indicating that while RtcB may 
function in mediating recovery following MazF activity, it does not appear to influence cell 
survival during MazF inhibition of growth. 
 Discussion 4.3
In this chapter, we investigated the conditions under which rtcBA is transcribed in E. coli K-
12.  We started from the premise that, as rtcBA was non-essential for growth in standard 
laboratory conditions and transcription was low in the absence of induction with 
constitutively active RtcRΔN (this study; Genschik et al., 1998), rtcBA was likely to be 
activated in response to some type of cellular stress.  Therefore, we used genome-wide 
screening approaches to search for genes that, when disrupted by transposon mutagenesis or 
expressed from a multi-copy plasmid, upregulated rtcBA transcription, as indicated by 
increased β-galactosidase activity from the chromosomal rtcBA-lacZ fusion. 
Genetic screening led to the identification of Rof as a candidate activator of RtcR-dependent 
rtcBA transcription.  A rof-carrying plasmid was found three times in the screen, indicating 
that adequate coverage of the genome was achieved, and independent expression of Rof from 
other plasmids was confirmed to induce rtcBA transcription.  The RtcR-dependency of the 
phenotype was verified in both rtcR deletion and null strains and using an rtcBA fusion 
lacking the putative RtcR binding region rtcO.  Further analysis of the phenotype revealed 
that rtcBA transcription increased concomitantly with a Rof-mediated reduction in growth rate 
at late exponential/early stationary phase, linking changes in rtcBA transcription to a growth 
phenotype associated with Rof expression in E. coli.  However, as deletion of the rtcBA 
operon had no effect on growth, either during Rof expression or upon outgrowth in fresh 
media (not shown), its physiological function under these conditions remains unclear. 
The only known function of Rof is to non-specifically inhibit the activity of the transcription 
terminator Rho by competitive inhibition of RNA binding (Gutierrrez et al., 2007; Pichoff et 
al., 1998).  As a global regulator of transcription, Rho has roles in a variety of processes  
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Figure 28  Levels of rtcB mRNA increase during MazF expression. 
(A) E. coli MG1655 carrying pSC3326 (MazF), pKW82 (VapC), pKP3035 (RelE), pKP3065 (YafQ) 
and pMCD8 (ParE) and pBAD33 (-; corresponding empty plasmid) were grown exponentially in LB 
medium supplemented with 50 µg/ml chloramphenicol and toxin expression was induced for 30 
minutes with 0.2% arabinose.  RNA was extracted from each sample, reverse transcribed and the fold 
change in transcript levels of rtcB in the strains expressing toxins relative to the strain carrying the 
empty plasmid were determined by qPCR.  qPCR data were analysed using the Pfaffl method and 
normalised against the tatA gene.  Data from three independent experiments are shown as the mean 
relative fold change ± standard deviation.  (B) Exponentially growing MG1655 (WT), 
MG1655rtcR
M1X
 (rtcR
M1X
) and MG1655ΔrpoN (ΔrpoN) carrying pSC3326 were treated with 0.2% 
arabinose to induce MazF expression for 30 minutes and rtcB transcription was analysed by qPCR as 
described for (A). 
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Figure 29  RtcB mediates recovery of growth following MazF expression. 
(A) E. coli MG1655 and MG1655ΔrtcB carrying pSC3326 (MazF) or pBAD33 (corresponding empty 
plasmid) were cultured exponentially in LB medium supplemented with 50 µg/ml chloramphenicol 
and 0.2% arabinose was added to induce MazF expression as indicated (+, red arrow).  OD600 was 
measured at regular intervals.  After 30 mins (B) and 120 mins (C) of MazF expression as indicated 
(grey arrows), cells from each culture were washed to remove the inductive agent and used to 
inoculate fresh LB medium containing 50 µg/ml chloramphenicol and 0.2% glucose to repress MazF 
expression from pSC3326 and recovery of growth was monitored.  The values are an average of three 
independent experiments.  
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Figure 30  Deletion of rtcB has no effect on cell viability during MazF expression. 
E. coli SC28 (MC1000ΔmazEF) and SC28ΔrtcB carrying pSC228 (pNDM220::mazE) and pSC3326 
(pBAD33::mazF) or pBAD33 were cultured exponentially in LB medium containing 30 µg/ml 
ampicillin and 50 µg/ml chloramphenicol.  At 0 minutes 0.2% arabinose was added to induce MazF 
expression.  Samples were taken from each culture at time 0, 60, 180 and 300 minutes and spread on 
NA plates supplemented with 30 µg/ml ampicillin, 50 µg/ml chloramphenicol and 0.2% glucose to 
repress MazF expression, with (closed symbols) and without (open symbols) 1 mM IPTG to induce 
MazE expression. 
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including formation of transcript 3ʹ-ends, suppression of antisense transcription and 
preventing the formation of RNA/DNA hybrids (Grylak-Mielnicka et al., 2016).  Rho 
mediates transcription termination by binding to regions of transcribing RNA that are C-rich, 
largely unstructured and around 80 nucleotides long and then hydrolyses ATP to stimulate 
translocation along RNA, causing the dissociation of RNAP from RNA and DNA (Peters et 
al., 2011).  Therefore, the increase in rtcBA levels observed upon expression of Rof could be a 
result of decreased premature transcription termination of rtcBA when the activity of Rho is 
inhibited.  Alternatively, it could imply that RtcB and/or RtcA have functional roles in 
conditions where Rho activity is disrupted.  Preliminary data (not shown) suggests that 
deletion of rof had no effect on the growth of E. coli in standard conditions (supported by 
(Pichoff et al., 1998)) and does not affect levels of β-galactosidase activity from the 
chromosomal rtcBA-lacZ fusion, indicating that investigation into the regulation of rof 
expression may be prudent in order to further characterise a role for RtcB or RtcA during Rof 
expression.  Furthermore, treatment of cells with bicyclomycin, which also inhibits Rho but 
via a different mechanism (Gutierrrez et al., 2007), could establish whether the observed 
increase in rtcBA transcription is specific to Rof-mediated Rho inhibition or a general effect 
of dysregulated transcription termination. 
A number of other conditions were found to increase the levels of rtcBA by qPCR analysis, all 
of which have the common function of targeting translation, either at the level of mRNA, 
tRNA or rRNA.  These include several antibiotics, namely chloramphenicol, tetracycline and 
kanamycin and the endoribonucleases MazF and VapC.  This finding corroborates a recent 
study by Engl et al. (2016), who also observed rtcBA induction upon treatment with a variety 
of agents that target the translation apparatus, which included chloramphenicol, tetracycline 
and VapC.  Interestingly, they were not able to detect healing of VapC-induced breaks in 
tRNA
fMet
 by RtcB, leading to the proposal that RtcB may have other functions possibly linked 
to secondary effects of damaged tRNA on the process of translation.  We did observe some 
specificity of the activation of rtcBA when targeting translation, as toxins RelE and YafQ 
were not able to induce rtcBA transcription.  Therefore, it appears that rtcBA responds to a 
subset of challenges to the translation apparatus. 
We further investigated this idea with chloramphenicol and MazF, which induced the greatest 
increases in rtcBA transcription of approximately 6.5-fold and 5-fold respectively.  During 
MazF expression, the growth rate and viability were found to be the same in wild-type and 
RtcB deficient strains.  A small difference was observed in the recovery of growth following 
MazF exposure, with cells lacking rtcB lagging slightly compared to wild-type.  This is in 
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contrast to a recent publication from Temmel et al. (2016), who also reported a 4- to 5-fold 
increase in rtcBA levels but observed a much clearer difference between wild-type and rtcB 
deletion strains in the recovery following MazF expression.  The reason for this is unclear, but 
could be due to technical differences in the experiment, such as the plasmid used to express 
MazF.  When treated with chloramphenicol, no difference was observed between wild-type 
and rtcBA deletion strains in growth rate, recovery or viability (not shown).  Therefore, the 
role of RtcB during chloramphenicol treatment and MazF expression remains unclear based 
on these analyses.  However, since MazF cleavage is known to produce 2ʹ,3ʹ-phosphate and 
5ʹ-hydroxyl terminals suitable for RtcB ligation (Zhang et al., 2005), we hypothesised that the 
induction of rtcB during MazF expression may be a stress response to mediate RNA repair.  
This is explored further in Chapter 5. 
Surprisingly, the effects of both chloramphenicol and MazF on rtcBA transcription were 
found to be independent of RtcR.  To eliminate the possibility that cross-activation from 
another bEBP in the absence of RtcR was responsible, levels of rtcBA were also assessed in 
an rpoN deletion strain.  This confirmed that transcription was also independent of σ54, 
indicating that transcription of rtcBA in these conditions was likely to be mediated via another 
promoter regulated by a member of the σ70 family.  In order to identify this additional 
promoter, primer extension could be used to map the 5ʹ end of the rtcBA transcript in the 
presence of MazF and chloramphenicol.  As several rtcBA activators identified by genetic 
screening were also found to be RtcR-independent, some of these may represent potentially 
interesting candidates for further study. 
In summary, using a combination of genetic screening and targeted analysis of various 
antibiotics and toxins by qPCR, we identified several conditions whereby rtcBA transcription 
is activated in E. coli.  Expression of Rof, a Rho inhibitor, led to an increase in rtcBA 
transcription, raising the possibility that RtcB functions in situations where Rho-dependent 
transcription termination is disrupted.  This could reasonably involve the RNA ligase activity 
of RtcB or the lesser studied DNA ligase or DNA capping activities.  Moreover, rtcBA seems 
to respond to the translational status of the cell, with challenges at multiple levels of 
translation resulting in induction of rtcBA.  These include targeting 23S rRNA 
(chloramphenicol), 16S rRNA (MazF, tetracycline and kanamycin), initiator tRNA
fMet
 (VapC) 
and mRNA (MazF).  The RNA targets of these agents imply that a functional role for RtcB in 
these conditions may more likely involve its RNA ligase activity. 
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Chapter 5 Function of RtcB in E. coli  
 Introduction 5.1
RtcB is a widely conserved protein with homologues in all domains of life (Popow et al., 
2012).  Biochemical studies of RtcB using a range of RNA substrates revealed a unique GTP- 
and Mn
2+
-dependent 3ʹ-5ʹ RNA ligase activity (Chakravarty and Shuman, 2012; Chakravarty 
et al., 2012; Tanaka et al., 2011a).  RtcB demonstrated specificity for 2ʹ,3ʹ-cyclic phosphate or 
3ʹ-phosphate RNA terminals and 5ʹ-hydroxyl terminals, ligating to form a 3ʹ,5ʹ-
phosphodiester bond. 
Complementation of the normally lethal deletion of Trl1 RNAL in S. cerevisiae by 
recombinant RtcB from E. coli provided an indication of the function in vivo (Tanaka et al., 
2011b).  RtcB was able to perform all essential RNA ligations in this organism including 
sealing of tRNA halves and XBP-1 mRNA of the UPR following intron excision and 
protected against site-specific endoribonuclease activity of fungal ribotoxin PaT.  
Accordingly, the human homologue of RtcB is known to be essential for tRNA maturation 
(Popow et al., 2011).  Moreover, RtcB is required for splicing of XBP-1 mRNA in metazoans 
(Jurkin et al., 2014; Kosmaczewski et al., 2014; Lu et al., 2014).  An inhibitory role for RtcB 
in axon regeneration has also been described that is independent of its functions in tRNA 
maturation and the UPR (Kosmaczewski et al., 2015).  This suggests that RtcB can perform 
RNA ligations in a range of contexts in multicellular organisms. 
However, the role of RtcB in bacteria is unclear as the majority of bacterial RNA transcripts 
do not require splicing or are self-splicing (Reinholdhurek and Shub, 1992) and the UPR is a 
phenomenon of eukaryotes (Hollien, 2013).  The expression of E. coli RtcB from a σ54-
dependent promoter combined with the fact that it is non-essential for growth of E. coli in 
standard laboratory conditions, as described in Chapters 3 and 4, suggests it may be involved 
in repair of stress-mediated RNA damage.  Consistent with this idea, Temmel et al. (2016) 
demonstrated that RtcB could repair MazF-cleaved 16S rRNA in E. coli.  Further, roles for 
RtcB in rRNA stability and cell motility were recently described by Engl et al. (2016).  These 
reports indicate that the RNA ligase activity of RtcB influences a variety of pathways in 
bacteria, as is the case in metazoans. 
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In the following chapter, potential RNA substrates of RtcB were identified by in vivo 
crosslinking in relevant conditions and high throughput sequencing, with the aim of further 
elucidating the spectrum of biological functions of RtcB in E. coli.  A role for RtcB in 
maintaining rRNA stability during amino acid starvation was also considered. 
 Results 5.2
5.2.1 CRAC of RtcB 
5.2.1.1 Experimental procedure and high throughput sequencing 
Cellular RNA substrates of RtcB in E. coli were investigated using a technique known as 
crosslinking and analysis of cDNA (CRAC).  CRAC detects both stable and relatively 
transient interactions between RNA and a tagged protein of interest and involves UV-induced 
protein-RNA crosslinking in vivo, followed by purification of the protein-RNA complexes 
and preparation and sequencing of a cDNA library, as shown in Figure 31A (Granneman et 
al., 2009; Tree et al., 2014; Winther et al., 2016). 
To implement CRAC, the rtcB gene was cloned into plasmid pKW220 downstream of the 
LacI-regulated promoter and in-frame with an N-terminal dual affinity tag consisting of three 
FLAG tags, a TEV protease cleavage site and a His6 tag (FTH), which enables stringent 
protein purification.  Resulting plasmid pKW220rtcB expressed FTH-tagged RtcB upon IPTG 
induction.  As treatment with chloramphenicol and expression of MazF were found to 
increase transcription of rtcB (Chapter 4), these conditions were selected to perform CRAC of 
RtcB to allow identification of potentially biologically relevant targets.  Therefore, four 
strains were used for CRAC: E. coli MG1655ΔrtcB carrying pKW220rtcB (RtcB); 
MG1655ΔrtcB carrying pKW220rtcB and treated with chloramphenicol (+Cml); 
MG1655ΔrtcB carrying pKW220rtcB and pSC3326 for expression of MazF (+MazF) and 
MG1655ΔrtcB carrying pKW220 (control).  Bacteria were cultured exponentially and FTH-
tagged RtcB expression was induced for 10 minutes with IPTG, followed by 30 minutes of 
treatment with chloramphenicol for the +Cml strain or 30 minutes of arabinose-induction of 
MazF expression for the +MazF strain.  Expression of FTH-RtcB was verified in each culture 
by Western blot using anti-His antibodies.  As shown in Figure 31B, RtcB was present in all 
samples carrying pKW220rtcB and absent in the sample carrying the corresponding empty 
plasmid. 
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Bacterial cultures were UV-irradiated, triggering covalent crosslinking between interacting 
RNAs and FTH-tagged RtcB and the resulting RtcB-RNA complexes were harvested from 
cell lysates using the FTH tag.  RtcB-bound RNAs were trimmed, radioactively labelled and 
ligated with linkers at the 5ʹ- and 3ʹ-ends.  The 5ʹ linker contained a barcode unique to each of 
the four samples, to allow multiplex sequencing.  RtcB-RNA complexes were separated by 
SDS-PAGE and visualized by autoradiography.  As RtcB was crosslinked to RNAs of varying 
lengths, the complexes appeared as smears on the autoradiogram, which were size-selected 
according to the molecular weight of RtcB (45.2 kDa), as indicated in Figure 31C.  Following 
protease digestion of RtcB, the RNAs were reverse transcribed to generate cDNA, amplified 
using linker-specific primers and resolved by agarose gel electrophoresis (Figure 31D).  
Fragments between 150 and 300 bp were selected from the gel, as this range was above non-
specific amplification products present in the control PCR reaction and purified to generate a 
cDNA library. 
A sample from each of the four cDNA libraries was cloned into plasmid pCR4-TOPO and 
five clones from each were sent for sequencing with plasmid-specific primers.  All four 
libraries were found to have the correct barcoded 5ʹ linker and identical 3ʹ linkers, suggesting 
that linker ligation steps of CRAC were successful.  The size of the fragment after accounting 
for the linkers and the primers used to amplify the cDNA ranged from 15 to 84 bp with an 
average of 41.1 bp, which was deemed appropriate (data not shown).   
Consequently, the cDNA libraries were pooled and sent for deep sequencing.  The raw data 
was sorted and analysed by Dr Kristoffer Winther (University of Copenhagen) using the 
PyCRAC software (Webb et al., 2014).  First, the reads were trimmed to remove the linkers 
and any low quality reads or reads without linkers were removed.  Next, reads were sorted 
according to their barcode, separating the RtcB, +Cml, +MazF and control sample reads.  The 
remaining reads were collapsed, removing copies of reads with identical barcode, sequence 
and length.  Finally, reads were normalised to number of reads per million and mapped to the 
E. coli genome. 
5.2.1.2 Identification of candidate RNA targets of RtcB 
The sorted data from Dr Kristoffer Winther enabled visual comparison of samples.  RNAs 
enriched in the control sample were used to assess the background of the experiment and were 
considered to arise from RNA binding to the FTH tag expressed from pKW220 or retained on  
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Figure 31  CRAC of RtcB in E. coli. 
(A) Schematic illustration of CRAC of RtcB.  The four bacterial cultures described in the text were 
exposed to 1800 mJ of UV light in vivo, crosslinking RNA in close contact with FLAG-TEV-His6 
(FTH)-tagged RtcB.  RtcB-RNA complexes were purified from bacterial lysates using anti-FLAG 
antibodies, followed by TEV protease cleavage to remove the complexes from the anti-FLAG resin.  
RNA was trimmed with an RNase cocktail, radioactively labelled and barcoded linkers were ligated.  
Further His6-tag purification on nickel beads was conducted and RtcB-RNA complexes were resolved 
by SDS-PAGE then transferred to a nitrocellulose membrane and visualised by autoradiography.  The 
smear, which comprises RtcB complexed with RNAs of differing length, were cut from the membrane 
and protease-treated, leaving RNA.  cDNA was synthesised by reverse transcription and amplified by 
PCR, using linker-specific primers.  The resulting cDNA library was deep sequenced using the 
Illumina platform.  (B) Western blot analysis of FTH-RtcB expression.  Samples were collected 
following induction of RtcB and treatment with chloramphenicol or MazF expression, resolved by 
SDS–PAGE, transferred to a PVDF membrane and RtcB was detected with anti-His antibodies.  (C) 
Autoradiogram of purified RtcB-RNA complexes.  Regions indicated by white dashed boxes were cut 
from the membrane and RNA isolated.  (D) Agarose gel electrophoresis of amplified cDNA.  Regions 
indicated by white dashed boxes were cut from the gel and purified, creating cDNA libraries.  ‘RtcB’ 
is MG1655ΔrtcB/pKW220rtcB, ‘+Cml’ is MG1655ΔrtcB/pKW220rtcB treated with chloramphenicol, 
‘+MazF’ is MG1655ΔrtcB/pKW220rtcB/pSC3326 and ‘Control’ is MG1655ΔrtcB/pKW220. 
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the column used during the CRAC protocol.  Generally, these represented the most abundant 
RNAs in the cell, including rRNA, some tRNAs and mRNA encoding highly expressed 
proteins.  Visual inspection of the peak profiles of the RtcB, +Cml and +MazF samples 
compared with the control identified significant enrichment of 93 RNAs in samples 
expressing RtcB.  Figure 32A illustrates that the majority of these increased in all three 
samples, while twelve were specific to the +Cml sample, +MazF sample or both and therefore 
represented targets of potential biological relevance. 
To gain an overall impression of the RNAs interacting with RtcB, the RNA types and 
functional groupings in the +Cml and/or +MazF only samples were compared to the whole 
RtcB data set.  As Figure 32B shows, the 93 RNAs found to be enriched in any RtcB-
containing sample were largely tRNAs, followed by mRNAs and rRNAs.  Accordingly, over 
75% of these RNAs were involved in translation, encoding tRNA, rRNA, ribosomal proteins 
or global regulators of translation (Figure 32C).  In contrast, the majority of +Cml- and/or 
+MazF-specific RNAs were mRNAs, while the remainder were small (s)RNAs (Figure 32B).  
Those involved in translation (59%) represented a smaller proportion compared with the total 
RtcB data set (Figure 32C).  A quarter had functional roles in metabolism and the rest were 
involved in transport or stress response.  
Rather than the non-coding RNA species that dominated the data set as a whole, RNAs 
involved in translation that were increased in the +Cml and/or +MazF samples only were all 
mRNAs encoding 50S or 30S ribosomal subunit proteins.  These accounted for seven of the 
twelve +Cml- and/or +MazF-specific RNAs interacting with RtcB.  The peak profiles of 
sequencing reads from RtcB CRAC revealed enrichment of rplL, rplD and rplM mRNAs, 
which encode L12, L4 and L13 proteins of the 50S subunit respectively, in both +Cml and 
+MazF samples (Figure 33A-C).  Enrichment of rpmA mRNA, encoding 50S protein L27, 
was most significant in the +MazF sample, while rplU mRNA, encoding 50S protein L21, 
was most enriched in the +Cml sample (Figure 33D and E).  CRAC of RtcB also revealed 
enrichment of rpsB and rpsJ mRNA, which encode 30S ribosomal subunit proteins S2 and 
S10 (also known as NusE) respectively, in the +Cml sample only (Figure 34A and B). 
The peak profiles for the remaining five RNAs found in +Cml and/or +MazF samples only 
are shown in Figure 35 and include two sRNAs, gcvB and glmY, which have regulatory 
functions in expression of amino acid transporters and an enzyme involved in hexosamine 
biosynthesis respectively.  Enrichment of gcvB sRNA by RtcB was observed in both +Cml 
and +MazF samples, whereas glmY sRNA was specific to +MazF.  Further, RtcB enriched 
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ilvL mRNA, encoding the leader peptide of the ilv operon, rraA mRNA, encoding an inhibitor 
of RNase E, and mazF mRNA in the +MazF sample only.  The results of CRAC of RtcB are 
summarised in Table 7. 
 
Table 7  Summary of RNAs identified by CRAC of RtcB during chloramphenicol 
treatment or MazF expression or both. 
Gene RNA type 
Functional 
classification 
 
Function 
 
Sample(s) 
rplL mRNA 
 
Translation 
 
50S ribosomal protein L7/12 
+Cml 
+MazF 
rplD mRNA 
 
Translation 
 
50S ribosomal protein L4 
+Cml 
+MazF 
rplM mRNA 
 
Translation 
 
50S ribosomal protein L13 
+Cml 
+MazF 
rpmA mRNA 
 
Translation 
 
50S ribosomal protein L27 
+MazF 
(+Cml) 
rplU mRNA 
 
Translation 
 
50S ribosomal protein L21 
+Cml 
(+MazF) 
rpsB mRNA 
 
Translation 
 
30S ribosomal protein S2 +Cml 
rpsJ mRNA Translation 
30S ribosomal protein S10 or 
ribosome-independent transcription 
termination regulator NusE 
+Cml 
gcvB sRNA Transport 
Regulates expression of amino acid 
transporters DppA, CycA SstT and 
others 
+Cml 
+MazF 
glmY sRNA Metabolism 
Regulates expression of glucosamine-
6-phosphate synthase involved in 
hexosamine biosynthesis 
+MazF 
ilvL mRNA Metabolism 
Leader peptide of ilv operon, 
encoding enzymes for valine and 
isoleucine biosynthesis 
+MazF 
rraA mRNA 
 
Metabolism 
 
Inhibitor of RNase E +MazF 
mazF mRNA 
 
Stress response 
 
Ribosome-independent sequence-
specific endoribonuclease 
+MazF 
(The ‘RNA type’, ‘Functional classification’ and ‘function’ was obtained from the EcoCyc database 
(Keseler et al., 2011).) 
  
122 
 
 
 
 
Figure 32  Overview of interactions between RtcB and RNAs identified by CRAC. 
(A) Venn diagram showing the number of RNAs significantly enriched in samples from E. coli 
MG1655ΔrtcB carrying pKW220rtcB (RtcB), MG1655ΔrtcB carrying pKW220rtcB and treated with 
chloramphenicol (+Cml) and MG1655ΔrtcB carrying pKW220rtcB and pSC3326 (+MazF) compared 
to MG1655ΔrtcB carrying pKW220 (corresponding empty plasmid).  (B) Pie charts illustrating the 
type of RNAs enriched in the total RtcB data set (total) and in those specific to chloramphenicol- 
and/or MazF-treated samples (+Cml and +MazF).  (C) Pie charts illustrating the functional 
classification of RNAs enriched in the total RtcB data set (total) and in those specific to 
chloramphenicol- and/or MazF-treated samples (+Cml and +MazF).  RNA types and functional 
classifications were obtained from the EcoCyc database (Keseler et al., 2011). 
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As described in Chapter 4, MazF specifically cleaves RNA at single-stranded ACA sites 
(Zhang et al., 2003).  The position of ACA sites in the RNAs found to crosslink RtcB in +Cml 
and/or +MazF samples only were mapped and are indicated on the X-axis of the profiles of 
sequencing reads by red arrows (Figure 33 to Figure 35).   
5.2.1.3 RNAs identified by CRAC are unaffected by deletion of rtcB 
To investigate whether RtcB functions in the repair of crosslinked RNAs specifically 
identified in the +Cml and/or +MazF samples, the relative levels of each RNA were compared 
by qPCR analysis in E. coli strains MG1655 and MG1655ΔrtcB following 30 minutes of 
chloramphenicol treatment or MazF expression as appropriate.   
Figure 36A shows the levels of rtcB, rtcA and eight RNAs found to be enriched by RtcB in 
the +Cml CRAC sample, rplL, rplD, rplM, rpmA, rplU, rpsB, rpsJ and gcvB, after 
chloramphenicol treatment.  In accordance with data shown in Chapter 4, levels of both rtcB 
and rtcA mRNA increased by approximately six-fold and as expected, rtcB transcripts were 
only detectable in MG1655 and not in the isogenic rtcB deletion strain, while rtcA was 
unaffected by deletion of rtcB.  The levels of rplL, rplD, rplM, rpmA, rplU, rpsB, rpsJ and 
gcvB RNA also increased in the chloramphenicol-treated samples compared to untreated.  
Moreover, there was no difference between the wild-type and rtcB deletion strains in treated 
and untreated conditions respectively, indicating that the presence or absence of RtcB had no 
effect on the stability of the RNAs during chloramphenicol treatment.   
qPCR analyses during MazF expression of rtcB, rtcA and RNAs enriched in the +MazF 
CRAC sample, including rplL, rplD, rplM, rpmA, rplU, gcvB, glmY, ilvL and rraA, are shown 
in Figure 36B.  Consistent with previous results, MazF expression produced a five-fold 
increase in rtcB transcript levels in wild-type cells.  Similar levels of rtcA were detectable in 
wild-type and rtcB deletion strains.  With the exception of rplD and rplM mRNA, MazF 
expression resulted in elevated levels of each RNA, suggesting they were not targets of MazF 
degradation.  Levels of rplD and rplM transcripts decreased in the presence of MazF, 
indicating that these mRNAs may be cleaved by MazF.  However, as observed for the RNAs 
tested during chloramphenicol treatment, in all cases the RNA levels were unchanged in the 
rtcB deletion strain during MazF expression, which suggests that RtcB is not involved in 
maintaining the stability of these RNAs. 
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Figure 33  Interactions between RtcB and RNAs encoding 50S ribosome proteins in E. 
coli. 
Enrichment of rplL (A), rplD (B), rplM (C), rplU (D) and rpmA (E) RNA by CRAC analysis of RtcB.  
Profiles are shown for RNA obtained from: E. coli MG1655ΔrtcB carrying pKW220rtcB (RtcB); the 
same strain treated with chloramphenicol (+Cml); E. coli MG1655 ΔrtcB carrying pKW220rtcB and 
pSC3326 (+MazF) and E. coli MG1655 ΔrtcB carrying pKW220 (control).  Note the changes in scale 
of the X- and Y-axes for parts (A) to (E).  The location of potential MazF cleavage sites are indicated 
on the X-axis (red arrow).  Primer annealing sites used for qPCR analysis (Figure 36) are indicated 
where appropriate (blue arrows).  
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Figure 34  Interactions between RtcB and RNA encoding 30S ribosome proteins in E. 
coli. 
Enrichment of rpsB (A) and rpsJ (B) RNA by CRAC analysis of RtcB.  Profiles are shown for E. coli 
MG1655ΔrtcB carrying pKW220rtcB (RtcB), the same strain treated with chloramphenicol (+Cml), E. 
coli MG1655 ΔrtcB carrying pKW220rtcB and pSC3326 (+MazF) and E. coli MG1655 ΔrtcB 
carrying pKW220 (control).  Note the changes in scale of the X- and Y-axes for parts (A) and (B).  
The location of potential MazF cleavage sites are indicated on the X-axis (red arrow).  Primer 
annealing sites used for qPCR analysis (Figure 36) are indicated where appropriate (blue arrows). 
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Figure 35  Other interactions between RtcB and RNA in E. coli.. 
Enrichment of gcvB (A) and glmY (B) regulatory sRNAs and ilvL (C), rraA (D) and mazF (E) mRNAs 
by CRAC analysis of RtcB.  Profiles are shown for E. coli MG1655ΔrtcB carrying pKW220rtcB 
(RtcB), the same strain treated with chloramphenicol (+Cml), E. coli MG1655 ΔrtcB carrying 
pKW220rtcB and pSC3326 (+MazF) and E. coli MG1655 ΔrtcB carrying pKW220 (control).  Note 
the changes in scale of the X- and Y-axes for parts (A) to (E).  The location of potential MazF 
cleavage sites are indicated on the X-axis (red arrow).  Primer annealing sites used for qPCR analysis 
(Figure 36) are indicated where appropriate (blue arrows). 
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Figure 36  Stability of RNAs crosslinked to RtcB are unchanged upon deletion of rtcB. 
(A) E. coli strains MG1655 and MG1655ΔrtcB were grown exponentially in LB medium then treated 
with 50 µg/ml chloramphenicol (cml) for 30 minutes.  RNA was extracted from each sample, reverse 
transcribed and the fold change in transcript levels of rtcB, rtcA and eight genes found to be enriched 
by CRAC of RtcB during chloramphenicol treatment (rplL, rplD, rplM, rpmA, rplU, rpsB, rpsJ and 
gcvB) were determined by qPCR, relative to untreated MG1655.  qPCR data were analysed using the 
Pfaffl method and normalised against the tatA gene.  Data from two independent experiments are 
shown as the mean relative fold change ± standard deviation.  (B) E. coli MG1655 and MG1655ΔrtcB 
carrying pSC3326 (MazF) or pBAD33 (corresponding empty plasmid) were grown exponentially in 
LB medium supplemented with 50 µg/ml chloramphenicol and toxin expression was induced for 30 
minutes with 0.2% arabinose.  RNA was extracted from each sample, reverse transcribed and the fold 
change in transcript levels of rtcB, rtcA and nine genes found to be enriched by CRAC of RtcB during 
MazF expression (rplL, rplD, rplM, rpmA, rplU, gcvB, glmY, ilvL and rraA) were determined by 
qPCR, relative to MG1655/pBAD33.  qPCR data were analysed as described for (A).  Primer 
annealing sites for rplL, rplD, rplM, rpmA, rplU, rpsB, rpsJ, gcvB, glmY, ilvL and rraA used for qPCR 
analysis are indicated in Figure 33 to Figure 35 (blue arrows). 
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5.2.2 No evidence for regulation of ribosomal RNA by RtcB 
5.2.2.1 RtcB does not influence rRNA levels in standard conditions 
CRAC of RtcB revealed a high coverage of reads across all rRNAs, including in the control 
sample, which was interpreted as non-specific enrichment of highly prevalent RNA species in 
the experiment (data not shown).  The few enriched areas in rRNAs that did not have 
equivalent peaks in the control were present in all three RtcB samples (RtcB, +Cml and 
+MazF).  Because they were not specific to samples subjected to stress conditions found to 
increase rtcB transcription, they were considered to arise from non-specific interactions 
between overexpressed RtcB and RNA and therefore not considered biologically relevant. 
However, Engl et al. (2016) recently proposed a function for RtcB in ribosome homeostasis 
that is operational in standard growth conditions.  In view of this, the levels of 23S, 16S and 
5S rRNA were assessed by qPCR in exponentially-growing E. coli MG1655 and 
MG1655ΔrtcB without any exogenous stress.  Contrary to the findings of a similar 
experiment by Engl et al. (2016), no difference was detected in rRNA stability between wild-
type cells and those lacking rtcB (Figure 37). 
5.2.2.2 RtcB does not repair rRNA following amino acid starvation 
Ribosomal RNA is known to be degraded under various conditions of nutrient deprivation 
(Sulthana et al., 2016; Zundel et al., 2009).  In collaboration with the Sørensen lab, University 
of Copenhagen, the role of RtcB in recovery of bacterial growth after a period of amino acid 
starvation was investigated.  The Sørensen group previously observed a rapid reduction in 
levels of 23S and 16S rRNA during isoleucine starvation, while 5S rRNA remained stable 
(unpublished observations).  Moreover, once starvation was terminated, they found that the 
rate of bacterial growth quickly recovered.   
Therefore, it was hypothesised that RtcB may repair rRNA in order to allow rapid recovery of 
growth when isoleucine became plentiful.  To explore this idea, E. coli MG1655 and 
MG1655ΔrtcB were cultured in minimal media and isoleucine starvation was induced by the 
addition of valine.  After 80 minutes, cultures were re-fed with isoleucine to end amino acid 
starvation.  As expected, the growth of the wild-type strain was inhibited upon isoleucine  
  
129 
 
 
 
 
 
 
 
 
Figure 37  Stability of rRNA is unchanged upon deletion of rtcB. 
E. coli strains MG1655 and MG1655ΔrtcB were grown exponentially in LB medium.  RNA was 
extracted from each sample, reverse transcribed and the fold change in levels of 23S rRNA, 16S rRNA 
and 5S rRNA in the rtcB deletion relative to wild-type MG1655 were determined by qPCR.  qPCR 
data were analysed using the Pfaffl method and normalized against the tatA gene.  Data from three 
independent experiments are shown as the mean relative fold change ± standard deviation.   
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starvation and quickly resumed when starvation was terminated.  However, the same pattern 
of growth was also observed in the strain lacking rtcB (data not shown).  Further, Northern 
blot analysis of 23S and 16S rRNA at regular intervals throughout the experiment revealed 
that levels of rRNA were the same at equivalent time points in wild-type and rtcB deletion 
strains (data not shown; conducted by Dr Michael Sørensen and Mrs Marit Warrer, University 
of Copenhagen).  Thus, RtcB does not appear to mediate rRNA repair during or after amino 
acid starvation. 
 Discussion 5.3
In this chapter, we investigated the hypothesis that MazF induction activates RtcB-mediated 
RNA repair processes in the cell using an RNA-protein crosslinking and deep sequencing 
approach known as CRAC, with the aim of further elucidating the function of RtcB in E. coli.  
This hypothesis was based on the finding that rtcB mRNA levels increased upon MazF 
expression (Chapter 4) and the knowledge that MazF cleavage yields suitable terminals for 
RNA ligation by RtcB (Tanaka and Shuman, 2011; Zhang et al., 2005).  Chloramphenicol 
treatment was included in the analysis because it was also found to increase transcription of 
rtcB (Chapter 4).  Aside from targeting 23S rRNA (Schlunzen et al., 2001), chloramphenicol 
is known to have secondary effects on cell physiology as a result of translation inhibition, 
such as induction of rRNA and tRNA synthesis (Shen and Bremer, 1977; Svenningsen et al., 
2017), transcription of genes encoding ribosomal proteins (Dennis, 1976) and stimulation of 
toxin activity including MazF (Sat et al., 2001).  We therefore reasoned that the cellular 
changes brought about by chloramphenicol may be interesting with respect to possible 
activities for RtcB. 
CRAC of four samples was conducted, namely RtcB expression alone from a plasmid (RtcB), 
RtcB expression with chloramphenicol treatment (+Cml), RtcB expression with induction of 
mazF (+MazF) and a control lacking RtcB.  Overall, there was an abundance of reads in all 
four samples mapping across the E. coli genome.  The majority of these reads belonged to 
highly abundant rRNA and tRNA species and were also highly enriched in the control 
sample, indicating that a shortcoming of the experiment is bias towards detection of highly 
transcribed RNAs.  Visual analysis led to the identification of 93 RNAs that were 
significantly enriched in RtcB-containing samples compared to the control.  Most were 
crosslinked to RtcB in the absence of MazF- or chloramphenicol-induced stress, when 
chromosomal rtcB expression is normally very low (Chapters 3 and 4), including many 
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tRNAs and mRNAs encoding highly prevalent proteins such as elongation factor Tu and acyl 
carrier protein.  This could suggest that RtcB is capable of interacting with many RNAs in the 
cell and has a broad substrate range, curtailed by the conditions in which it is actively 
expressed combined with its requirement for a 2ʹ,3ʹ-cyclic phosphate or 3ʹ-phosphate RNA 
terminal and a 5ʹ-hydroxyl RNA terminal.  Another possibility is that abundant RNAs 
transiently and non-specifically interact with overexpressed RtcB in the experiment and do 
not represent a genuine physiological interaction.  As CRAC analysis of other proteins 
expressed from plasmids have also revealed crosslinking with highly prevalent RNA species, 
this supports the latter suggestion (Gerdes group, unpublished observations).  Further, the 
enrichment of mazF mRNA in the +MazF sample may also indicate that RNA abundancy 
influences crosslinking with RtcB. 
Aside from mazF mRNA, 11 other RNA hits were specific to +MazF and/or +Cml conditions 
and thus deemed to be of potential biological relevance based on the induction of rtcB 
observed in these conditions.  Interestingly, the majority of mRNAs identified encoded 
ribosomal proteins, supporting a link between RtcB and the translation apparatus, as indicated 
in Chapter 4.  While interactions with non-coding RNAs dominated the data set as a whole, 
only two were specific to the +MazF and/or +Cml samples, namely the regulatory sRNAs 
gcvB and glmY.  In addition to a σ70–regulated promoter, transcription of glmY is known to 
occur from a σ54-dependent promoter (Gopel et al., 2011), suggesting a possible regulatory 
link with rtcB.  Mapping of ACA sites in the ORFs of the candidate RNAs in the +MazF 
sample revealed an apparent correlation between a lack of read coverage and the presence of a 
potential MazF cleavage site, indicating that RtcB may crosslink RNA fragments produced by 
MazF cleavage, which would support the hypothesis that RtcB ligates MazF-cleaved RNA.  
However, similar correlations can be observed in the +Cml sample, including those that are 
not highly enriched in the +MazF sample, and also in the smaller peaks in RtcB only and 
control samples.  As the same peak profiles are largely observed in all samples, this could 
suggest that these regions may instead be the preferred sites for the RNase cocktail used to 
trim crosslinked RNAs in the CRAC protocol.  In order to clarify which, if any, of the ACA 
sites are cleaved by MazF and are thus available for RtcB-mediated repair, an examination of 
the secondary structure of the relevant RNAs would be necessary, as only single-stranded 
ACA regions are suitable targets for MazF (Zhang et al., 2003), and could be confirmed by 
primer extension.   
To establish whether RtcB influences the stability of the candidate RNA targets identified by 
CRAC, qPCR analysis was used to assess the levels of each in rtcB deletion strains with and 
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without MazF expression or chloramphenicol treatment relative to untreated wild-type cells.  
No difference was detected between the levels of the candidate RNAs in wild-type and rtcB 
deletion strains, suggesting that RtcB is not involved in repair of these RNAs in the conditions 
tested.  In addition, in most cases the RNA levels were increased upon MazF expression or 
chloramphenicol treatment, indicating that these RNA were unlikely to be degraded by MazF 
cleavage or as a result of chloramphenicol-mediated translation inhibition and like rtcB are 
more prevalent in these conditions.  As some of the hits found, specifically rplL and ilvL, are 
part of the MazF regulon as reported by Sauert et al. (2016), this provides an explanation for 
the observed increase in these RNAs in the +MazF sample and could suggest that RtcB 
repairs these leaderless RNAs to restore canonical translation.  Owing to the position of the 
primers used for qPCR analysis (see Figure 33 to Figure 35), a role for RtcB in this context 
would likely be missed by this experiment and therefore qPCR analysis using primers that 
flank the 5ʹ untranslated region, where MazF reportedly processes mRNAs for selective 
translation by the stress ribosome (Vesper et al., 2011), may represent a possible avenue for 
further investigation of these candidates.  Alternatively, the increased abundance of these 
RNAs during MazF expression could indicate a non-specific interaction with RtcB, as 
observed with abundant RNAs in the RtcB alone sample and indicated by the identification of 
mazF mRNA in the +MazF sample.  The same explanation could also apply to the 
chloramphenicol-treated sample.  Accordingly, increased transcription of ribosomal proteins 
is known to occur during chloramphenicol treatment (Dennis, 1976).  Moreover, there was no 
detectable enrichment of reads in the +MazF sample in the vicinity of the MazF cleavage site 
in 16S rRNA, which removes the anti-SD sequence and generates the stress ribosome (Vesper 
et al., 2011).  As RtcB has been demonstrated to be capable of repairing this cleavage site and 
is postulated to mediate recovery as part of a post-MazF stress response (Temmel et al., 
2016), this may indicate that the experimental setup is not sufficiently sensitive to detect this 
interaction or that owing to the enrichment of reads across rRNAs in general, any specific 
interactions were masked.  Therefore, the approach undertaken here to identify and verify 
candidate RNA substrates of RtcB by CRAC and qPCR is inconclusive with regard to the 
hypothesis that RtcB mediates repair of MazF-cleaved RNAs and a role for RtcB during 
chloramphenicol treatment also remains unclear. 
We also investigated the levels of rRNA during growth of E. coli in standard laboratory 
conditions, to ascertain whether low levels of rtcB transcription in the absence of an activating 
signal might have a role in maintaining rRNA stability.  In contrast to Engl et al. (2016), who 
recently characterised a role for RtcB in rRNA homeostasis, there was no marked difference 
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observed in the levels of 23S, 16S or 5S rRNA under standard growth conditions.  The reason 
for this discrepancy is unclear, but supports the finding that the rtcBA operon is non-essential 
for growth in standard conditions (this study; Genschik et al., 1998; Temmel et al., 2016).   
A role for RtcB in rRNA repair following degradation during amino acid starvation was also 
investigated in collaboration with the Sørensen group, University of Copenhagen.  E. coli 
MG1655 was found to rapidly resume bacterial growth upon termination of amino acid 
starvation.  However, this was not found to be due to RtcB-mediated repair of rRNA degraded 
during starvation (not shown). 
In summary, we have attempted to learn more about the in vivo function of RtcB in E. coli by 
employing CRAC to identify potential RNA substrates of RtcB using conditions found to 
increase rtcB transcription in Chapter 4.  However, the outcomes were largely inconclusive, 
with qPCR analysis of the candidate RNAs specific to the MazF- or chloramphenicol-treated 
samples revealing there was no difference in stability upon rtcB deletion.  The high 
enrichment of reads in rRNA and tRNA genes in the untreated RtcB and control CRAC 
samples raises the possibility that non-specific interactions may mask genuine interactions in 
biologically relevant conditions.  In addition, we were unable to detect any difference in 
rRNA levels in the absence of RtcB in standard conditions or during amino acid starvation.  
Therefore, based on the analyses conducted here, the biological function of RtcB remains 
elusive. 
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Chapter 6 Summary and perspectives 
 
In this study, we have confirmed that σ54-dependent transcription of rtcBA proceeds in an 
RtcR-dependent manner in E. coli K-12.  Using a series of transcriptional rtcBA-lacZ fusions, 
a potential RtcR binding region has been uncovered, which is centred at -144 relative to the 
transcription start site  The region, termed rtcO, includes an IR sequence of ATATC-N12-
GATAT.  Mutation of the IR indicates that it forms part of an RtcR UAS but that additional 
bases or UASs may also contribute to RtcR binding.  In addition, a requirement for IHF in 
σ54-dependent transcription of rtcBA has been established and found to be mediated in a 
DNA-dependent manner via interaction with at least one of the IHF binding sites in the rtcBA 
promoter.  Investigation into the regulation of the bEBP RtcR has revealed the minimum 
promoter region necessary for rtcR transcription, which appears to be regulated by σ70-
associated RNAP.  A possible autoregulatory feedback loop for rtcR transcription has also 
been identified by which RtcR is postulated to maintain constant and relatively low levels, 
possibly by binding to rtcO, which overlaps the likely rtcR promoter region.  These findings 
have contributed to the characterisation of rtcBA regulation by the σ54-dependent promoter 
and are consistent with the known features of transcription by σ54-associated RNAP (Bush 
and Dixon, 2012; Shingler, 2010).  However, in searching for conditions where rtcBA 
transcription was activated, a more complex system of regulation for rtcBA was revealed, as a 
number of RtcR- and σ54-independent conditions were identified.  Therefore, it appears that 
rtcBA transcription may be activated from both σ54- and σ70-dependent promoters.  
Characterising the potential σ70-regulated promoter and identifying the different stimuli for 
activation of the σ54- and σ70-dependent promoters would further contribute to our 
understanding of rtcBA regulation in E. coli and may be applicable to other bacteria with an 
rtcBA-rtcR locus. 
We have found no evidence to suggest that rtcBA is necessary for the growth of E. coli in 
standard laboratory conditions.  This is in contrast to a recent publication that shows a growth 
phenotype associated with deletion of rtcBA and suggests that the rtcBA operon is involved in 
ribosome homeostasis (Engl et al., 2016).  In this study, deletion of the rtcBAR genes had no 
effect on the growth rate of E. coli, which is supported by the findings of others (Genschik et 
al., 1998; Temmel et al., 2016) and qPCR analysis and lacZ fusion data suggest that levels of 
rtcBA transcription are very low in the absence of activating conditions and/or activated RtcR.  
Furthermore, rRNA stability was found to be unaffected by deletion of rtcB.  In view of this, 
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rtcBA was considered to be induced in response to stress and we searched for cellular 
conditions that activated rtcBA transcription.   
Genetic screening resulted in the identification of an activator of rtcBA.  Expression of Rof, 
an inhibitor of Rho transcription termination, was found to induce transcription of rtcBA in an 
RtcR-dependent manner, suggesting that RtcB may have a role during dysregulated 
transcription termination.  The function of RtcB in this context is unclear and the signal that 
induces the CARF-like regulatory domain of RtcR during expression of Rof is unknown 
(Makarova et al., 2014).  Little is known about the conditions in which Rof inhibits Rho 
activity (Gutierrrez et al., 2007; Pichoff et al., 1998), thus investigation into the regulation of 
rof may enable further characterisation of this phenotype.  The levels of rtcBA were also 
found to increase in response to a variety of challenges to the translation apparatus, suggesting 
that rtcBA may respond to the translational status of the cell.  This was further investigated 
using CRAC to identify RNA substrates for RtcB in vivo during expression of the 
endoribonuclease MazF and treatment with the 23S rRNA inhibitor chloramphenicol.  
Although 12 candidate RNAs were identified in these conditions, it is not clear whether they 
represent biologically relevant targets of RtcB as their levels were unaffected by the absence 
of rtcB.  The function of RtcB in these conditions and during Rof expression could be further 
analysed by optimising the CRAC protocol.  For example, chromosomal rtcB could be FTH-
tagged to allow expression to be regulated naturally and more robust controls could be used, 
including an RtcB variant with defective RNA binding (Englert et al., 2012; Maughan and 
Shuman, 2016).  Alternatively, a different approach could be employed such as RNA-Seq, to 
analyse global changes in the transcriptome in relevant conditions in the presence and absence 
of RtcB. 
In summary, here we have characterised the regulation of bacterial rtcB in the context of the 
σ54-dependent rtcBA operon of E. coli.  We have located a novel DNA element, rtcO, 
confirmed and identified essential regulatory roles for RtcR and IHF respectively and 
discovered a potential negative feedback mechanism for rtcR transcription.  Furthermore, we 
have identified several conditions in which rtcBA transcription is activated in vivo, including 
expression of the Rho inhibitory protein Rof and exposure to several agents that target 
translation, for example MazF and chloramphenicol.  Recent publications by Engl et al. 
(2016) and Temmel et al. (2016) regarding the function of RtcB in E. coli complement the 
findings presented in this study.  In particular, Engl et al. (2016) also observed induction of 
rtcBA when translation was impaired by various agents and genetic lesions, while Temmel et 
al. (2016) characterised a role for RtcB in the repair of 16S rRNA during the MazF stress 
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response.  Together with our data, this indicates that RtcB functions in repair processes in a 
variety of cellular stresses in E. coli.  The current state of knowledge regarding the regulation 
and function of RtcB in E. coli is summarised in Figure 38.   
As the only bacterial RtcB to be functionally characterised to date, E. coli RtcB provides the 
first indication into the role of this family of proteins in bacteria, as previously described 
functions in archaea and eukaryotes in tRNA maturation (Popow et al., 2011) and the UPR 
(Lu et al., 2014) are not relevant to bacteria.  Owing to the conservation of the rtcBA-rtcR 
locus across four phyla, the regulatory and functional characteristics of E. coli RtcB may be 
applicable to other bacteria.  However, the identification of RtcB paralogues in M. xanthus 
with distinct RNA ligase, DNA ligase and DNA capping efficiencies in vitro (Maughan and 
Shuman, 2015), combined with the coevolution of RtcB with archease, a cofactor known to 
enhance the in vitro activity of RtcB, in some bacteria (Desai et al., 2015) suggests that 
characterisation of RtcB from multiple bacterial species would be beneficial.  It also appears 
that RtcB has at least one more function in eukaryotes, as a role for RtcB in inhibition of axon 
regeneration in C. elegans was found to be independent of tRNA maturation and the UPR 
(Kosmaczewski et al., 2015).  Therefore, while considerable progress has been made in 
defining the in vitro and in vivo activity of RtcB in recent years, further investigation may 
contribute to a greater understanding of the spectrum of biological functions of RtcB and the 
regulatory mechanisms governing its activity in organisms from all domains of life.   
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Figure 38  Overview of the regulation and function of the rtcBA operon of E. coli. 
Transcription of rtcBA by σ54-associated RNA polymerase binding at the -12/-24 promoter elements is 
initiated via interaction with activated RtcR.  RtcR is expressed from a σ70 family-dependent promoter 
and binds to upstream activating sequence rtcO, as indicated, which may mediate negative 
autoregulation of rtcR transcription.  The CARF-like regulatory domain of RtcR is activated by as yet 
undetermined signals (red star), derepressing the central ATPase domain of RtcR.  Interaction between 
σ54 and the ATPase domain is facilitated by IHF-induced DNA bending from the IHF binding region 
(ihf1 and ihf2), as indicated (curved arrow).  This results in transcription of rtcB from +1.  RtcB then 
mediates a range of cellular processes, as indicated, via its RNA ligase and possibly DNA ligase or 
capping activities. 
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Appendix A 
 
 
Levels of rtcB mRNA increase during chloramphenicol treatment (continued). 
E. coli MG1655 was grown exponentially in LB medium then treated with 50 µg/ml chloramphenicol 
(cml) for 30 minutes.  RNA was extracted from each sample, reverse transcribed and the fold change 
in transcript levels of rtcB relative to untreated MG1655 (-) was determined by qPCR.  qPCR data 
were analysed using the Pfaffl method and normalised against the gyrA and rpoB genes as indicated.  
Data from three independent experiments are shown as the mean relative fold change ± standard 
deviation. 
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Appendix B 
 
 
Levels of rtcB mRNA increase during MazF expression (continued). 
E. coli MG1655 carrying carrying pSC3326 was grown exponentially in LB medium then expression 
of MazF was induced with 0.2% arabinose for 30 minutes.  RNA was extracted from each sample, 
reverse transcribed and the fold change in transcript levels of rtcB relative to MG1655 carrying empty 
pBAD33 (-) was determined by qPCR.  qPCR data were analysed using the Pfaffl method and 
normalised against the tus and gyrA genes as indicated.  Data from three independent experiments are 
shown as the mean relative fold change ± standard deviation. 
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